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The generation of migratory cells from immotile precursors occurs frequently throughout 
development and is crucial to the formation and maintenance of a functioning organism. 
This phenomenon, called an epithelial-to-mesenchymal transition (EMT), involves the 
disassembly of intercellular adhesions and cytoskeletal rearrangements in order to promote 
migration. Importantly, aberrant EMTs and cell migration can lead to devastating human 
conditions including cancer metastasis and fibrosis. How cells accomplish EMT to become 
migratory is still an unanswered question in the biomedical field. To this end, we use chick 
neural crest cells as an in vivo model to elucidate the molecules and pathways that regulate 
EMT and migration. Neural crest cells are a population of embryonic cells that are 
originally stationary within the dorsal neural tube but later migrate to form a variety of 
adult derivatives, such as the craniofacial skeleton, skin pigment cells and portions of the 
heart. To facilitate EMT, chick premigratory neural crest cells lose intercellular contacts 
mediated, in part, by the transmembrane cell adhesion protein Cadherin-6B (Cad6B). 
While Cad6B mRNA is transcriptionally repressed in premigratory neural crest cells, loss 
of Cad6B protein does not directly follow and instead occurs ~90 minutes later, just prior 
to migration. This rapid depletion of Cad6B is all the more striking given that the half-life 
of most cadherins, including Cad6B, is ~6-8 hours in vitro. As such, unique post-
 
 
translational mechanisms must exist to remove Cad6B from premigratory neural crest cell 
plasma membranes to facilitate neural crest EMT. Since cadherins are known to be 
downregulated through internalization mechanisms (e.g., endocytosis, macropinocytosis) 
in other in vitro systems, the hypothesis of this dissertation is that Cad6B is internalized, 
and that this process plays a critical function to enable neural crest EMT. To this end, we 
document the existence of Cad6B cytoplasmic puncta in cultured cells, cultured neural 
crest cells and transverse sections of chick embryos. We subsequently identified a p120-
catenin binding motif in the Cad6B cytoplasmic tail and demonstrated its functionality 
through site-directed mutagenesis, revealing a role in enhancing Cad6B internalization and 
reducing the stability of membrane-bound Cad6B. Furthermore, we uncover for the first 
time that Cad6B is removed from premigratory cranial neural crest cells through cell 
surface internalization events that include clathrin-mediated endocytosis and 
macropinocytosis. Both of these processes are dependent upon the function of dynamin, 
and inhibition of Cad6B internalization abrogates neural crest cell EMT and migration. 
Collectively, our findings provide a molecular blueprint for how cadherins are dynamically 
regulated during the formation of migratory cell types required for normal embryonic 
development and tissue repair as well as those generated during human diseases and 
cancers. Importantly, our research is multi-disciplinary, integrating cell biology and 
physiology to reveal how a cellular event, the active downregulation of a membrane 
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Parts of this Introduction were adapted from the following published book chapter: 
Taneyhill LA and Padmanabhan R. (2013) 
Chapter 3: The Cell Biology of Neural Crest Cell Delamination and EMT (pp. 51-66). 
In: Neural Crest Cells: Evolution, Development and Disease. Edited by P. Trainor. 








1.1. The Neural Crest: An Overview 
Neural crest cells are an embryonic, multipotent cell population that played a crucial role 
in vertebrate evolution. It is thought that William His discovered neural crest cells in 1868, 
but the actual term was later coined by Arthur Milnes Marshall in line with the anatomical 
origins of these cells (Hall, 2008). Neural crest cells have been a subject of fascination for 
embryologists and cell biologists and have been used to investigate embryonic cell 
induction, specification, commitment, delamination, migration, cell fate determination. 
Neural crest cells are also known as the fourth germ layer, considering the wide range of 
adult derivatives that arise from these cells: neurons and glia of sensory, autonomic and 
enteric ganglia, smooth muscle cells, melanocytes, medullary secretory cells, and bone and 
cartilage cells. For this reason and the fact that they possess some regenerative capacity, 
neural crest cells have been considered for use for stem cell-based therapies (Crane and 
Trainor, 2006).  
Apart from their multipotency, the appearance of neural crest cells is synonymous 
with the appearance and evolution of vertebrates. The transition from protochordate body 
to a vertebrate body plan has been associated with an increasing ability to actively acquire 
food. The primitive chordates, including the cephalochordates and urochordates, were filter 
feeders that fed by taking in water through a primitive, non-muscularized ciliated pharynx 
and filtered whatever food particles came through it (Hall, 2009; Douarin NM, 2014). The 
shift from passive filter feeders to active predation (vertebrates) required several features, 
including a muscularized pharynx to push food (which later led to the development of jaws 
and the craniofacial skeleton), ectodermal placodes (to sense food in different aspects, such 
as smell, sight and sound, and a brain to integrate these signals), and pharyngeal breathing 
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characterized by gill capillaries. Of these vertebrate innovations, neural crest cells were 
responsible for the evolution of a muscularized pharynx and nervous systems to integrate 
placodal signals. Thus, neural crest cells were important in the evolution of vertebrates 
from their proto-chordate ancestors (Hall, 2009; Douarin NM, 2014).   
 Several diseases have been associated with abnormal development of neural crest 
cells and neural crest cell derivatives, and are referred to as neurocristopathies (Bolande, 
1997). Some of the most common birth defects linked to aberrations in neural crest cell 
formation include Waardenburg-Shah syndrome (aganglionic megacolon, 
hypopigmentation and deafness), Hirschsprung disease (megacolon, hypopigmentation 
and deafness), DiGeorge syndrome (thymic hypoplasia, craniofacial and heart defects), and 
Treacher-Collins syndrome (cleft palate, micrognathia and deafness) (Etchevers et al., 
2006; Jones et al., 2008; Passos-Bueno et al., 2009; Keyte and Hutson, 2012). Furthermore, 
tumors such as melanoma (melanocytes), neuroblastoma (sympathoadrenal cells), and 
pheochromocytoma (chromaffin cells of the adrenal medulla) are of neural crest origin 
(Kerosuo and Bronner-Fraser, 2012; Theveneau and Mayor, 2012; Mayor and Theveneau, 
2013).  
Neural crest cells can be grouped into four categories based primarily upon their 
axial level of origin in the embryo. These include cranial, vagal and sacral, cardiac, and 
trunk, and neural crest cells from each domain have distinct migratory characteristics and 
form specific adult structures upon differentiation (Sauka-Spengler and Bronner, 2010). 
Cranial neural crest cells migrate dorsolaterally to give rise to most of the craniofacial 
skeleton, cranial neurons and glia and connective tissues of the face (Fig. 1.1). Vagal and 
sacral neural crest cells generate the parasympathetic or enteric ganglia of the gut, while 
3 
 
cardiac neural crest cells (not shown in the figure) form the endothelium of the aortic arch 
arteries and the septum between the aorta and the pulmonary artery. Trunk neural crest 
cells will differentiate to give rise to melanocytes, sensory and sympathetic neurons, 
Schwann cells, and adrenomedullary cells (Sauka-Spengler and Bronner, 2010)  
 
1.2. Neural Crest Cell Induction 
Neural crest cell progenitors are induced at the border of the neural plate through signals 
from the neuroectoderm, which will form the future brain and spinal cord, the non-neural 
ectoderm, which will form the future epidermis, and the mesoderm. During neurulation 
(Fig. 1.1), an indentation forms along the midline as the neural plate invaginates and 
concomitantly the edges (which contain the neural crest cell progenitors) elevate to form 
the neural folds. At the end of neurulation, the elevating neural folds fuse in the dorsal 
midline creating the hollow neural tube, which eventually pinches off and separates from 
the overlying ectoderm. Neural crest cells now lie at the dorsal region of the neural tube, 
where they are referred to as premigratory neural crest cells. These cells lose intercellular 
contacts, delaminate (detach) and migrate away from the neural tube (Sauka-Spengler and 








Figure 1.1. Neural crest cells form a variety of adult derivatives. Shown on the left is a 
cartoon diagram of a developing human embryo (dorsal view), with the cranial region (rostral) 
at the top and the tail region (caudal) at the bottom. Based on the adult derivatives and the axial 
region of the embryo from which they originate, neural crest cells can categorized as cranial, 
vagal (including cardiac) and trunk. Shown on the right are transverse sections at the appropriate 
axial region in the whole-mount image on the left, with neural crest cells in blue residing at the 
dorsal region of the hollow neural tube as well as a list of the different adult derivatives that 




Although the overall steps in neural crest cell formation are conserved, the exact sequence 
varies between species. In mouse and Xenopus, cranial neural crest cell delamination 
occurs while the neural tube is still open (Nichols, 1981; Sadaghiani and Thiebaud, 1987), 
while in aves it occurs concurrent with neural fold fusion (Duband and Thiery, 1982; 
Theveneau et al., 2007) (Fig.1.2). Furthermore, cephalic and trunk neural crest cell 
populations fundamentally differ in their formation and delamination from the neural tube, 
and the implications of this are only recently coming to light. While cranial neural crest 
cells delaminate en masse, trunk neural crest cells delaminate progressively (Thiery et al., 
1982; Erickson and Weston, 1983; Sadaghiani and Thiebaud, 1987; Jesuthasan, 1996; 
Davidson and Keller, 1999; Duband, 2010; Krispin et al., 2010), leaving the neural tube 
one by one over an extended period of time (Fig. 1.2). The molecular differences between 
cranial and trunk neural crest cell delamination and EMT are very intriguing, and studies 
are required to elucidate the evolutionary rationale and the molecular mechanism(s) 

















Figure 1.2. Neural crest cell EMT varies temporally and spatially in different species. (A) 
The dorsal region of a vertebrate embryo at the early neurula stage, with neural crest cells shown 
in green at the border of the open neural plate (blue). (B) Xenopus cephalic neural crest cells 
delaminate between stages 16 and 18 while the neural tube is still open. (C) Similar to Xenopus, 
mouse cephalic neural crest cells delaminate at the open neural plate stage. (D) Chick cephalic 
neural crest cells undergo massive EMT after neural tube closure. (E) Delamination of chick or 
mouse rostral trunk neural crest cells occurs one by one in a drip-like fashion, and migration 
begins as neural crest cells leave the neural tube. The premigratory neural crest cell domain and 
neural crest cells are shown in green, and red round cells represent mesenchymal neural crest 
cells or neural crest cells undergoing EMT. The neural plate/tube is in blue, the non-neural 
ectoderm is in yellow, and the mesoderm and its derivatives are in pink. Two things that are 
noticeable in the figure are that (1) delamination and EMT are distinct events (see Section 2.2) 
and (2) cephalic neural crest cells undergo en masse EMT, as compared to trunk neural crest cells 













Neural crest cells are generated by complex signals that function to induce them at 
precise spatiotemporal locations. Chiefly, these signals include Bone Morphogenetic 
Protein (BMP), Fibroblast Growth Factors (FGFs), and vertebrate homologues of the 
Drosophila Wingless proteins (Wnts). BMPs play a crucial role in specifying prospective 
neural crest cells. In Xenopus embryos, high levels of BMP will lead to non-neural 
ectoderm, low levels give rise to neuroectoderm (Wilson and Hemmati-Brivanlou, 1995), 
and intermediate levels permit the formation of neural plate border cells (LaBonne and 
Bronner-Fraser, 1998; Marchant et al., 1998). In the chick, both BMP4 and BMP7 are 
expressed in the ectoderm, and each individually is necessary and sufficient for neural crest 
cell induction (Liem et al., 1995; Liem et al., 1997), suggesting that a single upstream 
activator can use either BMP4 or BMP7 as a downstream inducing factor.  This 
requirement was further refined by work from Ragland and Raible who showed that during 
gastrulation and neurulation, BMP inhibition and activation, respectively, is required to 
specify neural crest cell precursors (Ragland and Raible, 2004), indicating that the role of 
BMPs in chick neural crest specification is more complex than previously thought. 
Moreover, prior studies have shown that BMP signaling alone cannot account for neural 
crest cell induction in vivo or in vitro, and that other signaling pathways are also involved 
(LaBonne and Bronner-Fraser, 1998; Garcia-Castro et al., 2002).  
In keeping with this, FGFs and Wnts have also been implicated in neural crest cell 
induction. Inhibiting FGF signaling significantly hampers neural crest cell induction in 
Xenopus and the chick (Mayor et al., 1997; Villanueva et al., 2002). Similarly, Wnt 
inhibition suppresses expression of neural crest cell markers, while active Wnt is required 
for neural crest cell induction in the chick, Xenopus and zebrafish (Saint-Jeannet et al., 
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1997; LaBonne and Bronner-Fraser, 1998; Deardorff et al., 2001; Garcia-Castro et al., 
2002; Lewis et al., 2004; Wu et al., 2005; Steventon et al., 2009). Both of these signaling 
pathways, including crosstalk between them, are required for neural crest cell induction 
(Mayor et al., 1995; Mayor et al., 1997; Hong et al., 2008). Therefore, neural crest cell 
induction is complex and likely requires the convergence of multiple environmental cues. 
 
1.3. Neural Crest Cell Specification 
The combined signaling cues described above converge and induce a set of genes called 
the neural plate border specifiers, which sets apart neural plate border cells from other 
border progenitors by conferring on them the competence to respond to neural crest–
specifying signals and allocating them as neural crest cell precursors. These factors include 
protein products of Zic1, Msx1, Msx2, Dlx3, Dlx5, Pax3 and Pax7 (Fig.1.3). Although 
knowledge on the order and downstream effects of activation of these genes is sparse, 
considerable information is available regarding how distinct signaling pathways activate 
neural plate border specifier genes (for reviews see (Sauka-Spengler and Bronner-Fraser, 
2008; Betancur et al., 2010)). Nevertheless, work carried out in lamprey embryos has 
provided some insight into the temporal order of activation of these genes due to the slow 
development of these organisms (Nikitina et al., 2008). From these studies, Msx and AP2α 
reside at the top of the cascade, with border specifiers such as Msx, Pax3/7 or Zic and early 
neural crest specifiers such as AP2α, n-Myc or Id feeding back and cross-regulating one 
another (Nikitina et al., 2008). 
Once neural plate border cells have been primed by the expression of neural plate 
border specifiers, prospective neural crest cells commence the process of specification into 
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bona fide neural crest cells. This is noted by expression of a new set of genes, including 
Snail1, Snail2, Sox8, Sox9, Sox10, FoxD3, AP-2, Twist, c-Myc, and Id family members 
(Sauka-Spengler and Bronner-Fraser, 2008; Betancur et al., 2010) (Fig. 1.3). These genes 
regulate a variety of downstream targets that enable neural crest cells to segregate and 
delaminate from the neuroepithelium (a process referred to as the epithelial-to-
mesenchymal transition, or EMT), migrate away from the neural tube and cease migration 
and differentiate at their destination sites. Additionally they play important roles in 
controlling population size and the cell cycle (Betancur et al., 2010) (see below). The role 
of Snail and Twist genes, both of which are involved in EMT, will be discussed in detail 
later, but the functions of SoxE and FoxD3 will be briefly described here.  
The SoxE transcription factor family, which includes Sox8, Sox9 and Sox10, has 
well-established roles in neural crest cell development (Nelms BL, 2010). Knockdown of 
Sox8, Sox9 or Sox10 in Xenopus results in the loss of expression of several neural crest cell 
specifier genes, including Snail2, FoxD3 and Twist (O'Donnell et al., 2006). In zebrafish 
and mouse, neural crest cell specification is not perturbed after Sox10 knockdown, but 
neural crest cells fail to migrate and eventually undergo apoptosis (Dutton et al., 2001; 
Reiprich et al., 2008). In the chick, Sox9 functions in neural crest cell progenitor formation, 
delamination and in the development of specific neural crest cell derivatives (Cheung et 
al., 2005; Sakai et al., 2005). Similarly, the winged-helix transcription factor FoxD3 is an 
important regulator of neural crest cell development in all vertebrates. In the mouse 
embryo, FoxD3 is required for maintenance of multipotency (Lister et al., 2006) and 
controls cell survival (Teng et al., 2008). In zebrafish, FoxD3 homozygous mutants show 
increased apoptosis in a subpopulation of migratory hindbrain neural crest cells (Stewart 
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et al., 2006). Overexpression of FoxD3 in the chick embryo dorsal neural tube (containing 
the premigratory neural crest cells) expands the neural crest cell domain, as demonstrated 























Figure 1.3. The neural crest gene regulatory network is responsible for the induction, 
specification, EMT, migration and differentiation, of neural crest cells. Neural crest cell 
induction at the neural plate border is mediated by FGF from the underlying mesoderm as 
well as Wnts from the mesoderm and adjacent non-neural ectoderm (epidermis). These signals 
result in the expression of neural plate border specifiers such as Pax3 and Zic1 in a manner 
that is dependent upon intermediate levels of BMP. Pax3 and Zic1 act synergistically to 
upregulate other downstream neural crest cell specifiers in the neural folds such as Snail, 
FoxD3 and members of the SoxE transcription factors. Genes controlling later migration and 




1.4. The Epithelial-to-Mesenchymal Transition of Neural Crest Cells 
Epithelial cells are tightly associated to one another, exhibit apical-basal polarity and are 
anchored to the basement membrane, thereby providing a penetrable barrier and 
maintaining structural integrity (Hay, 2005). Mesenchymal cells, in contrast, are loosely 
associated with one another and the surrounding tissue, exhibit a front-to-back polarity 
required for locomotion and are capable of diverse morphological movements (Hay, 2005). 
Collectively, EMT is defined as the process by which stationary epithelial cells undergo a 
series of molecular and morphological changes to become migratory mesenchymal cells 
(Fig.1.4). EMT occurs throughout embryonic development and adult tissue homeostasis 
(Hay, 1995; Hay, 2005; Thiery et al., 2009) and has been categorized into three types based 
on the biological context in which the EMT occurs. Type I EMT occurs during 
implantation, embryo formation and organ development, while type II EMT takes place 
during wound healing, tissue regeneration and organ fibrosis. Type III EMT is exhibited 
by cancerous cells when they metastasize (Kalluri and Weinberg, 2009). Although EMT 
occurs in distinct tissues and at various times during development and disease, many of the 
cell biological changes and molecular mechanisms underscoring EMT are conserved 
(Thiery et al., 2009; Kerosuo and Bronner-Fraser, 2012) (Fig.1.4). This section will detail 








Figure 1.4. The Epithelial-to-Mesenchymal Transition is characterized by the expression of 
distinct molecular markers. Cartoon diagram of the transition of polarized epithelial cells into 
mesenchymal cells, with each phase of EMT characterized by the expression of distinct molecular 
markers. Epithelial cells express junctional components (cadherins, occludins, desmoplakins, 
claudins), polarity proteins (par and crumb), basement membrane proteins (laminin), and 
cytoskeletal proteins (cytokeratins), which provide structural integrity for this framework. 
Morphogens such as TGFβ, BMPs, HGF/SF, FGF, Wnt, and Notch activate transcription factors 
such as Snail, Zeb, Twist, and Fox, which suppress the expression of a variety of molecules 
involved in maintaining the epithelial nature of cells. As the epithelial cells become mesenchymal, 
they express a new repertoire of adhesion, cytoskeletal and matrix components that enable them 
to actively migrate in a foreign environment. Epithelial cells are depicted in beige, cells 
undergoing EMT in green and mesenchymal cells in blue. Green solid bars, basement membrane; 




1.5. The Transcriptional Control of Neural Crest Cell EMT 
Neural crest cell EMT is orchestrated by the aforementioned transcription factors in 
Sections 1.2 and 1.3, which all cause significant changes within neural crest cells to enable 
them to lose cell-cell adhesion, delaminate and emigrate from the neural tube. Snail genes 
are zinc finger transcription factors that were the first to be identified as important players 
during neural crest cell EMT (Nieto et al., 1994). Indeed, Snail proteins are involved in a 
wide variety of EMTs during development as well is in diseases characterized by aberrant 
cell migration (Nieto, 2002). While chick and mouse premigratory neural crest cells 
express Snail2 and Snail1, respectively, both Snail genes are expressed in Xenopus 
premigratory neural crest cells (Swanson, 1989; Thisse et al., 1993; Hewlett et al., 1994; 
Schnatwinkel et al., 2004). Gain-of-function experiments reveal that Snail1 in Xenopus and 
Snail2 in chick are sufficient to induce greater numbers of migrating neural crest cells, 
whereas knockdown severely decreases neural crest cell migration (Hewlett et al., 1994; 
Nieto et al., 1994; LaBonne and Bronner-Fraser, 2000). Cadherins have been identified as 
one of the major transcriptional targets of Snail proteins in various systems, including that 
of neural crest cells and cancers (Batlle et al., 2000; Cano et al., 2000; Taneyhill et al., 
2007; Wheelock et al., 2008). In chick premigratory cranial and trunk neural crest cells, 
Snail2 represses the expression of the premigratory neural crest cell cadherin cadherin6B 
(Cad6B) (Taneyhill et al., 2007). Snail proteins transcriptionally repress target genes by 
binding to E box sequences within their promoters. Specifically, Snail2, together with 
PHD12 and Sin3A/HDAC, deacetylates lysines on histone H3 within the Cad6B promoter, 
thereby repressing cad6B transcription (Taneyhill et al., 2007; Strobl-Mazzulla and 
Bronner, 2012). The tight junction genes claudin-3, claudin-4, claudin-7, and occludin are 
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also targets of Snail transcription factors (Ikenouchi et al., 2003). The function of Snail 
proteins is not necessarily restricted to transcriptional regulation of junction proteins. 
Snail1, together with Sox5, upregulates rhoB, which plays an important role in neural crest 
cell EMT by coordinating the rearrangement of the actin cytoskeleton and the formation of 
focal adhesions and stress fibers (Perez-Alcala et al., 2004).  
Additional transcription factors downstream of neural plate border specifier genes 
control neural crest cell EMT. For example, overexpression of FoxD3 in trunk neural crest 
cells downregulates N-cadherin while concomitantly upregulating expression of Cadherin-
7 and β1 integrin, both of which are expressed in migrating neural crest cells (Cheung et 
al., 2005; Liang et al., 2014). More recently, FoxD3 has been shown to transcriptionally 
repress Tspan18, whose expression is required for the post-translational downregulation of 
Cad6B in cranial neural crest cells (Fairchild et al., 2014). Sox10 overexpression also 
induces β1 integrin while inhibiting N-cadherin expression (Cheung et al., 2005). Mouse 
knockouts of Zeb-2, another transcription factor expressed in premigratory neural crest 
cells, have severe deficits in cranial neural crest cell migration along with persistence of E-
cadherin (Van de Putte et al., 2003). Recently, Rogers et al. (2013) identified a role for 
Sip1/Zeb-2 in chick cranial neural crest cell EMT, where Zeb-2 promotes an E-cadherin to 
N-cadherin switch during EMT (see Section 1.6.2.1 on “Cadherins in Neural Crest Cell 
EMT”) (Rogers et al., 2013). The transcription factor Twist is strongly expressed in 
migrating cranial, but not trunk, neural crest cells (Hopwood et al., 1989; Soo et al., 2002; 
Germanguz et al., 2007), and is found downstream of Snail1 (Linker et al., 2000). 
Importantly, Twist represses E-cadherin in several cell types in vitro (Vandewalle et al., 
2005), and although direct demonstration of Twist activity has not been shown, it is likely 
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to play a similar role in neural crest cells. Overexpression of c-Myb, another transcription 
factor present in chick premigratory and migratory neural crest cells, induces expression 
of Snail2 and leads to ectopic EMT of neuroepithelial cells in explant cultures (Karafiat et 
al., 2005; Vandewalle et al., 2005). Id-2 is another transcription factor expressed in cranial 
but not trunk premigratory neural crest cells. Ectopic expression of Id-2 in the non-neural 
ectoderm converts these cells to a neural crest cell-like fate as identified by expression of 
HNK-1 (labels migratory neural crest cells) (Lee et al., 2013) and the loss of epithelial 
features (Martinsen and Bronner-Fraser, 1998).  
Although the information described thus far focuses exclusively on individual 
transcription factors, there is extensive cooperation and feedback among them to regulate 
neural crest cell specification and EMT. For example, in Xenopus cranial neural crest cells, 
Snail1 can enhance its own expression and induce expression of Snail2, Twist, FoxD3, and 
Ets-1 (Hewlett et al., 1994). In turn, FoxD3 is able to induce itself and Snail2, Twist, Ets-
1, Sox2, and NCAM in Xenopus (Sasai et al., 2001). In chick cranial neural crest cells, Sox9 
induces Snail2 but not FoxD3 (Cheung et al., 2005; Sakai et al., 2006). The promoter 
regions of Xenopus Snail2 and Sox9 both contain binding sites for Lef/Tcf transcription 
factors, suggesting that they may be regulated by canonical Wnt signaling (Vallin et al., 
2001; Bagheri-Fam et al., 2006). Similarly, Sox10 enhancer sequences isolated from chick 
cranial neural crest cells possess binding sites for Sox9, Ets-1 and c-Myb, and mutation of 
these sites abolishes cranial Sox10 transcription (Betancur et al., 2010). Thus, the genetic 
network controlling neural crest cell induction, specification and EMT is very complex and 




1.6. The Cell Biology of Neural Crest Cell EMT 
From a cell biological standpoint, neural crest cell EMT can be divided into distinct phases, 
including cellular delamination, emigration and migration. Although the terms are loosely 
defined and are often used interchangeably (and thus incorrectly), they do possess distinct 
characteristics (Fig. 1.2). Delamination is the phase in which cellular adherens and tight 
junctions are dismantled and neural crest cells round up as they express mesenchymal 
markers and prepare to leave the neural tube. Emigration refers to the active exiting of 
neural crest cells from the neural tube prior to their emergence into the embryonic milieu. 
Migration occurs when neural crest cells have left the confines of the neural tube and have 
moved into the surrounding embryo tissue and extracellular matrix as they head to their 
target destinations. This introduction will focus solely on the delamination phase of neural 
crest cells. The delamination phase consists of three components: the presence of an 
appropriate substratum for migration, the loss of intercellular adhesion and the acquisition 
of migratory competence. Reviews on the appropriate substratum for neural crest cell 
migration and the acquisition of migratory competence are available at (Wilson and 
Hemmati-Brivanlou, 1995). Loss of intercellular adhesion in epithelial cells requires 
dismantling of adherens and tight junctions (Fig. 1.5). These junctions constitute the 
fundamental components that maintain premigratory neural crest cells in an epithelial state, 



















Figure 1.5. Epithelial sheets (cells) are characterized by intact cellular junctions and 
apicobasal polarity. Epithelial cells consist of cellular junctions, including adherens, tight and gap 
junctions; polarity complexes (par proteins); and desmosomes. Adherens junctions are comprised 
of nectin and cadherin transmembrane proteins, and tight junctions contain the occludin, JAM and 
claudin transmembrane proteins. Desmosomes and gap junctions are discussed elsewhere (Mese et 
al., 2007; Kowalczyk AP, 2014). These junctional proteins are bound by several cytoplasmic 
proteins that link them to the actin cytoskeleton, thus providing structural integrity to the epithelial 








1.6.1. Neural Crest Cell Tight Junctions  
Tight junctions or zonula occludens, present at the most apical surface of the membrane, 
regulate the diffusion of solutes through the plasma membranes of apposing cells with size 
and charge selectivity, and prevent the diffusion of transmembrane proteins between the 
apical and basolateral membranes (Furuse, 2010). Tight junctions consist of membrane-
bound and cytoplasmic proteins. Claudins constitute the key transmembrane proteins for 
tight junction formation and function, creating tight junctions through homophilic 
interactions with claudins of apposing cells (Ikenouchi et al., 2005; Furuse, 2010). Apart 
from claudins, occludin, tricellulin and JAM-A are the other transmembrane proteins of 
the tight junctions (Furuse, 2010). ZO-1, ZO-2 and ZO-3 are the major cytoplasmic 
proteins that interact with the cytoplasmic domain of these transmembrane proteins 
(Stevenson et al., 1986; Gumbiner et al., 1991; Haskins et al., 1998). Cingulin is another 
cytoplasmic protein concentrated relatively far from the tight junctions (Citi et al., 1988) 
that also interacts with ZO proteins (Cordenonsi et al., 1999; D'Atri et al., 2002). Cingulin 
and ZO proteins interact with the actin cytoskeleton and provide structural integrity for 
tight junctions (Fanning et al., 1998; Wittchen et al., 1999; D'Atri and Citi, 2001). Recent 
work in chick, described below, has shed light on the function of tight junction proteins in 
neural crest cell EMT. 
 In the chick, claudin-1 is observed in the apical region of the forming neural tube 
but is downregulated in the cranial dorsal neural folds (and premigratory neural crest cells) 
well prior to neural crest cell delamination. Migratory neural crest cells are also devoid of 
claudin-1 protein (Fishwick et al., 2012) (Fig. 1.6). Morpholino-mediated knockdown and 
overexpression of claudin-1 results in the presence of greater or fewer numbers of 
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migratory neural crest cells, respectively, but does not affect expression of important neural 
crest cell molecular markers such as Cad6B and laminin. Instead, the number of 
premigratory cranial neural crest cells is altered (Fishwick et al., 2012). Taken together, 
these results suggest that the observed effects on EMT are not through the basal lamina or 
other junctional proteins but instead through the number of neural crest cell precursors 
available to migrate (Fishwick et al., 2012).  
Expression of another tight junction protein in the chick, cingulin, is similar to that 
of claudin-1, except that cingulin continues to be diffusely expressed throughout the apical 
neural tube even after neural crest cell EMT (Wu et al., 2011). Morpholino-mediated 
knockdown of cingulin increases the number of migratory neural crest cells. Surprisingly, 
cingulin overexpression also expands the migratory neural crest cell population and is 
associated with nuclear localization and ectopic delamination of neuroepithelial cells. 
Interestingly, RhoA levels vary with cingulin in the ventrolateral neural tube, with cingulin 
knockdown or overexpression increasing or decreasing RhoA levels, respectively. 
Exogenous cingulin has no influence on RhoA levels in the dorsal neural tube, however, 
suggesting that the enhanced neural crest cell migration phenotype observed upon cingulin 
overexpression and knockdown is probably independent of cingulin-mediated RhoA 
modulation within the premigratory neural crest cell population (Wu et al., 2011). Neither 
cingulin knockdown nor overexpression causes any changes in the expression of Cad6B, 
claudin-1 and ZO-1, suggesting that the influence of cingulin on other junctional 





1.6.2. Neural Crest Cell Adherens Junctions 
Termed zonula adherens in polarized epithelial cells, adherens junctions form the 
“adhesion belt” by interacting with circumferential F-actin, thereby linking cells into a 
continuous sheet and separating the apical and basolateral membranes. In addition, they 
provide a penetrable barrier and protect the epithelial sheet against external hazards (Hay, 
2005). Adherens junctions consist of transmembrane cadherin and nectin/afadin molecules 
(Takai et al., 2008; Meng and Takeichi, 2009), the latter of which will not be discussed but 
detailed reviews are available at (Takai et al., 2008; Ridenour et al., 2014). 
 
1.6.2.1. Cadherins  
Cadherins are Ca2+-dependent integral membrane proteins that mediate cell-cell adhesion 
through the formation of homophilic interactions with cadherins on adjacent cells (Pokutta 
et al., 1994; Overduin et al., 1995). Cadherins link adherens junctions to the actin 
cytoskeleton through intracellular interactions with β-catenin, and subsequently α-catenin 
(Yonemura, 2011), thereby providing mechanical and structural support to epithelial cells. 
In addition to the binding site for β-catenin, many cadherin cytoplasmic tails also possess 
a binding site for p120-catenin (Kourtidis et al., 2013). The cadherin family is extremely 
diverse and is divided broadly into two different types based upon their adhesive properties 
and phylogenic relationships. Type I cadherins consist of cadherins-1 to -5, commonly 
referred as E-, N-, C-, P-, and R-cadherin, respectively, and type II cadherins constitute 
cadherin-6 and higher (Oda and Takeichi, 2011). In addition to the trans interaction 
between cadherins on different cells, the cadherin extracellular domain is also capable of 
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lateral cis interactions in the plasma membrane of a given cell, thereby forming cadherin 
dimers that form the basic adhesive unit (Brieher et al., 1996).  
Cadherins are crucial components for normal embryonic development and 
pathogenesis. During development, both small and large cellular rearrangements are 
associated with spatiotemporal changes in cadherin expression (Takeichi, 1991). 
Homozygous deletion of E-cadherin (Larue et al., 1994) or N-cadherin (Radice et al., 
1997) causes embryonic lethality in mice. Altering cadherin expression in embryonic cells 
(Detrick et al., 1990; Fujimori et al., 1990), expressing a non-adhesive mutant of cadherin 
(Radice et al., 1997), or blocking cadherin function with inhibitory antibodies (Bronner-
Fraser et al., 1992) leads to loss of adhesion, dispersion of cells and therefore serious 
morphological defects or loss of tissue architecture. Cadherins also function in tissue 
homeostasis. For example, VE-cadherin (Vascular Endothelial cadherin; cadherin-5) 
regulates the exchange of oxygen and carbon dioxide across the endothelial lining of 
pulmonary alveolae and the transendothelial transport of fluid and proteins (Giannotta et 
al., 2013). Furthermore, cadherin mutations or aberrant cadherin expression is frequently 
associated with the onset of esophageal, gastric and colon cancers (van Roy, 2014). 
Importantly, a change from E-cadherin to N-cadherin expression, termed “cadherin 
switching,” has been documented in numerous tumors of epithelial origin, including 
melanoma, breast, prostate, bladder, and squamous cell carcinoma. It is postulated that 
cadherin switching replaces an epithelial cadherin with a mesenchymal cadherin, although 
the switching mechanisms are not clear (Wheelock et al., 2008). Thus, cadherin regulation 




1.6.2.2. Cadherins in Neural Crest Cell EMT 
Much of the investigation on the expression and regulation of junctional proteins of neural 
crest cells has focused on cadherins. Chick premigratory cranial neural crest cells express 
at least three cadherins: Cad6B, N-cadherin and E-cadherin (Hatta and Takeichi, 1986; 
Duband et al., 1988; Nakagawa and Takeichi, 1995; Nakagawa and Takeichi, 1998; Dady 
et al., 2012) (Fig.1.6). Expression of E-cadherin is high in prospective neural crest cells 
prior to neurulation, but as neurulation progresses, E-cadherin is gradually reduced and 
only retained until early stages of neural crest cell delamination. N-cadherin protein, 
however, is expressed during neurulation but is lost before EMT in premigratory cranial 
neural crest cells (Dady et al., 2012; Rogers et al., 2013). On the other hand, in the trunk, 
only N-cadherin transcripts are downregulated, and expression of protein persists until 
EMT (our unpublished data). Cad6B expression is considered to be a definitive and unique 
marker of premigratory neural crest cells. In the crania, Cad6B expression begins in the 
apposing neural folds, gradually increases as premigratory neural crest cells prepare for 
EMT, and is completely downregulated as neural crest cells undergo EMT and migrate 
(Nakagawa and Takeichi, 1995; Nakagawa and Takeichi, 1998; Taneyhill, 2008). In the 
trunk, Cad6B levels (mRNA and protein) are qualitatively much higher compared to that 
of the midbrain (our unpublished data). The significance and the molecular mechanism 
behind this differing expression pattern are unknown at this time. In addition, why 
premigratory neural crest cells express multiple cadherins simultaneously is still not clear. 
One hypothesis is that prospective neural crest cells segregate from the newly formed 
neural tube through an N-cadherin to Cad6B switching event, and that differential 
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expression prevents mixing of neural crest cells and other neuroepithelial cells (Nakagawa 
and Takeichi, 1995; Nakagawa and Takeichi, 1998).  
 Once neural crest cells initiate migration, they express two other cadherins, 
Cadherin-7 and Cadherin-11 (Nakagawa and Takeichi, 1998; Chalpe et al., 2010). Xenopus 
cephalic and trunk neural crest cells do not express Cad6B and Cadherin-7, but express 
Cadherin-11, whose expression pattern seems to be the sum total of Cad6B and Cadherin-
7 expression within the chick embryo (Vallin et al., 1998). Mouse neural crest cells express 
Cadherin-6, the mouse orthologue of chick Cad6B, and, like Cadherin-11 in Xenopus, its 
expression appears to be the sum of chick Cad6B and Cadherin-7 (Inoue et al., 1997). In 
zebrafish, trafficking of N-cadherin is important in the normal migration of zebrafish neural 
crest cells (Piloto and Schilling, 2010).  
During neural crest cell EMT, cadherins undergo both transcriptional and post-
translational downregulation. Sip1/Zeb-2, a zinc finger transcriptional repressor, 
downregulates E-cadherin in emigrating neural crest cells but maintains N-cadherin levels 
in the neural tube of the chick embryo (Fig. 1.6). Knockdown of Sip1 reduces the number 
of neural crest cells undergoing EMT and is associated with enhanced expression of E-
cadherin in emigrating neural crest cells and reduced expression of N-cadherin in the neural 
tube (Bolande, 1997). Similar to E-cadherin, Cad6B also undergoes transcriptional and 
post-translational downregulation (Fig. 1.6). As mentioned previously (Section 2.1), 
Cad6B expression in chick cranial and trunk neural crest cells is repressed by Snail2 
(Taneyhill et al., 2007). The downregulation of Cad6B protein from the plasma membrane 
of premigratory cranial neural crest cells, however, occurs through the activity of several 





Figure 1.6. Junctional molecules in chick cranial neural crest cells are dynamically 
modulated during EMT. The top panel shows transverse cross-sections through the midbrain of 
a 5 somite stage (ss, left) and a 6ss (right) chick embryo showing the premigratory (left) and 
migratory neural crest cells (right). The bottom panel shows the magnified image of a neural crest 
cell and the junctional molecular components with demonstrated expression patterns and if 
available, molecular mechanisms associated with their regulation. The basal lamina that surrounds 
the neural tube on its basolateral surface is not shown but is absent in the dorsal region of the 




(ADAM)  ADAM10 and ADAM19, followed by γ-secretase (Schiffmacher et al., 2014), 
and through internalization (Padmanabhan, Ph.D. thesis). This proteolysis releases N- and 
C-terminal fragments (NTF, CTF1, CTF2) and thus likely decreases cell-cell adhesion by 
relieving intercellular adhesion. However, the released fragments may play other signaling 
roles in modulating neural crest cell EMT (Schiffmacher and Taneyhill, unpublished data). 
ADAM-mediated proteolysis of cadherins also occurs in the chick during trunk neural crest 
cell EMT. Shoval et al. (2007) showed that BMP signaling activates ADAM10, which 
proteolytically cleaves the N-cadherin extracellular domain. CTF2, one of the released 
cytoplasmic domain fragments, then translocates to the nucleus and directly or indirectly 
stimulates transcription of genes important for modulating neural crest cell EMT such as 
cyclin D1. Downregulation of cad6B is crucial in the chick midbrain because 
overexpression and knockdown of Cad6B inhibits and augments neural crest cell 
emigration, respectively (Coles et al., 2007). Cad6B is regulated differently in chick trunk 
neural crest cells, however, with cad6B expression triggering premigratory neural crest cell 
de-epithelialization and knockdown decreasing the number of migratory neural crest cells 
(Park and Gumbiner, 2010; Park and Gumbiner, 2012). This occurs through a non-
canonical LIM kinase/cofilin Wnt signaling pathway, and ectopic expression of LIM 
kinase (with Sox9) triggers ectopic EMT of trunk neural crest cells (Park and Gumbiner, 
2012). This observed difference with respect to Cad6B function in the chick head and trunk 
may be due to (1) differences in the properties of head and trunk neural crest cells and (2) 
the metric used to determine effects on neural crest cell migration. Cad6 facilitation of 
EMT is also observed in zebrafish hindbrain neural crest cells (Dixon et al., 2006).  These 
cells lose N-cadherin but upregulate Cad6 prior to EMT. Moreover, Cad6 promotes 
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detachment of neural crest cell “tails” by altering the spatiotemporal localization of Rho 
GTPase and through accumulation of F-actin in the tail region. Finally, Cad6 knockdown 
alters the subcellular distribution of active Rho, which is known to promote localized 
actomyosin contraction crucial for apical neural crest cell detachment (Dixon et al., 2006). 
Another example whereby cadherins facilitate EMT is the role of Cadherin-11 in Xenopus 
neural crest cells. Similar to Cad6B, knockdown and overexpression of Cadherin-11 in 
Xenopus neural crest cells augments or prevents neural crest cell migration, respectively 
(Borchers et al., 2001). Overexpression of ADAM13 was found to rescue the latter 
phenotype, and ADAM13 knockout embryos have elevated Cadherin-11 levels. 
Interestingly, this proteolytic cleavage occurs throughout cranial neural crest cell 
migration, unlike that of the chick in which ADAM10-mediated proteolytic cleavage 
occurs only within premigratory cranial neural crest cells (Borchers et al., 2001). Following 
ADAM13-mediated proteolysis, the membrane-bound cytoplasmic fragment of Cadherin-
11 localizes to the filopodia of migratory neural crest cells and associates with Trio, a small 
GTPase guanine exchange factor (Kashef et al., 2009) that activates Rho, Rac and Cdc42 
in vitro (Bateman and Van Vactor, 2001). Consistent with this observation, overexpression 
of Trio or constitutively active Rho, Rac and Cdc42 is sufficient to restore neural crest cell 
spreading and migration in Cadherin-11 knockdown embryos, suggesting that the 
membrane-anchored, cytoplasmic fragment of Cadherin-11 is crucial for the activation of 
these small GTPases in vivo (Kashef et al., 2009). These observations point to a new, 
emerging theme in cadherin regulation in which a fine balance between intracellular and 




1.6.2.3. Mechanisms of Cadherin Downregulation  
Cells employ multiple mechanisms to modulate cadherin protein levels at the plasma 
membrane, further to repressing their expression transcriptionally: (1) Phosphorylation and 
dephosphorylation of cadherins (reviewed in (Fujita et al., 2002)), (2) Interaction of 
cadherins with small GTPases such as Rho, Rac and Cdc42 (reviewed in (Watanabe et al., 
2009)), (3) Cadherin endocytosis and sequestration (reviewed in (Chiasson CM, 2008)), 
and (4) Shedding/proteolysis of the cadherin extracellular domain (reviewed in (Hayashida 
et al., 2010)). The rest of this section will focus on proteolysis and endocytosis as 
mechanisms of downregulation of cadherins from the plasma membranes of cells.   
 
1.6.2.3.1. Proteolysis 
The first of a series of studies demonstrating proteolysis of the ectodomain of cadherins 
was from Wheelock et al. (Wheelock et al., 1987). The authors purified an 80 kilodalton 
(kD) E-cadherin soluble fragment from serum-free medium conditioned by MCF-7 cells. 
This soluble fragment caused scattering of epithelial cells in culture, suggesting that it was 
able to interfere with cell adhesion in vitro (Wheelock et al., 1987).  
Cadherin ectodomain shedding occurs through ADAM/Matrix Metalloprotease 
(MMP)-mediated cleavage of the cadherin extracellular domain to release the NTF. In 
many instances, this is followed by γ-secretase-mediated proteolytic cleavage of the 
remaining, membrane-bound C-terminal intracellular domain (CTF1) at the 
juxtamembrane region to release the intracellular fragment CTF2 (Marambaud et al., 2002; 
Marambaud et al., 2003). ADAMs and MMPs belong to the metzincin zinc-dependent 
metalloprotease superfamily and cleave a variety of substrates in the extracellular matrix 
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during embryogenesis, adult tissue homeostasis and metastasis. Typical substrates for 
ADAMs include growth factors, cytokines, receptors, and cell-adhesion molecules (White 
JM, 2005), while traditional substrates of MMPs include extracellular matrix components 
as well as a range of membrane-bound proteins (Rodriguez et al., 2010). The link between 
the degradation of extracellular matrix by ADAMs/ MMPs and cancer cell invasion has 
been clearly established from earlier studies on tumor metastasis (Fingleton, 2006). 
Numerous reports show that knockdown or inhibition of MMPs (by synthetic and natural 
inhibitors) decreases cell invasion, whereas increased cell invasion is observed upon MMP 
activation (reviewed in (Fingleton, 2006)). γ-secretase is a membrane-bound protein 
complex composed of at least four subunits: presenilin (possesses the active site), nicastrin, 
anterior pharynx-defective 1, and presenilin enhancer 2. γ-secretase has generated much 
interest recently because it cleaves APP to generate amyloid-β peptide, the primary 
component of amyloid plaques characteristic of Alzheimer’s disease (reviewed in (Beel 
and Sanders, 2008)) 
ADAM/MMP- and γ-secretase-mediated proteolytic cleavage of the cadherin 
extracellular and intracellular domains is usually accompanied by the loss of intercellular 
adhesion. For example, MMP-7 cleaves E-cadherin during wound healing within the 
injured lung epithelium (McGuire et al., 2003), allowing cells to move to heal the injured 
site, and MMP-3 cleaves E-cadherin in mammary epithelial cells, resulting in EMT 
(Lochter et al., 1997). ADAM10 processes both E-cadherin (Maretzky et al., 2005) and N-
cadherin (Reiss et al., 2005) in epithelial cells to decrease cell-cell adhesion as well as VE-
cadherin in umbilical vein endothelial cells, promoting transmigration (Schulz et al., 2008). 
γ-secretase has been shown to cleave both E-cadherin and N-cadherin at their 
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juxtamembrane regions to release intracellular fragments that play signaling roles 
(Marambaud et al., 2002; Marambaud et al., 2003). In addition to a function in EMT, 
cadherin proteolysis is involved in several non-EMT developmental processes. N-cadherin 
cleavage during chick retinal development releases a truncated extracellular domain that 
promotes cell adhesion and neurite development (Wilkie and Morriss-Kay, 2001). 
Similarly, ADAM10-mediated E-cadherin proteolysis in response to Eph/ephrin signaling 
plays a role in cell sorting of epithelial tissues during development (Orpen et al., 2003). 
Furthermore, as discussed in the previous section (Section 3.1), cadherin proteolysis plays 
an important function in regulating cadherin levels during and after neural crest cell EMT. 
 
1.6.2.3.2. Endocytosis and Degradation 
1.6.2.3.2.1. Overview 
Cadherin endocytosis occurs both constitutively and under conditions in which cell 
adhesion is compromised. The degree of endocytosis and the fate of the endocytosed 
cadherin are dependent on the amount of cell-cell contact and presence of extracellular 
signals that trigger endocytosis. Upon endocytosis, cadherins are either recycled back to 
the plasma membrane or degraded in the lysosomes (Fig. 1.7). In the case of E-cadherin in 
MDCK cells, the internalized pool of cadherin is rapidly recycled to the cell surface (Le et 
al., 1999). VE-cadherin in endothelial cells, however, undergoes a certain level of 













Figure 1.7. Multiple mechanisms regulate cadherin endocytosis. Cadherins undergo both 
clathrin-dependent and clathrin-independent internalization. p120-catenin plays a critical 
role in regulating cadherin endocytosis through the clathrin-mediated pathway. Upon 
endocytosis, cadherins are recycled back to the plasma membrane or degraded in lysosomes. 
Image reproduced from (Kowalczyk and Nanes, 2012). 
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Cadherin endocytosis can directly influence the adhesive state of cadherins in vitro 
and in vivo. For example, using ATP depletion or hypertonic sucrose treatment to inhibit 
endocytosis, E-cadherin adhesive dimers were stabilized in the absence of endocytosis in 
vitro, leading to a dramatic increase in the amount of adhesive dimers and a parallel 
decrease in the pool of cadherin monomers (Troyanovsky, 2005). Similarly, inhibition of 
E-cadherin endocytosis enhances epithelial cell adhesion in vivo in Drosophila embryos 
(Harris and Tepass, 2008; Leibfried et al., 2008; Wirtz-Peitz and Zallen, 2009). Consistent 
with these observations, non-adhesive cadherin molecules that are able to flow within the 
plane of the plasma membrane were shown to enter endocytic routes in vitro (Le et al., 
1999; Izumi et al., 2004; Miyashita and Ozawa, 2007a). Cadherin endocytosis is also 
dependent on the adhesive state of the cell. For instance, endocytosis increases in cells 
lacking stable cell-cell contacts, such as in pre-confluent monolayers or following 
disruption of cell junctions by Ca2+ depletion (Kartenbeck et al., 1991; Ivanov et al., 2004).  
In addition to playing roles in adherens junction homeostasis, cadherin endocytosis 
can elicit cellular responses such as EMT. During EMT induced by v-Src activation, v-Src 
stimulates phosphorylation-dependent ubiquitination of E-cadherin, which is then 
trafficked through the endosomes to the lysosome for degradation through a pathway that 
requires hepatocyte growth factor-regulated tyrosine kinase substrate and the GTPases 
Rab5 and Rab7 (Palacios et al., 2005). In another study, Src-stimulated phosphorylation of 
the E-cadherin juxtamembrane domain recruits Hakai, an E3 ubiquitin ligase that 
monoubiquitinates E-cadherin and marks it for trafficking to lysosomes (Fujita et al., 2002) 
(Fig. 1.7). This process of cadherin ubiquitination, followed by degradation, has been 
hijacked by pathogenic viruses. For example, Kaposi’s Sarcoma-associated herpesvirus 
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protein K5, another E3 ubiquitin ligase, ubiquitinates and downregulates VE-cadherin and 
enhances endothelial permeability (Qian et al., 2004; Mansouri et al., 2008). In addition, 
increased endocytosis has been associated with some cancers. A mouse model of squamous 
cell carcinoma exhibits augmented E-cadherin endocytosis (Goodman, 2003), and 
cytoplasmic localization of E-cadherin is associated with poor survival in nasopharyngeal 
cancer (Xie et al., 2010)  
  
1.6.2.3.2.2. Clathrin-dependent Endocytosis of Cadherins 
Cadherins undergo endocytosis through both clathrin-dependent and -independent 
pathways (Fig. 1.7). For example, E-cadherin in MDCK cells undergoes constitutive 
endocytosis and recycling in a clathrin-dependent manner (Le et al., 1999). Similarly, in 
T84 cells, Ivanov et al. observed clathrin-dependent internalization of the entire apical 
junctional complex into an intracellular compartment enriched in syntaxin-4 upon Ca2+ 
depletion (Ivanov et al., 2004). In endothelial cells, VE-cadherin is internalized through a 
clathrin-dependent manner and is trafficked through early and late endosomes to the 
lysosome, where it undergoes degradation (Xiao et al., 2003a; Xiao et al., 2005).  
The clathrin-dependent endocytosis pathway is the most well characterized 
mechanism of endocytosis. Here, cargo proteins are recruited into clathrin-coated pits in 
the plasma membrane through recognition of distinct sorting motifs in their cytoplasmic 
domains by adaptor proteins. Prior work has revealed that cadherins possess sorting or 
endocytic motifs in their cytoplasmic domains, including a tyrosine-based sorting signal 
(YXXØ consensus in which X is any amino acid and Ø is a hydrophobic residue) (Canfield 
et al., 1991; Jadot et al., 1992) and a dileucine motif ([DE]XXXL[LI] consensus) 
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(Bonifacino and Traub, 2003). In MDCK cells, the dileucine motif is required for 
endocytosis of E-cadherin, and mutation of the dileucine motif at amino acids 587-588 
results in E-cadherin accumulation at the basolateral surface (Miranda et al., 2001)  and a 
significant reduction in endocytosis (Miyashita and Ozawa, 2007a). Mutating the region 
possessing the dileucine motif of N-cadherin decreases N-cadherin endocytosis in 
hippocampal neurons (Tai et al., 2007). Interestingly, VE-cadherin does not possess this 
dileucine motif, but its cytoplasmic tail is able to mediate clathrin-dependent endocytosis 
when attached to an unrelated transmembrane protein, indicating that cadherins may 
contain other as of yet identified endocytic motifs (Xiao et al., 2005). As mentioned above, 
these motifs are recognized by cytoplasmic adaptor protein, which serve as a scaffold for 
both clathrin and the cargo to which they bind. AP-2 is the most common adaptor protein, 
binding to clathrin, phospholipids and other proteins. (Benmerah and Lamaze, 2007; 
Rappoport, 2008) (Fig.1.7). Importantly, it is responsible for the recognition of cargo 
proteins through their cytoplasmically-localized sorting motifs, including the tyrosine and 
the dileucine motif described above (Bonifacino and Traub, 2003). AP-2 co-
immunoprecipitates with the VE-cadherin cytoplasmic tail during clathrin- and dynamin-
dependent endocytosis of VE-cadherin (Chiasson et al., 2009), and with the E-cadherin 
cytoplasmic tail during E-cadherin endocytosis in MCF-7 cells (Liem et al., 1997). In 
addition to AP-2, other adaptor proteins have been implicated in clathrin-mediated 
endocytosis of cadherins, such as β-arrestin in VEGF-stimulated endocytosis of VE-
cadherin (Gavard and Gutkind, 2006), and Numb in radial glial (Liem et al., 1995) and 
epithelial (Lewis et al., 2004; Ragland and Raible, 2004) cells (Fig. 1.7), which directly 
binds to and regulates E-cadherin endocytosis.  
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1.6.2.3.2.3. Clathrin-independent Endocytosis of Cadherins 
Clathrin-independent mechanisms of protein internalization, which include caveolae-
dependent pathways, lipid raft-mediated pathways and macropinocytosis, are now 
recognized as increasingly important pathways of transmembrane protein trafficking (Fig. 
1.7). In response to EGF treatment, E-cadherin in A431 cells is internalized through a 
pathway that requires caveolin-1 (Lu et al., 2003). In keratinocytes, E-cadherin is 
endocytosed through a caveolin-mediated pathway upon Rac activation (Akhtar and 
Hotchin, 2001). The desmosomal cadherin Desmoglein-3, the target of the autoimmune 
disease Pemphigus Vulgaris, is internalized through a lipid raft-dependent, but clathrin- 
and dynamin-independent, pathway (Delva et al., 2008).   
 In addition to clathrin-, caveolin- and lipid raft-dependent endocytic pathways, 
macropinocytosis-mediated cadherin internalization has also been observed (Fig. 1.7). In 
isolated MCF-7 cells, E-cadherin is internalized by ARF6- and dynamin-dependent 
macropinocytosis (Paterson et al., 2003). In epithelial cells, EGF induces macropinocytosis 
of the E-cadherin-catenin complex from ruffling cell membranes, which then undergo 
SNX1-dependent recycling back to the plasma membrane (Bryant et al., 2007). In another 
case of E-cadherin recycling, reggies/flottilins mediate E-cadherin macropinocytosis and 
junction formation by regulating EGFR phosphorylation and endocytosis in A431 cells 
(Solis et al., 2012). Thus, the existence of multiple internalization pathways to modulate 






1.6.2.3.2.4. Regulation of Cadherin Endocytosis by p120-catenin and Rho GTPases 
Of the three catenins, p120-catenin has the most significant influence on cadherin 
endocytosis. p120-catenin, a member of the armadillo family of proteins, binds to the 
juxtamembrane domain of cadherins and serves as an inhibitor of cadherin turnover by 
functioning as a “set-point” for cadherin expression levels (Kourtidis et al., 2013) (Fig. 
1.7). Experiments in a colon carcinoma cell line were the first to reveal the importance of 
p120-catenin in that the epithelial nature of these cells could be restored upon exogenous 
expression of p120-catenin. This occurs through an increase in the E-cadherin half-life and 
protein levels without changes to E-cadherin transcripts, suggesting that p120-catenin 
could stabilize cadherin protein levels. Subsequent studies showed that p120-catenin binds 
to the cadherin cytoplasmic tail and that loss of p120-catenin augments cadherin 
endocytosis (Davis et al., 2003; Xiao et al., 2003b). Interestingly, expressing cadherin 
mutants that compete for p120-catenin binding results in endocytosis of the endogenous 
cadherin, while cadherin mutants that cannot bind to p120-catenin lack this activity (Davis 
et al., 2003; Xiao et al., 2003b; Xiao et al., 2005). This suggests that p120-catenin could 
serve as a master regulator of cadherin levels in cells, and competition to bind to p120-
catenin could determine the cadherin expressed on the plasma membrane in cells that 
express two different cadherins. Indeed, exogenous expression of R-cadherin causes 
endocytosis and downregulation of endogenous E- and P-cadherins in A431 cells (Maeda 
et al., 2006), and exogenous VE-cadherin similarly affects N-cadherin (Ferreri et al., 2008). 
Subsequent studies have focused on the mechanism of action of p120-catenin, which is 
thought to serve as a physical mask and prevent the recognition of endocytosis sorting 
motifs by adaptor proteins of the clathrin-mediated endocytosis pathway (Miyashita and 
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Ozawa, 2007a; Chiasson et al., 2009; Ishiyama et al., 2010). Recently, the crystal structure 
of the E-cadherin-p120-catenin complex was solved, and it reveals that the p120-catenin-
E-cadherin interface contains both static and dynamic binding regions, supporting 
competitive binding of cadherins or of endocytic adaptor proteins (Ishiyama et al., 2010). 
The Rho family of small GTPases, including RhoA and Rac, plays important roles 
in cadherin endocytosis through regulation of the cadherin/catenin complex or intracellular 
trafficking steps. Activation of Rac1 has both stimulatory and inhibitory effects on cadherin 
endocytosis, depending on the cell type examined. In endothelial cells, VE-cadherin is 
refractory to regulation by Rho or Rac activity; however, when expressed in CHO cells, 
inhibition of Rho or Rac induces VE-cadherin endocytosis from junctions (Braga et al., 
1999). Similarly, inhibition of Rho or Rac causes endocytosis and degradation of E-
cadherin and P-cadherin (Braga et al., 1999). In L-cells, E-cadherin endocytosis is 
regulated by Rho but not Rac (Braga et al., 1999).  
 
1.6.2.3.2.5. Regulation of Cadherin Endocytosis by Growth Factors 
Given their fundamental importance in homeostasis, cadherins are not only regulated by 
intracellular processes but also by extracellular signals that include the hepatocyte growth 
factor (HGF), epithelial growth factor (EGF), vascular endothelial growth factor (VEGF), 
fibroblast growth factor (FGF), and transforming growth factor β (TGFβ) signaling 
pathways (reviewed in (Kowalczyk and Nanes, 2012)). Treatment of cells with HGF, 
which stimulates cell motility, causes endocytosis of both the HGF receptor and associated 
E-cadherin (Kamei et al., 1999) through a clathrin-mediated pathway that employs the 
Numb adaptor (Wang et al., 2009). Similarly, VEGF, which disrupts endothelial cell-cell 
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junctions and causes vasculogenesis and angiogenesis, functions through Src-mediated 
phosphorylation of VE-cadherin. This leads to the recruitment of β-arrestin and subsequent 
clathrin-mediated endocytosis of VE-cadherin (Gavard and Gutkind, 2006). Interestingly, 
VE-cadherin can reciprocally influence the endocytosis of the VEGF receptor. In confluent 
cells, VE-cadherin associates with the VEGF receptor and not only prevents VEGF 
receptor internalization but also redirects it from the lysosomal to a recycling pathway 
(Grazia Lampugnani et al., 2003). Treatment of cells with EGF, on the other hand, causes 
E-cadherin internalization through a caveolin-mediated (Lu et al., 2003) or a 
macropinocytic (Bryant et al., 2007) pathway. Similar to VE-cadherin, E-cadherin-EGF 
















1.7. Rationale and objectives 
In the developing chick embryo midbrain, Cad6B transcripts and protein expression begin 
at the 3 and 4 somite stages (ss), respectively, just as neural crest cells are segregating from 
the ectoderm and the non-neural ectoderm (there is 90 minutes between each somite stage) 
(Hamburger and Hamilton, 1992) (Fig. 1.8). The expression of the transcripts and protein 
gradually increases in premigratory cranial neural crest cells and at the 6ss, when neural 
crest cells undergo delamination, Snail2-mediated transcriptional repression of cad6B 
occurs (Taneyhill et al., 2007). By the 7ss, as neural crest cells undergo EMT, cad6B 
transcripts are completely repressed, and levels of Cad6B protein, surprisingly, are also 
significantly reduced (Taneyhill et al., 2007; Schiffmacher et al., 2014) (Fig. 1.8). Cad6B 
has a half-life of 5.5 hours in vitro (Schiffmacher et al., 2014), however, suggesting that 
this substantial loss of Cad6B protein from premigratory cranial neural crest cells may 
occur through active post-translational mechanisms to remove Cad6B from these cells. 
Studies by Schiffmacher et al. (2014) revealed that Cad6B undergoes proteolysis and 
separation of the extracellular and the intracellular domains mediated by ADAM10, 
ADAM19 and ƴ-secretase enzymes (Schiffmacher et al., 2014). Nevertheless, we note 
Cad6B localized to cytoplasmic puncta in premigratory and early migratory cranial neural 
crest cells, indicative of a potential role for Cad6B internalization as cranial neural crest 
cells undergo EMT. The possibility that internalization of Cad6B plays an important role 
during EMT is not without precedence, as discussed earlier in this Introduction, but has 
never been demonstrated in an in vivo EMT. As such, the aim of this dissertation is to 
investigate if and how Cad6B undergoes internalization in chick premigratory cranial 








Figure 1.8.  Cad6B protein downregulation occurs rapidly after mRNA 
downregulation. Cad6B protein expression (green) is restricted to premigratory neural 
crest cells in the dorsal neural tube (arrows, top panel), begins at 4ss, and correlates with 
the expression profile of cad6B transcripts (arrows, bottom panel, in situ hybridization for 
cad6B mRNA). During EMT (7ss), Cad6B mRNA and protein undergo rapid 




























2.1. Chick embryos 
Fertilized chicken eggs were obtained from B & E Farms (York, PA, USA) and incubated 
at 38°C in humidified incubators (EggCartons.com, Manchaug, MA, USA). Embryos were 
staged by the number of pairs of somites (somite stage, ss) according to Hamburger-
Hamilton (Hamburger and Hamilton, 1992). 
 
2.2. Neural crest cell explant preparation 
Neural crest cell explants were prepared as described in (Coles et al., 2007; Taneyhill et 
al., 2007; Jhingory et al., 2010). Dorsal neural folds (containing premigratory neural crests 
cells) from the midbrain region of chick embryos were dissected out of the embryo using 
tungsten needles in PB-1 standard medium and then placed into chamber slides coated with 
a 1:100 dilution (1µg/mL) of poly-L-lysine (P5899, Sigma, St. Louis, MO, USA) and 
fibronectin (356008, Corning, NY, USA). Cultures were incubated in serum-free 
Dulbecco’s Modified Eagle’s Medium (DMEM, 10-013-CV, CellGro, Manassas, VA, 
USA) supplemented with a 1:100 dilution of N-2 (17502-048, Life Technologies, Carlsbad, 
CA, USA) at 37˚C for varying time periods to observe effects on neural crest cell EMT.  
 
2.3. Cloning of Cad6B mutants  
Full-length Cad6B cloned in pCIG (Coles et al., 2007) was sub-cloned into pCI-H2B-RFP 
(gift from Dr. M. Bronner) along with a hemagglutinin (HA) epitope tag at the Cad6B C-
terminal end through standard cloning procedures. To create the endocytic mutants, Cad6B 
in the pCI-H2B-RFP vector was mutagenized using the QuikChange II XL Site-Directed 
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Mutagenesis Kit (200521, Agilent Technologies, Santa Clara, CA, USA). The primer 
sequences for cloning are:  
LI645AA-HA Forward: 5’ GAG ACG GCA AAG GAA AAA AGA GCC TGC GGC TAT 
TTC CAA AGA AGA CAT CAG AGA C 3’ 
LI645AA-HA Reverse: 5’ CTC TGC CGT TTC CTT TTT TCT CGG ACG CCG ATA 
AAG GTT TCT TCT GTA GTC TCT G 3’ 
EED666AAA-HA Forward: 5’ AAT GAT GAA GGT GGT GGA GCG GCA GCC ACC 
CAG GCA TTT GAT ATC 3’ 
EED666AAA-HA Reverse 5’ TTA CTA CTT CCA CCA CCT CGC CGT CGG TGG 
GTC CGT AAA CTA TAG 3’ 
Primers were chemically synthesized and PAGE-purified by Integrated DNA 
Technologies, Coralville, Iowa, USA. All clones were sequenced ensure sequence 
accuracy. 
  
2.4. FlpIn cell culture and reagents 
CHO cells stably expressing a single integrated copy of wild-type and various endocytic 
mutants of Cad6B were created as described previously using the FlpIn system (K6010-
02, R75807, Life Technologies, Carlsbad, CA, USA; (Schiffmacher et al., 2014)). Briefly, 
HA-tagged wild-type or mutant Cad6B was directionally sub-cloned from the pCI-H2B-
RFP vector (above) into the pcDNA5/FRT expression vector and co-transfected at a 1:9 
ratio with the pOG44 plasmid into FlpIn-CHO cells (R758-07, Life Technologies, 
Carlsbad, CA, USA). 24 hours posttransfection, media was replaced with antibiotic-free 
F12 media, and then another 24 hours later, cells were trypsinized and plated at 20–25% 
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confluency in F12 media supplemented with 1 mM L-glutamine and 600μg/ml hygromycin 
to select for individual clones of positive transfectants (cells were subsequently grown in 
this medium). Fresh medium was added every 2 days until small colonies of stable cells 
were observed. Individual colonies were aseptically transferred to 96 well plates and 
cultured to confluency. Colonies were then sequentially passaged into 48-, 24-, and 12-
well plates. Colonies were screened for Cad6B expression by immunohistochemistry and 
immunoblotting, and those with maximum transfection efficiency were eventually 
passaged to 10-cm plates, and grown in a humidified incubator (with 5% CO2 and 95% air) 
at 37˚C in Ham’s F12 growth media supplemented with 10% fetal bovine serum (S11150, 
Atlanta Biologicals, Flowery Branch, GA, USA), 600μg/mL hygromycin (30-240-R, 
CellGro, Manassas, VA, USA), 1mM L-glutamine (25-005, CellGro, Manassas, VA, 
USA), and 1:100 dilution of 1:1 penicillin-streptomycin (30-002-CI, CellGro, Manassas, 
VA, USA).  
 
2.5. Immunohistochemistry 
Embryos were collected at the 6ss and 7ss and fixed in 4% paraformaldehyde (PFA) for 30 
minutes at room temperature. The embryos were permeabilized in fresh Tris-buffered 
saline (TBS) containing 0.2% TX-100 (TBST) and blocked in TBST buffer containing 5% 
fetal bovine serum for one hour at room temperature. Immunofluorescence was performed 
on whole embryos overnight at 4˚C with Cad6B primary and anti-mouse Cad6B secondary 
antibodies as in (Jhingory et al., 2010; Schiffmacher et al., 2014). To observe Cad6B 
protein in explants, explants were fixed by serial dilution of the explant media with 4% 
PFA for 20 minutes at room temperature, permeabilized with fresh TBST, blocked with 
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5% FBS in TBST, and incubation with the Cad6B primary antibody overnight at 4˚C and 
with secondary antibody for three hours at room temperature. For immunostaining of cell 
lines, cells were fixed in either 4% PFA for 20 minutes at room temperature or in cold 5% 
ethanol/95% acetic acid for 20 minutes at -20˚C. For cells fixed in 4% PFA, 
permeabilization was carried out with TBST, and immunofluorescence was performed as 
for the explants. For cells fixed in ethanol/acetic acid, immunofluorescence was performed 
similarly as for explants but in TBS buffer without detergents. 
The following primary antibodies and concentrations were used in the experiments 
following fixation by conditions provided in the next section. Cad6B (1:100 in whole-
mount and 1:250 on sections and cells: Cad6B (CCD6B-1, Developmental Studies 
Hybridoma Bank, OH, USA; referred to as NT6B in the text), caveolin-1 (1:500; ab2910, 
Abcam, Cambridge, England), HA (1:750; 3F10, Roche, Basel, Switzerland), clathrin 
(1:750; ab21679, Abcam, Cambridge, England), Na+K+ATPase (1:750; ab76020, Abcam, 
Cambridge, UK), p120-catenin (1:500; sc-373751; Santa Cruz Biotechnology, Santa Cruz, 
CA, USA), β-catenin (1:500; AHO0462, Life Technologies, Carlsbad, CA, USA), GFP 
(1:1000; R10367, Life Technologies, Carlsbad, CA, USA), FoxD3 (1:500; kind gift from 
Dr. David Raible (Department of Biological Structure, University of Washington, Seattle, 
WA, and K-cad (1:200; ab64917, Abcam, Cambridge, UK; referred to as CT-6B in the 
text). Alexa Fluor488-conjugated phalloidin (Life Technologies, Carlsbad, CA, USA) was 
used at 1:50. Appropriate fluorescently-conjugated secondary antibodies (AlexaFluor 488, 
594, 647; Life Technologies, Carlsbad, CA, USA) were used at the following 
concentrations: Cad6B (1:250 in whole-mount and 1:500 on cells), HA (1:1000), clathrin 
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(1:1000), Na+K+ATPase (1:1000), p120 (1:1000), β-catenin (1:1000), GFP (1:1500), and 
K-cad (1:750). 
 
2.6. In ovo electroporation and FoxD3 cell counts 
Cad6B wild-type and mutant expression constructs were introduced into premigratory 
midbrain neural crest cells in developing 3ss chick embryos using a modified version of in 
ovo electroporation (Itasaki et al., 1999) procedure. Constructs were injected at a 
concentration of 3μg/μl into the neural tube lumen and two 30-ms pulses at 25 V were 
applied across the embryo for unilaterally introducing the constructs into one side of the 
neural tube (Jhingory et al., 2010; Wu et al., 2011; Wu and Taneyhill, 2012). Embryos 
were incubated at 37˚C until they grew to 6-7ss, harvested, fixed, and processed for 
immunofluorescence as described below. The embryos were subsequently embedded in 
20% gelatin in 1X phosphate-buffered saline (PBS), cryostat-sectioned at 14 μm, and 
mounted for imaging. In midbrain regions where neural crest cell migration had 
commenced, 5–7 serial images were captured for at least 8 embryos that had exogenous 
Cad6B expression in the dorsal neural tube. Every DAPI- and FoxD3-positive nuclei in the 
migratory streams on both the electroporated and non-electroporated side was counted and 
recorded to detect population effects of expressing exogenous Cad6B. The fold differences 
were averaged over the number of sections in which cells were counted, and the standard 
error of the mean was calculated and compared for embryos electroporated with wild-type 
Cad6B. Significance of results was established using the unpaired Student's t test, as in 




2.7. Cad6B antibody feeding assays  
The feeding assay was performed in vivo as in (Arancibia-Carcamo IL, 2006) with the 
following modifications. The hollow neural tube lumen of 5ss embryos was filled with 
CCD6B-1 antibody after electroporation with an expression construct coding for 
membrane-GFP to label plasma membranes (a kind gift from Dr. Paul Kulesa, Stowers 
Institute of Medical Research, Kansas, MO). After incubation for a few hours to allow for 
EMT to occur, the embryos were fixed and immunofluorescence was performed for Cad6B 
and GFP as described above (Fig. 2.1).  
The feeding assay was performed in vitro as in (Arancibia-Carcamo IL, 2006) with 
minor modifications. FlpIn-CHO cells stably expressing wild-type Cad6B were washed 
with 3X ice-cold fresh PBS2+ (PBS supplemented with 1.5mM MgCl2 and 0.2mM CaCl2) 
to slow down cellular processes and incubated with a 1:50 dilution of NT6B antibody in 
cell culture media at 4˚C for an hour to allow for the NT-6B antibody to recognize Cad6B. 
The cells were washed with 3X ice-cold PBS2+ to remove excess antibody, replaced with 
warm media, and incubated at 37˚C for an hour to permit internalization to occur. 
Following this, the cells were brought back to 4˚C and subjected to 3X acid wash with a 
low pH buffer (0.1M glycine, pH 2.0) for 5 minutes at 4˚C. The cells were washed 2X with 













Figure 2.1. Cad6B antibody feeding assay in vivo. Cad6B antibody recognizes and binds to 
endogenous Cad6B protein. The Cad6B antibody-Cad6B complex should be processed in the 
same way as endogenous Cad6B protein. Membrane GFP serves as a marker of individual 




To perform the feeding assay ex vivo, cranial dorsal neural folds from 5ss embryos 
were explanted as described above into one well of a 4-well chamber slide and incubated 
at 37˚C for 90 minutes to allow the tissue to attach to the chamber slide. The media was 
serially diluted with ice-cold fresh PBS2+, and the explants were incubated at 4˚C for 5 
minutes. PBS2+ was then serially diluted with ice-cold explant media containing a 1:50 
dilution of CCD6B-1 antibody and incubated at 4˚C for an hour. Following serial dilution 
with ice-cold PBS2+ to remove excess antibody, fresh warm explant media was serially 
added to the explants and incubated at 37˚C for three hours to allow for EMT and cellular 
processes such as internalization to occur. The explants were brought back to 4˚C to slow 
down cellular processes and following serial dilution of the explant media with ice-cold 
PBS2+, non-internalized antibody (bound to the plasma membranes) was removed by 
treatment with a low pH buffer as described above for 15 minutes at 4˚C temperature. The 
explants were then fixed, permeabilized, and immunofluorescence was performed as 














Figure 2.2. Cad6B antibody feeding assay ex vivo. Similar to feeding assay in vivo 
(Fig. 8), the Cad6B antibody-Cad6B complex gets processed in the same way as 
endogenous Cad6B protein (red). Internalized Cad6B-Cad6B antibody complex and 
membrane-bound Cad6B is differentiated by means of an antibody that recognizes the 
C-terminal end of Cad6B (green). Thus, green immunofluorescence denotes membrane-
bound Cad6B, while yellow immunofluorescence denotes internalized Cad6B. 
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2.8. Protein extraction and immunoblotting 
Protein extraction and immunoblotting was performed as described in (Schiffmacher et al., 
2014). FlpInCHO cells expressing wild-type or mutant Cad6B were scraped in ice-cold 
PBS2+ and pelleted with low-speed centrifugation at 2300rpm for 5 minutes at 4˚C. The 
PBS2+ was completely removed and the cell pellets were stored at -80˚C until required. For 
cell lysis, 2X volume of lysis buffer (50mM Tris, pH 8.0, 150mM NaCl, 1% IGEPAL CA-
630) supplemented with cOmplete Protease Inhibitor Cocktail (Roche, Basel, Switzerland) 
and 1 mM PMSF was added to the cell pellets on ice and subjected to gentle vortexing 
every 5 minutes for a total lysis time of 30 minutes at 4˚C. The lysate was subjected to 
high-speed centrifugation at 14000rpm for 15 minutes at 4˚C in order to separate the debris, 
and the protein concentration was quantified by Bradford assay (Thermo Scientific, 
Rockford, IL). Equivalent amounts of protein per sample were boiled at 95°C for 5 minutes 
in 4X reducing Laemmli sample buffer and centrifuged at maximum speed for 5 min at 
room temperature. The lysates were processed by SDS–PAGE electrophoresis in 1.5mm-
thick 7.5% PAGE gels at 100V for 2 hours at room temperature. The gels were rinsed in 
water and soaked in cold 1X transfer buffer (1X running buffer without SDS) along with 
pre-cut PVDF membranes for 20 minutes at 4°C.  The separated proteins were transferred 
on to the PVDF membranes in 1X transfer buffer at 100V for 1 hour in ice-cold conditions. 
Membranes were blocked in 5% non-fat milk in PBS supplemented with 0.1% Tween 
(PBS-Tween) for 30 minutes at room temperature and incubated overnight at 4°C with the 
following primary antibodies diluted in the blocking solution: Cad6B (1:80, CCD6B-1), β-
actin (1:1000; sc-47778, Santa Cruz Biotechnology, Santa Cruz, CA, USA), p120-catenin 
(1:1000; sc-373751; Santa Cruz Biotechnology, Santa Cruz, CA, USA), and HA (1:2500; 
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3F10, Roche, Basel, Switzerland). Non-specifically bound antibodies were washed off with 
PBS-Tween 3X for 10 mins at room temperature. Membranes were subsequently incubated 
with species- and isotype-specific horseradish peroxidase-conjugated secondary antibodies 
(40ng/ml; Jackson ImmunoResearch, West Grove, PA, USA) in blocking solution for 1 
hour at room temperature. Following 3X 10 minutes antibody washes with PBS-Tween, 
antibody detection was performed using the Supersignal West Pico or Femto 
chemiluminescent substrates (Thermo Pierce Scientific, Waltham, MA, USA) by mixing 
the substate and the enhancer solutions at a ratio of 1:1 and laying it on the membrane for 
5 mins at room temperature. Following removal of excess substrate:enhancer solution, 
protein bands on the PVDF membrane were visualized using the ChemiDoc XRS system 
(Bio-Rad, Hercules, CA, USA). Immunoblot band volumes (intensities) were calculated 
from unmodified immunoblot images using Image Lab software (Bio-Rad, Hercules, CA, 
USA) and analyzed by repeated measures analysis of variance assuming a compound 
symmetric covariance matrix for time and an unstructured covariance matrix for band 
intensity based on AIC values within the PROC MIXED procedure in SAS statistical 
software (SAS Institute, Cary, NC). Levels were deemed significantly different when p < 
0.05 based on Fisher’s LSD multiple mean comparison test. Confidence intervals were 
calculated for the cytoskeleton (CSK) extraction assays and were deemed statistically 
significant if the confidence intervals did not overlap.   
 
2.9. Magnetic beads co-immunoprecipitation  
For reversible co-immunoprecipitation, cells from four 10cm plates were scraped in ice-
cold PBS2+ and centrifuged at 2300rpm for 5 minutes at 4˚C. The PBS2+ was completely 
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removed, and 4X volume of lysis buffer (50mM Tris, pH 8.0, 150mM NaCl, 0.5% IGEPAL 
CA-630) supplemented with cOmplete Protease Inhibitor Cocktail (Roche, Basel, 
Switzerland) and 1mM PMSF was added to the cell pellets, pooled, and lysed gently on a 
rotator platform for 30 minutes at 4˚C. The lysate was then subjected to high- speed 
centrifugation at 14000rpm for 15 minutes at 4˚C in order to separate the debris from the 
supernatant. The supernatant was separated into two halves and each half was pre-cleared 
individually with a mixture of 40µL each of protein A and protein G beads. Antibody pre-
clearing was performed by adding 2µg of mouse IgG for the p120 immunoprecipitation 
and 2ug rat IgG for the HA immunoprecipitation for one hour at 4˚C. Protein concentration 
was then determined by a Bradford assay (Thermo Scientific, Rockford, IL). Two 
micrograms of p120 and HA antibody was added to 1.5 and 1.2mg of appropriate pre-
cleared lysates for immunoprecipitation, respectively, and the antigen-antibody complexes 
were allowed to form overnight at 4˚C in the rotator platform. On the next day, the antigen-
antibody complexes were captured on protein A/G magnetic beads (88804, Thermo 
Scientific, Rockford, IL) for one hour at room temperature. Following 3X washes with 1X 
lysis buffer at room temperature, the beads were boiled at 95°C for 5 minutes in 4X 
reducing Laemmli sample buffer and centrifuged at maximum speed for 5 min at room 
temperature. The lysates were processed by SDS–PAGE electrophoresis in 1.5mm-thick 
4% PAGE gels at 100V for 2 hours at room temperature and transferred to PVDF 
membranes as described earlier. Antibody addition and detection was performed as 





2.10. Cell surface biotinylation 
Four 6cm plates of confluent layers of FlpInCHO cells stably expressing wild-type or 
endocytic mutants of Cad6B were brought to 4˚C to significantly slow down cellular 
processes and washed twice with ice-cold PBS2+ for 5 minutes at 4˚C (Fig. 2.3). After 
removing all traces of PBS2+, 1mL of freshly-prepared solution of EZ-Link Sulfo-NHS- 
Biotin (21326; Thermo Scientific, Waltham, MA, USA) dissolved in ice-cold PBS2+ was 
added to the cells at a concentration of 1mg/mL, and was incubated on a rocking platform 
at low speed for 30 minutes at 4˚C. After removal of the biotin solution, excess biotin was 
quenched with by washing 3 times, 5 minutes each, with ice-cold PBS2+ supplemented with 
100mM glycine and 0.5% BSA at low speed on the rocking platform. After rinsing off the 
residual quenching buffer with ice-cold PBS2+, cells were scraped off the dish from one of 
the plates in ice-cold PBS2+, pelleted at 2300rpm for 5 minutes at 4˚C, and set aside as 
positive control for the “Total Surface” fraction. Biotin was then stripped off of cells from 
another plate by washing cells 3 times, 10 minutes each, at 4˚C using a stripping buffer 
(75mM NaCl, 75mM NaOH, 50mM L-glutathione (0399, Amresco, Solon, OH, USA) 
supplemented with 1% BSA) at low speed on a rocking platform, followed by scraping the 
cells in ice-cold PBS2+, centrifugation, and the cell pellets set aside as negative control 
(T=0). Warm growth media (see above) was added to the cells in the remaining two plates, 
and cells were incubated at 37˚C for 60 minutes and 180 minutes, respectively, to allow 












Figure 2.3. Cad6B biotinylation assays in vitro. Cells expressing Cad6B are biotinylated at 
cold and incubated for various times at physiological temperature to allow for internalization. 
Following release of non-internalized biotin, cells are lysed and biotinylated proteins are 
immunoprecipitated with streptavidin. The amount of immunoprecipitated protein is a direct 




At the indicated time points, cells were brought back to 4˚C, rinsed 2X with ice-cold PBS2+, 
and any remaining biotin from cell surface-bound, non-endocytosed proteins was removed 
with the biotin stripping conditions as described above (Fig. 2.3). All the cell pellets were 
stored at -80˚C until ready for use. Cell pellets were thawed on ice and was lysed and 
subjected to a Bradford protein analysis with the protocol as described above in the 
immunoblotting section. Meanwhile, Streptavidin-Agarose resin (20347, Thermo 
Scientific, Waltham, MA, USA) was pre-blocked by rinsing the beads 3X with a 4% BSA 
solution, and replaced with 1X lysis buffer. Streptavidin-Agarose resin was incubated at a 
volume equivalent to 0.33μL per μg protein lysate with 175 (for wtCad6B-HA and 
LI645AA-HA cell lysates) or 200μg (for EED666AAA-HA lysate) of total protein lysate 
(in a total volume of 400μL) in a rotating-platform overnight at 4˚C to immunoprecipitate 
biotin-labeled proteins (Fig. 2.3). The following day, non-specific interactions were 
removed by rinsing the beads three times with 1X lysis buffer through gentle tube 
inversion. Freshly prepared 2X Laemmli sample buffer was added to the resin, and samples 
were boiled at 95˚C for 5 minutes and loaded onto a 7.5% PAGE gel. Electrophoresis, 
immunoblotting, and band intensity quantification for Cad6B was performed as described 
above.  
 
2.11. TX-100 extraction of soluble and insoluble proteins 
Sixty microliters of ice-cold cytoskeleton extraction buffer (CSK) (50mM NaCl, 10mM 
Pipes pH 6.8, 3mM MgCI2, 0.5%Triton X-100, 300mM sucrose), supplemented with 
1.2mM PMSF (36978; Thermo Pierce, Waltham, MA, USA) and 1X dilution of cOmplete 
Protease Inhibitor Cocktail (04693124001; Roche, Basel, Switzerland), was added to equal 
59 
 
numbers of FlpIn-CHO cells expressing wild-type or mutant Cad6B in 12-well dishes and 
incubated on a rocking platform for 30 minutes at 4˚C with occasional manual mixing. The 
extraction buffer was collected, centrifuged at maximum speed for 5 minutes at 4˚C, and 
the supernatant was designated as the TX-100 soluble fraction. The cells remaining on the 
plate were scraped and pelleted in ice-cold PBS2+, and 2X Laemmli sample buffer was 
directly added to the cell pellet. Following brief pulses of sonication to shear genomic 
DNA, the lysate was centrifuged at maximum speed for 5 minutes at 4˚C, and designated 
as the TX-100 insoluble fraction. Following addition of 6X Laemmli sample buffer to the 
TX-100 soluble fraction, both the TX-100 insoluble and soluble fractions were boiled at 
95°C for 5 minutes and all the lysates were loaded on to a 7.5% PAGE gel and subjected 
to SDS-PAGE electrophoresis as describe above. Immunoblotting and band intensity 
quantification as also performed described above.  
 
2.12. Inhibitor treatment of explants 
Cranial neural folds containing premigratory neural crest cells were directly explanted onto 
4-well chamber slides containing 0.5% (vol/vol) DMSO, Dynasore (100uM; 304448-55-3, 
Adipogen, San Diego, CA, USA), Latrunculin A (100nM; L5163, Sigma-Aldrich, St. 
Louis, MO, USA), or EIPA (50uM; 3378, Tocris Bioscience, Sunnyvale, CA, USA) 
dissolved in 500μL neural crest explant media. The explants were incubated for 3 hours at 
37˚C to allow for the neural crest cells to undergo EMT, and were fixed by serial dilution 
of the explant media with 4% PFA five times and incubating for 10 minutes at room 
temperature. Following removal of the fixative and a brief rinse with TBS, the explants 
were permeabilized with TBST and processed for immunofluorescence as described 
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previously. To quantify the size of the putative macropinocytic vesicles, each vesicle (n = 
18) was visualized in 3D using the Zen software (Zeiss), and vesicle length was measured 
at its greatest extent using the Measurement tool provided in the software.  
 
2.13. Confocal microscopy 
All images were acquired with the LSM Zeiss 710 microscope (Carl Zeiss Microscopy, 
Thornwood, NY, USA) at the Imaging Core Facilty, University of Maryland, College Park. 
Where possible, the laser power, gain, and offset were kept consistent for the different 
channels throughout experiments. The pinhole was always set to one airy unit. The z-
section optical images were acquired between 0.25-0.4μm per optical section and 






















 Cad6B is internalized in premigratory cranial neural crest 






Parts of this section were adapted from the following article under re-review at the   
Journal of Cell Science: 
Padmanabhan R, Taneyhill LA (2015). Cadherin-6B undergoes macropinocytosis and 









In chick premigratory cranial neural crest cells, Cad6B is proteolytically processed by 
ADAM10, ADAM19 and ƴ-secretase (Schiffmacher et al., 2014). Nevertheless, Cad6B is 
also observed as puncta in premigratory neural crest cells and in cultured cells, suggesting 
that Cad6B could get internalized through endocytosis (or other mechanisms) during 
cranial neural crest cell EMT. The hypothesis that internalization of Cad6B could play an 
important role during EMT is not without precedence, as described in Chapter 1, Section 
3.2, but such findings for cadherins have never been described for an in vivo EMT. To 
confirm that the observed Cad6B cytoplasmic puncta were due to 
internalization/endocytosis rather than exocytosis, we performed Cad6B antibody feeding 
assays in vivo, using an antibody against the Cad6B extracellular domain, to follow the 
processing of endogenous Cad6B protein. The antibody feeding assays showed the 
presence of Cad6B antibody-Cad6B complexes in the cytoplasm of premigratory cranial 
neural crest cells, suggesting that Cad6B could be internalized. To rule out the possibility 
that addition of Cad6B antibody could be stimulating Cad6B internalization, the antibody 
feeding assays were performed with the inclusion of an acid wash to remove any non-
internalized (membrane-bound) Cad6B. Together with the preceding results, these data 
reveal that addition of Cad6B antibody does not stimulate Cad6B internalization, strongly 
suggesting that the Cad6B cytoplasmic puncta observed in wild-type embryos, in cultured 







3.2. Generation of a stable cell line for biochemical analysis of Cad6B  
Prior work demonstrated that the transcription factor Snail2 represses cad6B transcription 
in chick premigratory cranial neural crest cells prior to EMT (Taneyhill et al., 2007). 
Cad6B protein levels, however, are rapidly reduced over a span of ninety minutes (the 
developmental time frame for the addition of one somite pair in the chick embryo) during 
EMT (Hamburger and Hamilton, 1992) (Fig. 1.8). Since cadherins generally possess long 
half-lives (Ireton et al., 2002; Pujuguet et al., 2003; Pon et al., 2005), the loss of the majority 
of Cad6B protein within ninety minutes raised the possibility that additional mechanisms 
besides transcriptional repression and steady-state protein turnover were in place. To 
substantiate this possibility, we first determined the stability of Cad6B in vitro by creating 
a Cad6B stable cell line.  
A cell line stably expressing wild-type Cad6B (tagged with a hemagglutinin (HA) 
epitope at the C terminus) from a single genomic locus was generated using CHO cells as 
the parent cell line (FlpInwtC6B-HA). Single-copy expression of Cad6B was important to 
minimize any deleterious effects that might occur due to Cad6B overexpression 
(Levenberg et al., 1999; Bryant et al., 2005), and CHO cells were chosen because they do 
not express any endogenous cadherins (Hong et al., 2010). Immunofluorescence for Cad6B 
was performed on fixed FlpInwtC6B-HA cells with an antibody that recognizes the N 
terminal, extracellular domain of Cad6B (this antibody will now be referred to as NT6B) 
and HA to determine if the transgene was properly expressed. FlpInCHO cells stably 
transfected with the empty expression vector had no detectable immunofluorescence for 
Cad6B (Fig. 3.1A-A”), while FlpInwtC6B-HA cells exhibited Cad6B immunofluorescence 
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on the plasma membranes of apposing cells (Fig. 3.1C”, arrows) and in what appear to be 
cytosolic puncta (Fig. 3.1C”, arrowheads). Cad6B (NT6B) was also at times observed to 
be negative for HA immunoreactivity, suggesting these could be the N-terminal fragments 
post-proteolysis by unknown proteases in the FlpInCHO cell lines (Fig. 3.1C”, caret), 
consistent with our prior results (Schiffmacher et al., 2014). These data demonstrate that 
Cad6B-HA localizes to the correct location as other cadherins in vitro and endogenous 
Cad6B in embryos (see Fig. 3.4 below) (Breviario et al., 1995; Nakagawa and Takeichi, 
1995; Navarro et al., 1998; Taneyhill et al., 2007; Schiffmacher et al., 2014). We also 
performed immunoblotting for Cad6B (NT6B) in lysates prepared from FlpInwtC6B-HA 
cells and compared the relative molecular weight of Cad6B-HA to endogenous Cad6B 
expressed by embryos in vivo. As shown in Fig. 3.1D, Cad6B-HA expressed by the 
FlpInwtC6B-HA cells and by embryos is approximately the same molecular weight, 
indicating that Cad6B-HA is biosynthesized and localizes similarly in this cell line as 
observed in vivo. Additionally, we notice an additional ~100kDa band recognized by the 
Cad6B (NT6B) antibody, which could be a proteolytic product of Cad6B (Schiffmacher et 
al., 2014) and thus the identity of the Cad6B (NT6B)-positive HA-negative puncta seen 











                                                                                                                                                                                                                                                                  
Figure 3.1. Cad6B in the FlpInwtC6B-HA cells is observed in the correct sub-cellular 
pattern and is expressed at the appropriate molecular weight. Immunofluorescence 
performed for NT6B (green) and HA (red) on FlpInCHO cells stably transfected with 
empty vector (A-A”) and FlpInwtC6B-HA cells (B-B”) (n = 30). (C-C”) are higher 
magnification views of the boxed region in (B”). Arrows and arrowheads represent Cad6B 
(NT6B) and HA co-staining at the membrane and cytoplasm, respectively. Caret in (C”) 
represents NT6B-positive but HA-negative puncta that are occasionally observed. Panels 
represent the 3D composite of 17 Z-stack images (0.25 µm/optical slice) acquired with a 
confocal microscope. (D) Immunoblotting for Cad6B (NT6B) in lysates prepared from 12-
16ss embryos and FlpInwtCad6B-HA cells (Cad6B bands in the last two lanes will be 
discussed in the next chapter). The band at ~100kDa is presumed to be a proteolytic 
product of Cad6B due to the action of endogenous proteases in CHO cells, as observed in 
(Schiffmacher et al., 2014). Immunoblotting for β-actin was performed as a loading 






3.3. Cad6B is stable for 5.5 hours in vitro 
As mentioned above, the loss of the majority of Cad6B protein within ninety minutes in 
premigratory cranial neural crest cells is suggestive of either Cad6B turnover through 
additional mechanisms or that Cad6B possesses a short half-life. To address the latter 
possibility, the stability of Cad6B was determined in vitro by examining Cad6B-HA levels 
over time upon inhibition of de novo protein synthesis with addition of cycloheximide. Our 
results reveal that Cad6B-HA is stable for 5.5 hours in FlpInwtC6B-HA cells (Fig. 3.2). 
This is in agreement with what has been observed for E-cadherin (4-6 hours; (Ireton et al., 
2002; Pujuguet et al., 2003)) and N-cadherin (6 hours; (Pon et al., 2005)) in vitro, 
suggesting that other mechanisms likely operate to remove Cad6B from the plasma 















Figure 3.2. Cad6B is stable for 5.5 hours in FlpInwtC6B-HA cells. FlpInwtC6B-
HA cells were treated with cycloheximide for different periods, lysed and subjected 
to SDS-PAGE electrophoresis. Immunoblotting was performed using Cad6B (NT6B) 
and β-actin (loading control) antibodies, and a representative blot is shown (top). 
Densitometric band intensities of Cad6B and β-actin from three independent 
replicates were quantified and plotted on a graph (below). Image reproduced from 
(Schiffmacher et al., 2014). 
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3.4. Cad6B localizes to the cytoplasm in vitro 
To explore the possibility that Cad6B might undergo internalization via endocytosis, we 
performed immunofluorescence for Cad6B (NT6B) and several markers of the endosomal 
and lysosomal compartments (Appendix 1). Most of these latter antibodies (raised against 
human antigens in mouse and rabbit) did not recognize their cognate antigens in chick 
tissue (data not shown; Appendix 1), except for clathrin (discussed in further detail in 
Chapter 5). As an alternative, we obtained endosomal/lysosmal marker-fluorescent protein 
fusion constructs (a kind gift from Dr. Iqbal Hamza, University of Maryland, College Park) 
and expressed them in chick embryos at trace levels (Appendix 2). Although we noted that 
certain endosomal marker-fusion proteins co-localized with Cad6B-HA in vivo, we were 
unable to validate this observation upon performing immunofluorescence against 
endogenous antigens in chick tissue (Appendix 2). Moreover, several constructs were 
ubiquitously expressed leading to spurious co-localization with Cad6B-HA (Appendix 2), 
forcing us to return to our previous approach using antibodies against endogenous proteins. 
For this reason, Na+K+ATPase, a marker of the plasma membrane (Van Dyke, 2004), was 
chosen for use in future assays, as it was one of the few antigens for which successful 
immunostaining could be performed. Since Na+K+ATPase plays an important role in the 
acidification of endosomes (Cain et al., 1989; Fuchs et al., 1989; Feldmann et al., 2007) 
and localizes to Rab5-positive endosomes (Feldmann et al., 2007), we reasoned that 
cytosolic Na+K+ATPase could serve as a marker for the early endosomal compartment. 
Through confocal microscopy analysis of Z-stack images, we observe Cad6B-HA (NT6B) 
on the plasma membrane and in the cytoplasm in apparent puncta, where it partially co-
localizes with Na+K+ATPase (Fig. 3.3A-A”, arrowheads; carets represent puncta in which 
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Cad6B-HA and Na+K+ATPase do not co-localize). These results suggest that Cad6B-HA 














Figure 3.3. Cad6B localizes to the cytoplasm in vitro. (A-A”) FlpInwtC6B-HA cells were fixed 
and immunostained for NT6B (green) and Na+K+ATPase (red). Cad6B-HA (NT6B) partially co-
localizes with Na+K+ATPase in several cytoplasmic puncta (arrowheads in A”; carets represent 
puncta in which Cad6B-HA and Na+K+ATPase do not co-localize) (n = 3). Panels represent the 3D 
composite of 20 Z-stack images (0.35 µm/optical slice) acquired with a confocal microscope. Scale: 







3.5. Cad6B is observed in the cytoplasm of premigratory and early migratory neural 
crest cells (in vivo) and in neural crest cell explants (ex vivo) 
To ascertain whether internalization plays a role in the post-translational downregulation 
of Cad6B in vivo, we performed immunohistochemistry for endogenous Cad6B (NT6B) 
and Na+K+ATPase on 6 and 7ss embryos, when premigratory cranial neural crest cells 
begin to reduce Cad6B levels during EMT (Taneyhill et al., 2007; Schiffmacher et al., 
2014). In addition to Cad6B marking cell membranes (Fig. 3.4A-A’’, arrow), we observe 
Cad6B (NT6B) co-localizing with Na+K+ATPase in cytoplasmic puncta within 
premigratory cranial neural crest cells (Fig. 3.4A”, arrowheads). These results indicate that 
Cad6B (NT6B) may be internalized in these precursor cells prior to and/or during EMT. 
To further address this question, we conducted cranial neural crest cell explant assays 
(Taneyhill et al., 2007) and examined Cad6B (NT6B) in neural crest cells undergoing EMT 
ex vivo in culture. Immunostaining with the NT6B antibody reveals several puncta in the 
cytosol of emigrating neural crest cells (the Na+K+ATPase antibody did not recognize its 
cognate antigen in this ex vivo system), strongly suggesting that Cad6B (NT6B) may be 
internalized in premigratory neural crest cells undergoing EMT and in early migratory 






Figure 3.4. Cad6B localizes to the cytoplasm of neural crest cells undergoing EMT in vivo and ex 
vivo. (A-A”) Embryos possessing neural crest cells initiating EMT were harvested, fixed and 
immunostained for Cad6B (NT6B; green) and Na+K+ATPase (red). Cad6B co-localizes with 
Na+K+ATPase on the plasma membrane (arrows) as well as in cytoplasmic puncta (arrowheads) (n = 20 
transverse sections from at least 10 embryos). (B-B’) Cranial dorsal neural folds possessing premigratory 
neural crest cells were explanted onto chamber slides, allowed to undergo EMT for 3 hours (longer 
incubation time results in significant reduction of immunofluorescence due to natural loss of Cad6B in 
explants), fixed, and immunostained for NT6B (n = 3 explants). The antibody against Na+K+ATPase did 
not recognize their cognate antigen in the explant system. (B’) is a higher magnification view of the 
boxed region in (B). Cad6B (NT6B) localizes to the cytoplasm (arrowheads in B’), similar to what is 
observed in vitro and in vivo. Panels represent the 3D composite of 20 (A-A”) and 23 Z-stack images 
(B-B”) (0.25 µm/optical slice) acquired with a confocal microscope at 63x magnification. Scale bars: 
10μm. Image reproduced from (Padmanabhan R, Taneyhill LA, under re-review at J Cell Sci). 
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3.6. Cad6B antibody feeding assays demonstrate Cad6B in the cytosol of delaminating 
neural crest cells in vivo  
Although suggestive of an internalization event, Cad6B cytoplasmic puncta could also be 
due to exocytosis, as cad6B transcripts (and protein) persist until the 6ss in premigratory 
cranial neural crest cells (Taneyhill et al., 2007; Schiffmacher et al., 2014). To differentiate 
between internalization events and exocytosis, we performed Cad6B antibody feeding 
assays (Arancibia-Carcamo IL, 2006) in which we introduced the NT6B antibody into the 
lumen of embryos electroporated with a membrane GFP construct (to label premigratory 
neural crest cell plasma membranes; a gift from Dr. Paul Kulesa, Stowers Institute of 
Medical Research, Kansas City, MO, USA) (Fig. 3.5B-C”). We reasoned that since the 
NT6B antibody recognizes the lumen-exposed, extracellular domain of Cad6B, the NT6B-
Cad6B complex would be processed in the same way as endogenous Cad6B protein when 
premigratory cranial neural crest cells undergo EMT. As a control, we introduced an 
antibody to RFP into a separate set of embryos and performed the same experiment. RFP 
antibody-fed embryos fail to show any discernable immunofluorescence for Cad6B (Fig. 
3.5A-A”), indicating that addition of an unrelated antibody does not non-specifically 
stimulate internalization of Cad6B. In embryos fed with the NT6B antibody, however, we 
note NT6B-Cad6B in several cytosolic puncta (Fig. 3.5C”, arrowheads) within the confines 
of a membrane GFP-expressing delaminating neural crest cell (Fig. 3.5C”, arrow), as 
discerned by confocal imaging. These data indicate that the Cad6B-containing puncta 













Figure 3.5. Cad6B feeding assays demonstrate that Cad6B puncta are endocytic rather 
than exocytic in nature. RFP (A-A”) or NT6B (B-B”) antibody was introduced into the 
lumen of embryos electroporated with a membrane GFP construct. Embryos were incubated 
to allow for EMT to occur, fixed and then immunostained to detect RFP antibody-Cad6B or 
NT6B antibody-Cad6B complexes (red) and GFP (green) (n = 6 from 3 different embryos). 
(C-C”) are high magnification images of the boxed region in (B). Embryos fed with RFP 
antibody fail to elicit any detectable immunofluorescence with a secondary antibody to detect 
Cad6B (A-A”). Internalized NT6B antibody-Cad6B complexes (C”, arrowheads) are seen in 
the cytoplasm within the confines of the GFP-expressing plasma membrane (C”, arrow) of a 
delaminating neural crest cell. Panels (B-C”) represent the 3D composite of 22 Z-stack 
images (0.25 µm/optical slice) acquired with a confocal microscope at 63x magnification. 
Scale bars: 10μm. Image modified from (Padmanabhan R, Taneyhill LA, under re-review at 










3.7. Addition of Cad6B antibody does not stimulate Cad6B internalization  
Although our current data reveal that Cad6B is internalized both in vitro and in vivo, 
binding of the NT6B antibody to Cad6B protein exposed on cell membranes could have 
artificially stimulated internalization of Cad6B-NT6B complexes. To eliminate this 
possibility, we performed the same antibody assay in vitro (Fig. 3.6A-B”) and ex vivo in 
explants (Fig. 3.7C-D”) with the inclusion of an acid wash protocol. Following addition of 
the NT6B antibody, cells were washed with a low pH buffer, which strips off any plasma 
membrane-bound NT6B antibodies but does not disturb internalized complexes 
(Arancibia-Carcamo IL, 2006). The cells were then fixed, permeabilized and 
immunofluorescence performed to detect the NT6B antibody (through addition of 
secondary antibody alone) and the HA tag at the C terminal end of Cad6B. Cad6B that 
remains on the plasma membrane is recognized only by the HA antibody, while 
internalized NT6B-Cad6B complexes are recognized by both the HA and NT6B antibodies 
(see Fig. 2.2, Materials and Methods). When the assay was performed at 4˚C to slow down 
cellular processes, most of the NT6B antibody was stripped off (Fig. 3.6A) without 
affecting overall membrane distribution of Cad6B, as noted by the continued presence of 
Cad6B on the plasma membrane detected by HA immunoreactivity (Fig. 3.6A”, arrows). 
Performing the assay at 37˚C led to the appearance of several internalized NT6B-Cad6B 
cytoplasmic puncta (Fig.3.6B”, arrowheads) but did not stimulate global internalization of 
Cad6B protein, as indicated by retained plasma membrane HA (Cad6B) immunoreactivity 
(Fig. 3.6B”, arrows).  
The same assay was then performed ex vivo in explants (Figs. 3.7C-C” and 3.7D-
D”) to corroborate these in vitro observations. Here plasma membrane-bound Cad6B was 
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distinguished from internalized NT6B-Cad6B complexes with an antibody that recognizes 
the C terminus of endogenous Cad6B (CT6B). Explants remaining at 4˚C and subjected to 
the low pH wash resulted in the removal of virtually all NT6B antibody bound to non-
internalized (plasma membrane-localized) Cad6B without affecting general Cad6B 
membrane distribution, as shown by the CT6B antibody immunoreactivity (Fig. 3.7B’, B”, 
arrows). Incubating the explants at 37˚C, however, led to the appearance of several NT6B-
Cad6B cytosolic puncta (Fig. 3.7D”, arrowheads) and the persistence of some membrane-
bound Cad6B (Fig. 3.7D”, arrows). These data suggest that addition of the Cad6B antibody 
(NT6B) does not stimulate significant internalization of Cad6B and corroborates our earlier 
observation that the puncta are likely of endocytic rather than exocytic nature. Collectively, 
our observations reveal that Cad6B is internalized in cultured cells and in premigratory 

















Figure 3.6. Cad6B antibody feeding assays in the presence of an acid wash demonstrate 
that the NT6B antibody does not stimulate internalization of Cad6B in vitro. The NT6B 
antibody was added to the media of FlpInwtC6B cells (A-A” and B-B”) and incubated for an 
hour. The cells were then washed with a low pH buffer, fixed and immunostained with the 
NT6B and HA antibodies (n = 4). At 4˚C, little to no internalized NT6B-Cad6B complexes 
are observed, with most (if not all) Cad6B immunofluorescence localized to the plasma 
membrane (A”, arrows). At 37˚C, internalized NT6B-Cad6B complexes are observed in the 
cytoplasm (B”, arrowheads), and Cad6B immunofluorescence is still noted on the plasma 
membrane (B”, arrows). All images represent a single optical slice acquired with a confocal 
microscope. Inset boxes in (A-A”, B-B”) show the original image at 63x, with the asterisks 
in (A, B) indicating the location of the higher magnification field of view shown in the main 
panels. Scale bars: 10μm. Image reproduced from (Padmanabhan R, Taneyhill LA, under re-
























Figure 3.7. Cad6B antibody feeding assays in the presence of an acid wash demonstrate 
that the NT6B antibody does not stimulate internalization of Cad6B ex vivo. The NT6B 
antibody was added to the media of dorsal neural fold explants containing premigratory 
cranial neural crest cells (A-A” and B-B”), and the explants were incubated for to allow for 
EMT to occur. Explants were then washed with a low pH buffer, fixed and immunostained 
with the NT6B and CT6B antibodies (Fig. 2.2) (n = 2 explants). At 4˚C, little to no 
internalized NT6B-Cad6B complexes are observed, with most (if not all) Cad6B 
immunofluorescence localizing to the plasma membrane (A”, arrows). At 37˚C, internalized 
NT6B-Cad6B complexes are noted in the cytoplasm (B”, arrowheads), but some Cad6B 
immunofluorescence is still observed on the plasma membrane (B”, arrows). All images 
represent the 3D composite of 61 (A-A”) and 124 Z-stack images (B-B”) (0.25 µm/optical 
slice) acquired with a confocal microscope at 63x magnification. Inset boxes in (B-B”) show 
the original image at 63x, with the asterisks in (B) indicating the location of the higher 
magnification field of view shown in the main panels.  Scale bars: 10μm. Image reproduced 


















EMT is a highly dynamic and tightly regulated process that is mediated by multiple 
mechanisms (see Introduction, Section 1.4). Endocytosis is one such mechanism, in which 
the internalization of growth factor receptors, cell junction proteins, integrins, and/or 
polarity proteins all facilitate EMT. Aberrant endocytosis of one or more of these 
molecules is now recognized as an emerging feature of cancer (Mosesson et al., 2008). 
Intrigued by the finding that Cad6B is observed in cytosolic puncta in premigratory and 
emigrating cranial neural crest cells, we wondered if Cad6B could be internalized (possibly 
through endocytosis) in premigratory neural crest cells as they undergo EMT. As described 
in the Introduction (Section 1.4.2.2.2), Cad6B is unique in its exclusive expression by the 
premigratory neural crest cell population and its reduction during EMT. Rapid loss of 
Cad6B protein (Taneyhill et al., 2007) suggests that other mechanisms besides 
transcriptional repression exist to remove Cad6B post-translationally from the plasma 
membranes of premigratory neural crest cells. Indeed, Cad6B-HA is stable for 5.5 hours in 
vitro through cycloheximide-inhibition assays, supporting our hypothesis for a potential 
role for post-translational downregulation of Cad6B during EMT, and internalization of 
Cad6B through endocytosis could be one such means by which this occurs. Although the 
half-life of a protein can be more accurately determined through pulse-chase 
immunoprecipitation of radiolabeled proteins, cycloheximide inhibition still provides a 
reasonable estimate of the half-life of Cad6B protein (Zhou 2004). Furthermore, cadherin 
endocytosis during EMT has been demonstrated in vitro (Fujita et al., 2002; Lu et al., 2003; 




A definitive indicator of Cad6B endocytosis would have been a demonstration of 
the co-localization of cytoplasmic Cad6B puncta with known markers of endosomal 
compartments and the lysosome, such as Rab4, Rab7 and LAMP-1. Since antibodies for 
these markers failed to recognize their cognate antigens under various experimental 
conditions in the chick embryo (Appendix 1), and approaches to express endosomal and 
lysosomal marker-fusion proteins proved futile (Appendix 2), Na+K+ATPase, a generic 
plasma membrane marker, was chosen. In addition to serving as a marker of the plasma 
membrane and thus delineating cell boundaries, Na+K+ATPase plays an important role in 
the acidification of endosomes (Cain et al., 1989; Fuchs et al., 1989; Feldmann et al., 2007) 
and localizes to Rab5-positive endosomes (Casciola-Rosen and Hubbard, 1992; Feldmann 
et al., 2007), facilitating a reasonable extrapolation that cytosolic Na+K+ATPase serves to 
denote the early endosomal compartment. Immunofluorescence experiments revealed that 
Cad6B-HA (NT6B) cytosolic puncta noted in FlpInwtC6B-HA cells co-localize with 
Na+K+ATPase (and both proteins also co-localize at the membrane), both in vitro (Fig. 3.3) 
and in vivo (Fig. 3.4). These results suggest not only that Cad6B-HA could undergo 
internalization and localize to the early endosome, but also that the puncta are present 
within the vicinity of the plasma membrane (Fig. 3.3), indicating that these cytoplasmic 
puncta could represent bona fide internalized Cad6B molecules (Fig. 3.3).  
We also observed several NT6B-positive, Na+K+ATPase-negative and NT6B-
negative, Na+K+ATPase-positive puncta (Fig. 3.3, carets), raising questions as to their 
identities.  Since the early endosome serves as an initial sorting compartment (Jovic et al., 
2010), these puncta could represent later events in the endosomal pathway, where Cad6B 
(NT6B) and/or Na+K+ATPase are routed differently, either recycled back to the plasma 
85 
 
membrane or trafficked to the lysosome for degradation. Indeed, Na+K+ATPase-positive 
vesicles undergo both clathrin- and caveolin-mediated endocytosis and subsequently 
localize to the late endosome (Liu et al., 2004; Liu et al., 2005; Periyasamy et al., 2005). 
Further proof for the presence of intracellular Cad6B puncta came from experiments 
performed in neural crest cell explant cultures, in which endogenous Cad6B (NT6B)-
containing puncta localize within the confines of Cad6B (NT6B)-positive neural crest cell 
plasma membranes (Fig. 3.4).  
To ascertain the nature of these puncta (endocytic versus exocytic), in vivo Cad6B 
antibody feeding assays were performed, which showed cytosolic localization of NT6B-
Cad6B complexes within cells expressing membrane GFP (Fig. 3.5). Antibody feeding 
assays have been widely used to study trafficking and endocytosis of a variety of 
transmembrane proteins (Arancibia-Carcamo IL, 2006), including cadherins (Paterson et 
al., 2003; Xiao et al., 2003b; Tai et al., 2007). Importantly, this assay rests on the 
fundamental assumption that the addition of the antibody does not stimulate endocytosis 
of the antigen. Although studies have shown that antibody addition does not increase 
endocytosis in the case of other cadherins (Paterson et al., 2003; Xiao et al., 2003b; Tai et 
al., 2007), this had yet to be shown for Cad6B, thus necessitating the use of the same assay 
(acid wash, Fig.3.6 and 3.7). If the NT6B antibody were stimulating internalization of 
Cad6B, its addition would likely result in gross internalization of Cad6B. Since a 
significant portion of Cad6B was still retained/localized to the plasma membrane, these 
results instead suggest that such stimulation of Cad6B internalization was not occurring, in 
agreement with what is observed for other cadherins. Moreover, performing the assay at 
4˚C did not result in any cytoplasmic NT6B-Cad6B complexes, indicating that the 
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observed puncta are not due to non-specific “antibody-trapping” inside the cells. Taken 
together, the in vitro and ex vivo feeding experiments validate the results obtained in the in 
vivo Cad6B antibody feeding assay. Interestingly, although the Cad6B antibody feeding 
assays were performed identically, a striking difference was observed in the number of 
cytosolic NT6B-Cad6B puncta in vitro (Fig. 3.6B”) compared to ex vivo (roughly 10-fold; 
Fig. 3.7B”). This disparity could be attributed to a variation in the rates of Cad6B protein 
internalization (i.e., Cad6B basal turnover rates in vitro versus en masse Cad6B 
internalization in explant cultures during EMT in response to extrinsic and intrinsic 
signals). Furthermore, this difference supports our initial hypothesis that additional 
mechanisms controlled by such signals must operate to rapidly remove Cad6B from the 
plasma membranes of premigratory neural crest cells for EMT to occur. In addition, the 
size of the Cad6B cytoplasmic puncta observed in vivo, ex vivo and in vitro vary 
considerably. The larger complexes observed ex vivo and in vivo could represent one or 
more internalized compartments merging together as multi-vesicular bodies,                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
indicating that additional mechanisms operating solely in neural crest but not cultured cells 
may be in place to internalize Cad6B. Collectively, our observations reveal that Cad6B 
undergoes internalization in cultured cells and in premigratory cranial neural crest cells in 
vivo and ex vivo.  
Although convincing, additional experiments could be performed to further 
validate that the NT6B antibody does not stimulate Cad6B internalization: (1) After 
addition of the NT6B antibody, the neural fold explants could be incubated for a shorter 
time period (less than the current 3.5 hours used herein) to investigate whether there is a 
decrease in the number of NT6B-Cad6B complexes. (2) The assay could be performed 
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using tissue that is negative for Cad6B. (3) An antibody against another neural crest 
cadherin, such as E-cadherin or N-cadherin, could be fed to dorsal neural fold explants to 
determine if another cadherin antibody can affect Cad6B localization. (4) Cad6B in the 
midbrain could be knocked down through morpholinos and then the NT6B antibody could 
be fed. (5) The feeding assays could be performed following inhibition of endocytic 
pathways (e.g., through use of Latrunculin A; see Chapter 5). 
Another important observation from our experiments was the relatively few NT6B-
positive Cad6B puncta in vivo (and ex vivo to a certain extent). If Cad6B is downregulated 
through internalization, it is perplexing that only few Cad6B (NT6B) puncta are observed 
in vivo and ex vivo. Moreover, the NT6B-antibody feeding assays (discussed below) reveal 
a large number of NT6B-Cad6B antibody complexes in emigrating neural crest cells as 
compared to native NT6B immunofluorescence performed on embryos. This difference 
could be partially explained by the conservative image acquisition settings employed, 
wherein only large fluorescence emitters are captured and not their faint counterparts. As 
such, increasing the photomultiplier sensitivity (gain) of the confocal microscope will 
enable visualization of additional NT6B puncta, albeit with increased background. Indeed, 
enhancing the signal of the images post-image acquisition reveals several faint NT6B-
positive immunofluorescence puncta (data not shown). Another explanation is the dynamic 
nature of Cad6B protein downregulation, involving both proteolysis and internalization. 
Our results indicate that neural crest cells possess different degrees of Cad6B 
downregulation in the same transverse section of a chick midbrain, wherein some neural 
crest cells still harbor Cad6B on the membrane while some have started to remove Cad6B 
(Fig. 3.4 illustrates this very well). This, coupled with the occurrence of ADAM-mediated 
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proteolysis (Schiffmacher et al., 2014), could translate into very few cells actively 
internalizing Cad6B at a given time point in the chick midbrain. Moreover, with the 
coordination between ADAM-mediated proteolysis and internalization being unknown, a 
possibility exists that subpopulations of premigratory neural crest cells may employ solely 
proteolysis or internalization to remove Cad6B from their plasma membranes. As such, 
these factors could explain the occurrence of only a few Cad6B puncta in vivo on chick 


























 Cad6B possesses a functional endocytosis motif in its 






Parts of this section were adapted from the following article under re-review at the   
Journal of Cell Science: 
Padmanabhan R, Taneyhill LA (2015). Cadherin-6B undergoes macropinocytosis and 









Although strongly suggestive of internalization, the identification of cytosolic Cad6B-
containing puncta through immunostaining and antibody feeding assays necessitated 
additional biochemical experiments to demonstrate this removal of Cad6B from cellular 
plasma membranes. To this end, we identified and mutated putative endocytosis motifs 
within Cad6B and examined their effects on Cad6B localization and biochemical properties 
in vitro. Multiple sequence alignment of the Cad6B cytoplasmic domain with the 
cytoplasmic domains of other type II cadherins revealed the conservation of two putative 
endocytosis motifs, a dileucine motif and p120-catenin binding motif, which function to 
promote or inhibit endocytosis, respectively. Site-directed mutagenesis was performed to 
change critical residues in these motifs to alanine, and these mutants were expressed stably 
from a single genomic locus in FlpInCHO cells. Experiments were then performed to 
examine Cad6B-HA distribution, including its localization with respect to its catenin-
binding partners, and to biochemically characterize the different Cad6B mutants. We 
hypothesized that mutation of the dileucine motif would decrease Cad6B endocytosis, 
leading to increased cell surface Cad6B and possibly its associated catenins, while 
alterations to the p120-catenin binding motif would augment Cad6B endocytosis and 
decrease Cad6B (and potentially catenin) membrane localization, causing increased 
intracellular distribution of all molecules. 
 In keeping with our hypothesis, mutation of the p120-catenin binding motif to 
alanine resulted in Cad6B-HA localization primarily to the cytosol, enhanced 
internalization of Cad6B-HA in vitro, decreased the ability of Cad6B-HA to form stable 
cell-cell adhesions, and reduced the overall stability of Cad6B. Surprisingly, there was no 
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loss of ability of this mutant to interact with p120-catenin. Furthermore, mutation of the 
EED residues resulted in enhanced cytoplasmic distribution of α- and p120-catenin, but 
not of β-catenin. Interestingly, mutation of the dileucine motif did lead to increased 
presence of Cad6B-HA and β-catenin on the plasma membrane but did not elicit any 
significant effects on the distribution of α- and p120-catenin or on Cad6B-HA 
internalization, stability and cell-cell adhesion. These observations reveal that Cad6B 
internalization, likely through endocytosis, is negatively regulated by a functional p120-
catenin binding motif in vitro. In order to address the question whether Cad6B endocytosis 
is critical for neural crest cell EMT in vivo, we expressed wtCad6B-HA and the endocytosis 
mutants in premigratory neural crest cells and analyzed for effects on neural crest cell 
EMT. Unlike our expectation, expression of wtCad6B-HA and the endocytosis mutants did 















4.2. Generation of putative Cad6B endocytosis mutants 
Several cadherins possess motifs within their C terminal intracellular domains that regulate 
their internalization and degradation (Xiao et al., 2005; Miyashita and Ozawa, 2007b; 
Miyashita and Ozawa, 2007a; Tai et al., 2007; Hong et al., 2010; Kowalczyk and Nanes, 
2012; Nanes et al., 2012). We compared the amino acid sequence of the cytoplasmic 
domain of Cad6B to that of several type II cadherins through the ClustalW algorithm 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/), and identified two conserved motifs that 
could potentially regulate internalization of Cad6B given their function in the endocytosis 
of other cadherins (Fig. 4.1, yellow highlight). Mutation of the dileucine motif negatively 
influences endocytosis (Miyashita and Ozawa, 2007a; Hong et al., 2010), whereas 
mutations in the p120-catenin binding motif promote endocytosis due to the inability of 
p120-catenin to bind to and mask the dileucine motif (Ireton et al., 2002; Xiao et al., 2003b; 
Xiao et al., 2005; Miyashita and Ozawa, 2007a; Ishiyama et al., 2010; Nanes et al., 2012). 
To investigate whether these two motifs regulate the internalization of Cad6B through 
endocytosis, we performed site-directed mutagenesis to create two Cad6B mutant 
constructs, LI645AA-HA and EED666AAA-HA. These constructs were expressed 
independently from a single genomic locus (tagged with the HA epitope at the C terminus) 
in CHO cells using the FlpIn system described in Chapter 3, generating the FlpInLI645AA-







Figure 4.1. Cad6B possesses putative endocytosis motifs in its cytoplasmic tail at the 
juxtamembrane region.  (A) A portion of the ClustalW multiple sequence alignment of the 
Cad6B juxtamembrane domain with those from other type II cadherins. The multiple 
sequence alignment output was then exported into Jalview2 (Waterhouse et al., 2009), 
manually edited and is represented here. The putative dileucine motif (which in these type II 
cadherins is a leucine-isoleucine motif) and the p120-catenin binding motif are highlighted 
in yellow. (B) Cartoon of the Cad6B putative endocytosis motif mutants. EC, Extracellular 
domain; T, Transmembrane domain; JMD, Juxtamembrane domain; β-catenin, β-catenin 
binding domain; HA, Hemagglutinin tag cloned into the mutants. Image modified from 
(Padmanabhan R, Taneyhill LA, under re-review at J Cell Sci). 
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4.3. Putative endocytosis motif mutants of Cad6B exhibit distinct intracellular  
localization  
To validate that the mutant expression constructs express a full-length protein similar to 
wild-type Cad6B in FlpInwtC6B-HA cells and embryos, immunoblotting was performed 
on lysates prepared from the two mutant cell lines, FlpInwtC6B, empty vector control, and 
13-16ss whole embryos (Fig. 4.2A). Cad6B expressed by embryos and the FlpInLI645AA-
HA, FlpInEED666AAA-HA and FlpInwtC6B-HA cell lines is approximately the same 
molecular weight, indicating that Cad6B-HA protein is synthesized normally and not 
grossly altered by mutations within putative endocytosis motifs (Fig. 4.2A). We noticed, 
however, that the levels of Cad6B-HA expressed by each of these mutant cell lines varied 
compared to cells expressing wtCad6B-HA. We associate this difference with variations 
in the degree of transfection we obtained  for each construct  in CHO cells with respect to 
the percentage of transfected cells expressing the transgene (Fig. 4.2B-D’’’), especially 
























Figure 4.2. Cad6B mutants in FlpInwtC6B-HA cells are expressed at the appropriate 
molecular weight and exhibit varying transfection efficiencies. (A) Immunoblots of Cad6B 
(NT6B) and β-actin with lysates from control cells, 12-16ss embryos, FlpInwtCad6B-HA, 
FlpInLI645AA-HA and FlpInEED666AAA-HA cells. The band at ~100kDa is presumed to be 
a proteolytic product of Cad6B as a result of the activity of unknown endogenous proteases in 
CHO cells. β-actin is shown as an internal loading control. (B-D) 40x images of FlpIn cells 
stably expressing wtCad6B-HA (B-B”), LI645AA-HA (C-C”), and EED666AAA-HA (D-D”) 
constructs and immunostained for NT6B (green) and HA (yellow) (n = 3). Panels represent the 
3D composite of 22-25 Z-stack images (0.25 µm/optical slice) acquired at 63x magnification 







To determine the effects of the mutations on Cad6B distribution, 
immunofluorescence was performed with antibodies to the Cad6B extracellular (NT6B) 
and intracellular (HA) domains, along with an antibody to Na+K+ATPase (Figs. 4.3-4.5). 
As shown in Figs. 4.4 and 4.5, both mutants express Cad6B but they possess different 
localization patterns. Compared to wild-type Cad6B (FlpInwtC6B-HA) (Fig. 4.3A-A’’’, 
B-B’’’, arrows and arrowheads), the LI645AA-HA mutant localizes preferentially to the 
plasma membrane (Fig. 4.4A-A’’’ and B’-B’’’’, arrows). Interestingly, the EED666AAA-
HA mutant exhibits increased presence in the cytoplasm relative to wild-type Cad6B-HA, 
indicating that those mutated residues may modulate Cad6B distribution (Fig. 4.5A-A’’’ 








Figure 4.3. Wild-type Cad6B localizes to the membrane and cytoplasm. FlpInCHO cells stably 
expressing wtCad6B-HA were fixed and immunostained for NT6B (green), HA (red), and 
Na+K+ATPase (purple) (n = 5). (B’-B’’’’) is a higher magnification view of the boxed region in 
(A’’’). Arrows and arrowheads point to co-localization of Cad6B (NT6B), HA and Na+K+ATPase 
at the plasma membrane and in the cytoplasm, respectively. Panels represent the 3D composite of 13 
Z-stack images (0.25 µm/optical slice) acquired at 63x magnification with a confocal microscope. 











Figure 4.4. The Cad6B LI645AA-HA-HA mutant shows increased plasma membrane 
localization. FlpInCHO cells stably expressing the LI645AA-HA Cad6B mutant were fixed and 
immunostained for NT6B (green), HA (red) and Na+K+ATPase (purple) (n = 5). (B’-B’’’’) is a 
higher magnification view of the boxed region in (A’’’). Arrows and arrowheads point to co-
localization of Cad6B (NT6B), HA and Na+K+ATPase at the plasma membrane and in the 
cytoplasm, respectively. Panels represent the 3D composite of 16 Z-stack images (0.25 µm/optical 









Figure 4.5. The Cad6B EED666AAA-HA mutant exhibits enhanced localization to the cytosol. 
FlpInCHO cells stably expressing the EED666AAA-HA mutant were fixed and immunostained for 
NT6B (green), HA (red) and Na+K+ATPase (purple) (n = 5). (B’-B’’’’) is a higher magnification view 
of the boxed region in (A’’’). Arrows and arrowheads point to co-localization of Cad6B (NT6B), HA 
and Na+K+ATPase at the plasma membrane and in the cytoplasm, respectively. Panels represent the 3D 
composite of 25 Z-stack images (0.25 µm/optical slice) acquired at 63x magnification with a confocal 




4.4. Mutation of the EED and LI residues alters the distribution of catenins bound to 
the cytoplasmic domain of Cad6B  
Plasma membrane-localized cadherins are normally bound directly to both p120-catenin 
and β-catenin and indirectly to α-catenin through motifs within their cytoplasmic domains 
(see Literature Review, 1.6.2.3.2.1). To ascertain the effects of mutating the LI and EED 
amino acids on the localization (and thus the Cad6B-bound state) of α-, β- and p120-
catenin, immunofluorescence was performed on the FlpInwtC6B-HA and two mutant cell 
lines using antibodies against the Cad6B extracellular domain (NT6B), β-catenin, α-
catenin, and p120-catenin (Figs. 4.6-4.9). Mutation of the LI motif does not qualitatively 
alter the distribution of α- and p120-catenin (Figs. 4.6C-D’’’ and 4.8 C-D’’’’, respectively), 
as confirmed by the observation that the LI645AA-HA mutant co-localizes with catenins 
on the plasma membrane and in the cytoplasm. Nonetheless, mutation of these residues 
does appear to affect the localization of β-catenin, as it is observed preferentially on the 
membrane in the FlpInLI645AA-HA cells (Fig. 4.7C-D’’’’) compared to wild-type Cad6B-
HA (Fig. 4.7A-B’’’’).  Conversely, mutation of the EED motif qualitatively affects the 
distribution of α- and p120-catenin, but not of β-catenin. β-catenin localization in 
FlpInEED666AA-HA cells is similar to that observed for wild-type Cad6B-HA-expressing 
cells, localizing both to the plasma membrane and the cytoplasm (Figs. 4.7A-B’’’’, E-F’’’’, 
arrows and arrowheads). Although Cad6B (NT6B) and β-catenin co-localize at the plasma 
membrane in the FlpInEED666AAA-HA cells, we also note Cad6B (NT6B)-positive, β-
catenin-negative puncta in the cytoplasm (Fig. 4.7F’’’’, caret), suggesting a loss or 
reduction in this interaction, at least in the cytoplasm. Furthermore, α-catenin in the 
FlpInEED666AAA-HA cells are observed diffusely throughout the cytoplasm and on the 
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plasma membrane, co-localizing all along with the EED666AAA-HA mutant (Fig. 4.6E-
F’’’). The most striking effect of mutating the EED residues is seen with the p120-catenin 
where its observed diffusely throughout the cytoplasm and below the limit of detection by 
this assay on the plasma membrane (Fig. 4.8E-F’’’’). This distribution of p120-catenin is 
in keeping with our hypothesis that mutation of the EED amino acids should alter the ability 








Figure 4.6. Mutation of EED666AAA-HA motif alters the distribution of αE-
catenin. FlpInCHO cells stably expressing wtCad6B-HA (A-B’’’), the LI645AA-HA 
mutant (C-D’”) and the EED666AAA-HA mutant (E-F’”) were fixed and 
immunostained for HA (Cad6B, red) and αE-catenin (αE-cat, green; note: we were 
unable to perform co-immunofluorescence with the Cad6B (NT6B) antibody because it 
is the same isotype as the αE-catenin antibody) (n = 3). (B’-B’’’, D-D’’’ and F-F’’’) are 
higher magnification views of the boxed regions in (A’’), (B’’) and (C’’), respectively. 
Arrows and arrowheads in (B’’’, D’’’ and F’’’) indicate co-localization of Cad6B (HA) 
and αE-catenin at the plasma membrane and in the cytoplasm, respectively. Panels 
represent the 3D composite of 17 (A-B’’’), 17 (C-D’’’), and 15 (D-E’’’) Z-stack images 
(all at 0.25 µm/optical slice) acquired at 63x magnification with a confocal microscope. 











Figure 4.7. β-catenin exhibits enhanced localization to the plasma membrane in 
FlpInLI645AA-HA cells. FlpInCHO cells stably expressing wtCad6B-HA (A-B’’’), the 
LI645AA-HA mutant (C-D’”) and the EED666AAA-HA mutant (E-F’”) were fixed and 
immunostained for Cad6B (NT6B; green), HA (purple), and β-catenin (red) (n = 3). (B’-
B’’’, D-D’’’ and F-F’’’) are higher magnification views of the boxed region in (A’’), 
(B’’) and (C’’), respectively. Arrows and arrowheads in (B’’’, D’’’ and F’’’) indicate co-
localization of Cad6B (NT6B), HA and β-catenin at the plasma membrane and in the 
cytoplasm, respectively. Carets in (F’’’) represent Cad6B-positive, β-catenin-negative 
puncta in FlpInEED666AAA-HA cells, representing either endocytosed Cad6B-HA 
proteins post β-catenin dissociation or proteolytic products of Cad6B. Panels represent 
the 3D composite of 23 (A-B’’’’), 24 (C-D’’’’), and 23 (E-F’’’’) Z-stack images (all at 
















Figure 4.8. p120-catenin exhibits primarily cytosolic distribution in 
FlpInEED666AAA-HA cells. FlpInCHO cells stably expressing wtCad6B-HA (A-B’’’’), 
the LI645AA-HA mutant (C-D’’”) and the EED666AAA-HA mutant (E-F’’”) were fixed 
and immunostained for Cad6B (NT6B; green), HA (red), and p120-catenin (purple) (n = 
3). (B’-B’’’, D-D’’’ and F-F’’’) are higher magnification views of the boxed region in 
(A’’’), (B’’’) and (C’’’), respectively. Arrows and arrowheads in (B’-B’’’’) and (D’-D’’’’) 
indicate co-localization of Cad6B (NT6B), HA and p120-catenin at the plasma membrane 
and in the cytoplasm respectively. Carets in (B’-B’’’’) and (D’-D’’’’) represent Cad6B 
(NT6B)-positive p120-catenin negative puncta. Large patches of fluorescence in (E-F’’’’) 
could either represent the endoplasmic reticulum/golgi or the lysosomes. Panels represent 
the 3D composite of 22 (A-B’’’’), 24 (C-D’’’’) and 21 (E-F’’’’) Z-stack images (0.25 








4.5. The p120-catenin-Cad6B interaction is not affected in the FlpInEED666AAA-HA 
mutant 
The reduced membrane localization of p120-catenin in the FlpInEED666AAA-HA cell 
line suggests an inability of p120-catenin to interact with this mutant form of Cad6B. To 
test this hypothesis, Cad6B was immunoprecipitated from lysates of FlpInwtC6B-HA and 
FlpInEED666AA-HA cells using an antibody to the C terminal HA tag. SDS-PAGE and 
immunoblotting on the immunoprecipitated lysates with the p120-catenin antibody, 
however, revealed no effect on the ability of p120-catenin to interact with the 
EED666AAA-HA Cad6B mutant (Fig. 4.9). CHO cells express two isoforms of p120-
catenin, isoform 1 and isoform 3 (isoform 1 is longer than isoform 3 by 101 amino acids) 
(Wang et al., 2013), and wild-type and mutant Cad6B both interact efficiently with the 
higher molecular weight p120-catenin isoform (Fig. 4.9, left panel). Similarly, p120-
catenin immunoprecipitated equally well from lysates of FlpInwtC6B-HA and 
FlpInEED666AAA-HA cells when the reciprocal experiment was performed (p120-
catenin immunoprecipitation and immunoblotting for HA) (Fig. 4.9, right panel). These 
data demonstrate that although the EED residues of the p120-catenin binding domain in 
Cad6B-HA are not critical for the Cad6B-HA-p120-catenin biochemical interaction, they 















Figure 4.9. The EED mutation does not abrogate the interaction of Cad6B with p120-
catenin. FlpInwtCad6B-HA and EED666AAA-HA cells were lysed and 
immunoprecipitated with an antibody to HA to detect Cad6B followed by immunoblotting 
for p120-catenin (left panel) (n = 1). The converse experiment was performed (p120-
catenin immunoprecipitation and immunoblotting for HA) and is shown on the right (n = 
1). Arrowheads denote full-length Cad6B. Mutation of the EED residues does not appear 




4.6. The Cad6B EED666AAA-HA mutant is deficient in forming stable associations 
with the actin cytoskeleton 
The higher intracellular distribution of Cad6B in the EED666AAA-HA mutant implies that 
this mutant Cad6B might possess a reduced ability to localize to the plasma membrane and 
form intercellular contacts. To investigate this, we analyzed the proportion of Cad6B-HA 
anchored to the actin cytoskeleton, as cadherins dynamically interact with the actin 
cytoskeleton to modulate cell-cell adhesion (see Literature Review, Section 1.6.2.1), and 
any decrease in cytoskeletal association would be a read-out of the amount of functional 
cadherin present on the plasma membrane. To this end, a low percentage TX100-
containing buffer was employed to separate cytoskeleton-associated (TX100-insoluble) 
from cytoplasmic (TX100-soluble) proteins in the FlpInwtC6B-HA and two putative 
endocytosis mutant cell lines, and the separated pools were subjected to SDS-PAGE 
electrophoresis and immunoblotting with the NT6B antibody to note Cad6B distribution 
(Fig. 4.10A). Although possessing enhanced membrane localization (Fig. 4.4B-B”), the 
LI645AA-HA mutant did not show a difference in its Cad6B actin-anchored proportion 
compared to wild-type Cad6B-HA, in line with observation that αE-catenin, which plays 
an important role in anchoring cadherins to the cytoskeleton (Yonemura, 2011), exhibits a 
“wild-type” localization pattern in the FlpInLI645AA-HA cells (Figs. 4.6A-B’’’, C-D’’’). 
With the EED666AAA-HA mutant, however, we observe a statistically significant 
reduction in the proportion of actin-anchored Cad6B (Fig. 4.10B, p < 0.05) compared to 
the LI645AA-HA mutant or wild-type Cad6B-HA, in keeping with our observation that 
αE-catenin is diffusely distributed in the cytoplasm in this mutant (Fig. 4.6E” and F’’’). 
These results corroborate our immunofluorescence data (Fig. 4.5) and substantiate our 
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Figure 4.10. The Cad6B EED666AAA-HA mutant is deficient in forming stable 
associations with the actin cytoskeleton. Equal numbers of FlpInwtC6B, 
FlpInLI645AA-HA and FlpInEED666AAA-HA cells were extracted with a buffer 
containing 0.5% TX100 to separate TX100-soluble and TX100-insoluble fractions, and 
the separated pools were subjected to SDS-PAGE electrophoresis. Immunoblotting was 
performed with the NT6B antibody to identify Cad6B. Sol, TX100-soluble fraction; Insol, 
TX100-insoluble fraction (cytoskeleton-associated). (B) Densitometric ratios of 
insoluble/soluble Cad6B bands evaluated from triplicate blots. Error bars represent ± 
standard error of mean (SEM), and the asterisk denotes statistical significance where the 
confidence intervals do not overlap. Image modified from (Padmanabhan R, Taneyhill 




4.7. The Cad6B EED666AAA-HA mutant undergoes increased internalization in vitro 
In cultured cells, cadherins that are unable to interact with the actin cytoskeleton are rapidly 
endocytosed (Ivanov et al., 2004; Izumi et al., 2004), indicating that the EED666AAA-HA 
mutant may undergo enhanced internalization. To investigate the steady state 
internalization of wild-type Cad6B-HA and the EED666AAA-HA and LI645AA-HA 
mutants, biotinylation assays were performed. Although wild-type-HA and the LI645AA-
HA mutant form of Cad6B do not show significant differences in internalization, the 
EED666AAA-HA mutant undergoes rapid internalization by 60 minutes post-biotinylation 
(Figs. 4.11A and B, p < 0.05), confirming that this motif normally negatively regulates 
Cad6B internalization. Surprisingly, however, the levels of internalized Cad6B in the 
EED666AAA-HA mutant decrease at 180 minutes post-biotinylation (Fig. 4.11B), 

















Figure 4.11. The Cad6B EED666AAA-HA mutant undergoes enhanced 
internalization in biotinylation assays in vitro. (A) FlpInwtC6B-HA, FlpInLI645AA-HA 
and FlpInEED666AAA-HA cells were surface-biotinylated at 4˚C and incubated at 37˚C 
for 0, 60, and 180 minutes. Following glutathione stripping, cells were lysed and 
internalized biotin was immunoprecipitated with streptavidin-agarose beads. 
Immunoprecipitates were subjected to SDS-PAGE electrophoresis followed by 
immunoblotting with the NT6B antibody. Separately, cells were harvested after the initial 
biotinylation step without stripping (Total surface). (B) Graphical representation of 
densitometric ratios of the proportion of internalized Cad6B protein with respect to the total 
surface biotinylated protein (“Total surface”) from triplicate blots. Error bars represent ± 
SEM, and the asterisk denotes a statistically significant difference determined using the 
Fishers LSD test. Image reproduced from (Padmanabhan R, Taneyhill LA, under re-review 
at J Cell Sci). 
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4.8. The Cad6B EED666AAA-HA mutant is inherently unstable in vitro 
The decreased levels of the EED666AAA-HA mutant Cad6B observed 180 minutes post-
biotinylation (Figs. 4.11A and B) denotes that this mutation negatively impacts Cad6B 
stability and may make it more susceptible to degradation. To address this possibility, we 
inhibited de novo protein synthesis through cycloheximide treatment of the wild-type 
Cad6B-HA and mutant cell lines and then analyzed levels of Cad6B protein over time. 
Compared to wild-type Cad6B-HA and the LI645AA-HA mutant, the EED666AAA-HA 
mutant undergoes a rapid and statistically significant reduction in total Cad6B levels, 
particularly by 180 minutes. These results reveal that the EED residues contribute to the 


















Figure 4.12. The EED666AAA-HA mutant is inherently unstable in vitro. (A) 
FlpInwtCad6B-HA, FlpInLI645AA-HA and FlpInEED666AAA-HA cells were treated 
with cycloheximide (CHX) for 0, 3, and 6 hours, lysed and subjected to SDS-PAGE 
electrophoresis. Immunoblotting was performed with the NT6B and β-actin antibodies. 
(B) Graphical representation of the quantification of densitometric ratios of Cad6B/actin 
from triplicate blots. Error bars represent ± SEM, and the asterisks denote a statistically 
significant difference determined using the Fishers LSD test. Image reproduced from 




4.9. Mutations in Cad6B endocytosis motifs do not additionally impact neural crest cell 
EMT  
Given that Cad6B possesses a functional p120-catenin binding motif that negatively 
regulates Cad6B internalization in vitro, we then investigated if Cad6B internalization 
plays a role in neural crest cell EMT and emigration from the neural tube. We hypothesized 
that if Cad6B internalization (potentially through endocytosis) is critical for neural crest 
cell EMT, introduction of the Cad6B EED666AAA-HA mutant (increased Cad6B 
internalization) should enhance EMT by stimulating precocious loss of endogenous (and 
exogenous) Cad6B when compared to wild-type Cad6B-HA overexpression. Although the 
Cad6B dileucine motif mutant (LI645AA-HA) had no significant effects on Cad6B 
internalization in vitro, we surmised that it, too, could have effects on neural crest cell EMT 
when introduced into its native environment in the chick embryo. Initial efforts to express 
these endocytosis mutants in vivo in the absence of endogenous Cad6B (with knockdown 
of endogenous Cad6B mediated by a Cad6B morpholino) proved futile because of the 
mosaic nature of electro-transfection (electroporation) and the inability to successfully 
electroporate cells with both the morpholino and expression construct (Appendix 3). As 
such, wild-type and mutant Cad6B-HA constructs were introduced in the presence of 
endogenous Cad6B in premigratory neural crest cells. Embryos were incubated until EMT 
and early migration stages and then immunostained for FoxD3, a marker of premigratory 
and migratory neural crest cells. The influence of each construct was determined by 
counting the number of FoxD3-positive cells on the electroporated versus the contralateral 




 In agreement with prior work (Coles et al., 2007), we find that expression of wild-
type Cad6B-HA decreases the number of migratory neural crest cells (Fig. 4.13B’’’, arrow; 
fold differences quantified in Fig. 4.14). Expression of the LI645AA-HA mutant, however, 
results in a similar reduction in the number of neural crest cells undergoing EMT when 
compared to wild-type Cad6B (Figs. 4.13C’’’, arrow; 4.14). Surprisingly, expression of the 
EED666AAA-HA mutant failed to rescue neural crest cell EMT, with this construct 
showing a similar general trend on EMT (but not statistically significant) as observed for 
overexpression of wild-type and the LI645AA-HA mutant form of Cad6B (Fig. 4.13D’’’, 
arrow; Fig. 4.14). We also note a general decrease in the number of neural crest cells 
undergoing EMT on either side of the neural tube upon introduction of any form of Cad6B 
when compared to electroporation of the empty vector (Fig. 4.14). This suggests that 
general overexpression of Cad6B could have both cell and non-cell autonomous effects on 













Figure 4.13. Expression of EED666AAA-HA mutant in vivo does not qualitatively 
influence neural crest cell EMT and migration. Empty expression vector (A-A’’’), wild-
type Cad6B (B-B’’’), LI645AA-HA (C-C’’’), or EED666AAA-HA (D-D’’’) expression 
constructs were introduced unilaterally into premigratory neural crest cells, and embryos 
were harvested at stages when neural crest cells are undergoing EMT. Immunostaining 
was performed on whole embryos for RFP (marking electroporated cells), HA (exogenous 
Cad6B) and FoxD3 (marking premigratory and migratory neural crest cells), followed by 
transverse sectioning to reveal effects on neural crest cell EMT. Shown here is one 
representative transverse section of embryos electroporated with the empty vector or the 
Cad6B-HA expression constructs. Arrows in (A’’’) denote normal neural crest migration 
on the electroporated side, and arrows in (B’’’, C’’’, and D’’’) denote a reduction in the 















Figure 4.14. Expression of the EED666AAA-HA mutant in vivo does not quantitatively 
influence neural crest cell EMT and migration. FoxD3-positive migratory neural crest 
cells were counted from at least four serial transverse on the non-electroporated contralateral 
control side (blue) and the side electroporated with the empty vector or the Cad6B constructs 
(red). The counts were averaged and graphically represented here. The number of embryos 
analyzed for each construct is as follows: Vector, 6; wtCad6B-HA, 3; LI645AA-HA, 6; and 
EED666AAA-HA, 6. Error bars represent ± SEM, and asterisk represents a statistically 
significant difference (p<0.05) as determined by the unpaired Student’s t-test (Jhingory et 





Through co-localization studies and antibody feeding assays, we demonstrated that Cad6B 
localizes to the cytoplasm of premigratory cranial neural crest cells through internalization 
(Chapter 3). Substantiating this observation, however, requires biochemical evidence, as 
immunofluorescence-based assays are at best qualitative in nature. To characterize Cad6B 
internalization biochemically, we exploited an in vitro approach using single-copy stable 
cell lines expressing Cad6B-HA mutants due to the technical limitations associated with 
the chick embryo, namely the inability to generate stable Cad6B mutants in the absence of 
endogenous wild-type Cad6B. For this dissertation, we created Cad6B mutants that were 
likely to be deficient in internalization due to the known roles of these mutations in 
affecting endocytosis of other cadherins. As such, any differences in Cad6B internalization 
would imply that the putative endocytosis motifs are in fact functional in mediating Cad6B 
internalization. If Cad6B internalization is critical for neural crest cell EMT, introducing 
mutants with altered endocytosis capabilities should affect neural crest cell EMT in vivo. 
For example, a Cad6B mutant that undergoes enhanced or reduced internalization should 
increase or decrease the number of neural crest cells undergoing EMT, respectively.  
 The plasma membrane localization of cadherins is regulated by distinct endocytosis 
motifs within the cadherin cytoplasmic domain (Xiao et al., 2005; Miyashita and Ozawa, 
2007b; Miyashita and Ozawa, 2007a; Tai et al., 2007; Hong et al., 2010; Ishiyama et al., 
2010; Kowalczyk and Nanes, 2012; Nanes et al., 2012). A comparison of the Cad6B 
cytoplasmic domain sequence to those found in other type II cadherins revealed the 
presence of two conserved motifs that have been shown to regulate endocytosis of other 
cadherins in vitro: A LI (dileucine motif) at position 645 and a DEGGGEED (p120-catenin 
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binding motif) at position 666. These two motifs are important because p120-catenin 
binding masks the LI motif and thus negatively regulates endocytosis. Additional residues 
that could affect Cad6B internalization include a lysine at position 642 (Hong et al., 2010) 
and two generic tyrosine-based endocytosis signals (YDSL, position 738 and YDYL, 
position 765) within the β-catenin-binding domain. Based on the interrelationship between 
the LI645 and DEGGGEED666 residues in the internalization of other cadherins, the 
LI645AA-HA and EED666AAA-HA mutants were created through site-directed 
mutagenesis and expressed stably from a single genomic locus in FlpInCHO cells. The 
generation of Cad6B lysine and tyrosine motif mutants was left for future experimentation. 
 Immunofluorescence experiments revealed that, compared to wild-type Cad6B-
HA, the LI645AA-HA mutant exhibits enhanced localization to the plasma membrane. 
This was corroborated by our observation that β-catenin is primarily observed on the 
plasma membrane in this cell line. The distribution pattern of p120-catenin and α-catenin, 
however, is not perturbed. The lack of a significant difference in the proportion of 
cytoskeleton-bound LI645AA-HA compared to wild-type Cad6B-HA provides 
biochemical evidence to support this more qualitative observation by immunostaining. As 
anticipated, p120-catenin is not localized differently in these mutant cells compared to the 
wild-type Cad6B cell line. In summary, from immunofluorescence observations, the 
mutation of the LI residues appears to only affect localization of β-catenin.  
Contrary to LI645AA-HA, the relative cytoplasmic localization of the 
EED666AAA-HA mutant is higher as compared to wild-type Cad6B-HA, and 
concomitantly exhibits reduced membrane localization. These data indicate that the EED 
residues, which comprise a portion of the p120-catenin binding domain (DEGGGEED), 
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have a functional role in regulating the localization of Cad6B. Indeed, mutation of the EED 
residues causes a re-distribution of α- and p120-catenin, but not of β-catenin, from the 
plasma membrane to the cytoplasm. The persistence of membrane β-catenin in these cells 
(similar to that of wild-type cells) and the reciprocal observation upon mutation of the LI 
residues is quite interesting, and suggests that the LI residues potentially play a role in the 
either the affinity or stability of the Cad6B-β-catenin interaction. The mechanism behind 
the re-distribution of α-catenin to the cytoplasm and the co-localization with 
EED666AAA-HA Cad6B is somewhat perplexing and is in keeping with the fact that the 
molecular basis for the α-catenin-cadherin interaction is still not well understood (Miller 
et al., 2013).  
On the other hand, p120-catenin localizes more diffusely in the cytosol in the 
EED666AAA-HA mutant, with less immunoreactivity observed on the plasma membrane 
and co-localizing with Cad6B, compared to what is observed in the wild-type and 
LI645AA-HA mutant cell lines. The lack of co-localization with Cad6B-HA suggested a 
reduced interaction with the EED666AAA-HA mutant. Surprisingly, immunoprecipitation 
experiments revealed no loss in the ability of p120-catenin to interact with the 
EED666AAA-HA mutant (Fig. 4.9). This is unlike what is observed with E-cadherin 
(Miyashita and Ozawa, 2007a) where there is a complete loss of interaction, and suggests 
that the EED residues in Cad6B-HA are only required for proper localization p120-catenin 
but not its biochemical interaction with Cad6B-HA. A possible explanation is that the 
localization and/or stabilization of p120-catenin on the membrane could be mediated by an 
unknown factor(s) that serves as a scaffold for the creation of the p120-catenin-Cad6B 
interaction. This factor could require the EED residues and the region around it for 
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maintaining the stability of the p120-catenin-Cad6B complex only at the plasma membrane 
but not in the cytoplasm. In this instance, our immunoprecipitation experiments would be 
detecting this cytoplasmic Cad6B-p120-catenin complex. Such an interpretation of our 
results is in keeping with our observation that the EED-HA mutant Cad6B is localized 
predominantly in the cytoplasm. Furthermore, the EED666AAA-HA Cad6B mutant is less 
stable, undergoes enhanced endocytosis, and has impaired interactions with the actin 
cytoskeleton in vitro (see below). These observations collectively suggest that the mutation 
of the EED residues (and its indirect effects on p120-catenin localization) critically affects 
Cad6B function in vitro. Indeed, p120-catenin is a known regulator of cadherin 
endocytosis, performing its function by “masking” the dileucine motif present very near to 
it (Miyashita and Ozawa, 2007a; Ishiyama et al., 2010; Nanes et al., 2012). Dissociation of 
p120-catenin from the cadherin cytoplasmic domain exposes the dileucine motif, which in 
turn is recognized by adaptor proteins of the clathrin-mediated endocytic pathway and 
leads to cadherin endocytosis (Miyashita and Ozawa, 2007a; Ishiyama et al., 2010; Nanes 
et al., 2012). As such, it is likely that the dileucine motif in the EED666AAA-HA Cad6B 
mutant is continuously exposed, thereby causing constitutive and rapid endocytosis of 
plasma membrane Cad6B, as noted for E-cadherin (Xiao et al., 2003b; Miyashita and 
Ozawa, 2007a). These observations could be validated by performing site-directed 
mutagenesis experiments of putative Cad6B-binding sites of p120-catenin and observing 
for changes in Cad6B internalization. Interestingly, we also note Cad6B cytoplasmic 
puncta negative for β-catenin in the FlpInEED666AAA-HA cells, which could be 
internalized Cad6B (NT6B) molecules post-β-catenin dissociation.  
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In addition to preferential localization to the cytoplasm, the EED666AAA-HA 
Cad6B mutant is deficient in forming stable cell-cell adhesive interactions due to the 
decreased proportion of actin-anchored Cad6B. The increased endocytosis of this Cad6B 
mutant could translate into fewer opportunities for the mutant to form stable interactions 
with the actin cytoskeleton, as observed for other cadherins in this in vitro assay (Collinet 
and Lecuit, 2013). Alternatively, association with p120-catenin could be required for 
cadherins to interact with the actin cytoskeleton (Hoshino et al., 2005), such that the 
reduction of p120-catenin binding in this mutant in turn leads to enhanced endocytosis. 
These possibilities are not mutually exclusive and could in fact be occurring 
simultaneously, further augmenting Cad6B endocytosis.  
Although the EED666AAA-HA Cad6B mutant undergoes rapid endocytosis 
initially, the internalized protein levels rapidly drop at 180 minutes post-biotinylation. Such 
results suggest that the absence of these residues may decrease the stability of this 
particular Cad6B mutant protein. In agreement with this, cycloheximide assays 
demonstrate that the EED666AAA-HA Cad6B mutant is less stable compared to both wild-
type Cad6B-HA and the LI645AA-HA mutant (Fig. 4.10). Interestingly, loss of p120-
catenin binding to endogenous cadherins (through expression of dominant negative 
cadherin mutants that function by titrating away p120-catenin) drives endocytosis and 
degradation of these endogenous cadherins (Kintner, 1992; Zhu and Watt, 1996; Nieman 
et al., 1999; Xiao et al., 2003b; Xiao et al., 2003a). Knockdown of p120-catenin similarly 
causes internalization and degradation of E-cadherin, while inhibition of lysosomal 
degradation through chloroquine treatment rescues this loss (Davis et al., 2003). Our work 
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now shows that p120-catenin plays a critical role in regulating the stability and endocytosis 
of another cadherin, Cad6B, in cultured cells.  
 A surprising observation in this study, however, is that the dileucine motif in Cad6B 
plays a minimal role in regulating Cad6B stability or membrane localization. This motif 
(normally masked by p120-catenin) binds several proteins required for clathrin-mediated 
endocytosis (Ishiyama et al., 2010), and thus mutation of this motif was hypothesized to 
negatively affect Cad6B endocytosis. On the contrary, mutation of the LI residues in 
Cad6B-HA does not significantly affect Cad6B internalization or its association with the 
actin cytoskeleton but does affect β-catenin distribution. This is in contrast with what has 
been observed with E-cadherin (Miyashita and Ozawa, 2007b) and N-cadherin (Tai et al., 
2007). A more detailed molecular analysis of this motif in Cad6B provides insight into this 
observation. First, the LI motif, corresponding to the consensus (DE)XXXL(LI) 
(Bonifacino and Traub, 2003), is present in the form of QRKKEPLIIS in Cad6B. The 
existence of acidic residues at position -4 and -5 from the first leucine is critical for the 
endocytosis and targeting of other proteins to the late endosomes or lysosomes (Pond et 
al., 1995; Sandoval et al., 2000; Bonifacino and Traub, 2003; Pandey, 2009). Cad6B 
instead possesses the basic residues arginine and lysine in these positions, and these amino 
acids may provide the reasoning behind the lack of effect on internalization upon mutation 
of the LI residues. Second, the lysine at position 748 of E-cadherin was recently shown to 
control E-cadherin endocytosis in vitro, and complete loss of E-cadherin endocytosis was 
only observed when both the dileucine motif and lysine residue were mutated (Hong et al., 
2010). Because Cad6B has a conserved lysine in a similar position (position 642), mutating 
it along with the LI motif may be necessary to block Cad6B endocytosis. Third, the -5 to -
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8 positions upstream of the LI motif of Cad6B and several other type II cadherins are 
characterized by the presence of several arginine and glutamate residues. The glucose 
transporter GLUT4 similarly has two arginine residues -4 and -5 upstream of its dileucine 
motif (RRTPSLL), and substitution of these arginines with glutamate impairs its 
internalization and sorting to storage compartments (Sandoval et al., 2000). Conversely, 
substitution of the aspartate-glutamate pair (DERAPLI) of the lysosomal membrane 
protein LIMP-II with two arginines also impairs internalization and lysosomal targeting 
(Sandoval et al., 2000). Taken together, these contrasting examples suggest that Cad6B 
internalization may be additionally dependent on unknown residues upstream of its 
dileucine motif. Finally, Cad6B may just possess a different combination of endocytosis 
motifs protected by p120-catenin binding, as observed for VE-cadherin (Nanes et al., 
2012), which lacks the dileucine motif altogether. Instead, the amino acids DEE 
(corresponding to DEG at position 650 in Cad6B) within the core-binding region of p120-
catenin plays the role of the dileucine motif in VE-cadherin (Nanes et al., 2012). Similarly, 
p120-catenin could be masking a different motif in Cad6B and preventing its 
internalization, as our data suggest that mutation of the p120-catenin binding domain 
(EED666AAA-HA mutant) augments Cad6B endocytosis in vitro. Further mutational 
analyses of the region preceding the p120-catenin binding domain of Cad6B will be 
required to accurately identify the region masked by p120-catenin.  
 Although Cad6B possesses YDSL and YDYL motifs (YXXØ consensus) at 
position 738 and 765, respectively, these motifs are unlikely to play a role in Cad6B 
endocytosis because of their distance from the transmembrane domain. Purely endocytic- 
and lysosomal-targeting YXXØ signals are most often situated 10–40 and 6-9 residues 
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from the transmembrane domain, respectively, but not at the C terminus of proteins 
(Bonifacino and Traub, 2003). The YDSL and YDYL motifs of Cad6B are present nearly 
100-140 amino acids away from the transmembrane domain and lie within the putative β-
catenin binding region of Cad6B, suggesting that these residues could also be masked from 
cytosolic adaptor proteins by β-catenin. Nevertheless, considering that these residues are 
conserved across all type II cadherins, novel functions may exist for them in the context of 
cadherin internalization.  
 The role of the LI and EED motif with respect to Cad6B function and localization 
raises interesting questions particularly regarding the ability of these motifs to influence 
neural crest cell EMT in vivo. If Cad6B modulation through internalization is critical for 
neural crest cell EMT, introducing a Cad6B mutant that undergoes enhanced 
internalization (EED666AAA-HA) should result in increased numbers of neural crest cells 
undergoing EMT. Conversely, expressing a mutant with reduced internalization should 
decrease the number of neural crest cells undergoing EMT. Although the LI645AA-HA 
mutant is internalized in a similar fashion to wild-type Cad6B-HA in vitro, we 
hypothesized that this mutant might behave differently in vivo in regulating neural crest 
cell EMT.  Our initial strategy to study the function of these mutants in a Cad6B-depleted 
background proved technically challenging due to the mosaic nature of electroporation 
(Appendix 3), and thus instead these mutants were expressed in the presence of endogenous 
Cad6B. This method has been used previously to successfully study Cad6B function in 
neural crest cells (Coles et al., 2007; Park and Gumbiner, 2010; Park and Gumbiner, 2012).  
 Our experimental observations regarding the effects of Cad6B endocytosis mutants 
on neural crest cell EMT have actually disproved our initial hypotheses (at least when 
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introduced in the presence of endogenous Cad6B). We find that expression of the Cad6B 
EED666AAA-HA or LI645AA-HA mutant does not rescue or further impede cranial 
neural crest cell EMT, respectively. There are several reasons for why are in vivo 
observations are not in complete agreement with what we note in vitro. First, all of the 
constructs were expressed in premigratory cranial neural crest cells possessing endogenous 
Cad6B. As described earlier, expression of cadherin mutants that can compete for p120-
catenin binding leads to the endocytosis of the endogenous cadherin (Davis et al., 2003; 
Xiao et al., 2003b; Xiao et al., 2005). Our in vitro studies revealed that although the p120-
catenin-EED666AAA-HA biochemical interaction is not affected, the localization of p120-
catenin is perturbed, suggesting that p120-catenin can still be recruited to de novo 
synthesized EED666AAA-HA, only to be dissociated rapidly. Moreover, the localization 
of p120-catenin upon expression of the EED666AAA-HA mutant in vivo is unknown, and 
this may or may not replicate what is observed in vitro, as p120-catenin is potentially bound 
by cadherins other than Cad6B in the neural tube (see Literature Review, Section 1.6.2.2 
for cadherins expressed in the neural tube and premigratory neural crest cells). Additional 
experiments are underway to investigate the localization of p120-catenin upon expression 
of wtCad6B-HA and the EED666AAA-HA mutant in order better explain this observation. 
Taken together, constitutive expression of EED666AAA-HA in vivo could be hypothesized 
to only weakly compete for p120-catenin binding at the plasma membrane and thus cause 
no effects on the membrane localization endogenous Cad6B. Nevertheless, since the 
EED666AAA-HA Cad6B mutant occasionally localizes to the plasma membrane both in 
vitro (Fig. 4.5) and in vivo (Fig. 4.13 D-D’’’), these transient localizations to the plasma 
membrane, combined with membrane-bound endogenous Cad6B, could be sufficient to 
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cause an overall reduction in neural crest cell EMT, as seen previously after wild-type 
Cad6B-HA overexpression (Coles et al., 2007). Thus, novel strategies (e.g. CRISPR) that 
can completely knockout endogenous Cad6B in premigratory neural crest cells are required 
in order to fully discern the effects of these Cad6B endocytosis mutants in vivo in the 
absence of any competing endogenous Cad6B.  
In addition, the lack of spatiotemporal control over the expression of the Cad6B-
HA mutant constructs could negatively impact the ability to investigate construct function 
in vivo. Endogenous Cad6B expression in neural crest cells is tightly regulated both 
spatially and temporally (Chapter 1, Section 1.6.2.2), so this must be taken into 
consideration for any experimental manipulations. Although we controlled for the temporal 
expression by harvesting embryos as cranial neural crest cells were undergoing EMT (6 
and 7ss), it is possible that we have not allowed sufficient time for expression and function 
of the mutant constructs. This is due to the fact that we target premigratory neural crest 
cells at the 3ss and then harvest embryos 5-6 hours later when neural crest cells are 
undergoing EMT. Furthermore, the large size of the expression constructs (~10kb) could 
also negatively impact the ability of the DNA to enter cells of the neural tube and thus 
affect electroporation efficiency, as observed in our own experiments (Fig. 4.13). Future 
experiments will include introducing Cad6B mutant constructs earlier, but these assays can 
only be performed after the function of Cad6B at these even earlier embryonic stages has 
been determined (i.e., in wild-type embryos). Methods to introduce cad6B mRNA into 
premigratory neural crest cells could also be a strategy to circumvent this issue. Third, we 
lack the ability to properly control expression of exogenous Cad6B-HA. Endogenous 
cad6B is transcriptionally regulated by the Snail2 repressor (and likely by other 
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transcription factors as well), but the promoter driving exogenous cad6B in our constructs 
lacks any cad6B regulatory elements and is instead constitutively active, as we detect some 
migratory cranial neural crest cells expressing exogenous Cad6B-HA (data not shown). 
Driving the expression of exogenous cad6B and its mutants from a minimal cad6B 
promoter would be one way to overcome this limitation but requires additional work to 
identify these regulatory regions. Finally, our work indicates that Cad6B-HA partially co-
localizes with clathrin in vitro and in vivo, suggestive of a role for clathrin-mediated 
endocytosis in Cad6B internalization (see Chapter 5). Our own studies, however, reveal 
that this pathway may not in fact be the primary mechanism of Cad6B internalization in 
vivo, and that alternative mechanisms are likely functioning. These pathways for 
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Parts of this section was adapted from the following article under re-review at the   
Journal of Cell Science: 
Padmanabhan R, Taneyhill LA (2015). Cadherin-6B undergoes macropinocytosis and 










Cad6B undergoes internalization and possesses a functional p120-catenin binding motif in 
its cytoplasmic domain. Since we were unable to determine the importance of Cad6B 
internalization in neural crest cell EMT through the introduction of endocytosis mutants in 
vivo, we undertook an ex vivo approach, treating neural crest cell explants with chemical 
inhibitors to various internalization pathways. Furthermore, we sought to determine the 
pathway through which Cad6B is internalized, and in doing so identified that Cad6B 
partially co-localizes with clathrin in vitro and in vivo, suggesting that Cad6B is 
endocytosed through the clathrin-mediated pathway. Interestingly, though, we observed 
intracellular puncta positive for Cad6B, p120-catenin and β-catenin in vitro and in vivo, 
indicating that internalization of entire adherens junctions might be occurring through a 
process called macropinocytosis. To test whether clathrin-mediated endocytosis and 
macropinocytosis of Cad6B occur in neural crest cells, pharmacological inhibitors of these 
processes (Dynasore, a dynamin inhibitor, and Latrunculin A and EIPA, both 
macropinocytosis inhibitors) were employed and Cad6B distribution was documented in 
neural crest cell explants. While addition of Latrunculin A results in retention of Cad6B on 
the membrane, addition of EIPA and Dynasore causes the accumulation of large vesicles 
in the cytoplasm of neural crest cells undergoing EMT and starting to migrate. 
Furthermore, although correlative, the reduction in EMT upon inhibition of 
macropinocytosis and clathrin-mediated endocytosis suggested that Cad6B internalization 
through macropinocytosis is critical for neural crest cell EMT. These data suggest that 
Cad6B undergoes macropinocytosis and clathrin-mediated endocytosis through a 




We have demonstrated that Cad6B is internalized and possesses a functional p120-catenin 
binding motif in its cytoplasmic domain, but its mechanism of internalization is still not 
clear. In this chapter, we now investigate the pathway(s) of Cad6B internalization in vitro 
and in vivo and explore the role of this internalization during neural crest EMT. Cadherins 
are known to be internalized through multiple pathways, including clathrin-dependent and 
–independent (e.g., caveolin) endocytosis and macropinocytosis (Le et al., 1999; Akhtar 
and Hotchin, 2001; Paterson et al., 2003; Bryant et al., 2005; Palacios et al., 2005; Xiao et 
al., 2005; Bryant et al., 2007; Toyoshima et al., 2007). Detecting co-localization of Cad6B 
with molecular markers of endosomal compartments would provide insight into pathways 
mediating Cad6B internalization. As mentioned in Chapter 4, however, we faced 
challenges in detecting co-localization of Cad6B with several endogenous (Appendix 1) 
and exogenous (Appendix 2) molecular markers of endosomal compartments in vivo. 
Nonetheless, we were able to detect the co-localization of endogenous clathrin with Cad6B 











5.2. Cad6B co-localizes with clathrin in vitro and in vivo 
To determine the pathway by which Cad6B is internalized and endocytosed, we performed 
immunohistochemistry for Cad6B-HA (NT6B), caveolin-1 and clathrin in our cultured cell 
lines. We note that intracellular Cad6B (NT6B) does not co-localize with caveolin-1 
(Appendix 2, Figs. A2.3 and A2.4), but partially co-localizes with clathrin in vitro (Fig. 
5.1A-A”, arrowheads). This co-localization was corroborated by examining Cad6B-HA 
(NT6B) and clathrin sub-cellular distribution in the LI645AA-HA (Fig. 5B-B”, 
arrowheads) and EED666AAA-HA (Fig. 5C-C”, arrowheads) mutant cell lines. 
Intriguingly, though, all cell lines show some intracellular puncta that are Cad6B(NT6B)-




 Figure 5.1. Cad6B partially co-localizes with clathrin in vitro. FlpIn cells expressing 
wtCad6B-HA (A-A”), LI645AA-HA (B-B”) and EED666AAA-HA (C-C”) constructs were 
fixed, and immunofluorescence was performed for NT6B (green) and clathrin (red) (n = 3 
from each cell line). Arrowheads in (A”, B”, C”) show Cad6B (NT6B) and clathrin co-
localization, and carets point to Cad6B (NT6B) puncta that do not co-localize with clathrin. 
Panels represent the 3D composite of 9 (A-A”), 11 (B-B”), and 11 (C-C”) Z-stack images 
(0.25 µm/optical slice) acquired at 63x magnification with a confocal microscope. Inset 
boxes show the original image at 63x, with the asterisks in (A-C) indicating the location of 
the higher magnification field of view shown in the main panels. Scale bars: 10μm. Image 











To confirm these findings in vivo, embryos at stages where premigratory cranial 
neural crest cells are actively undergoing EMT were dissected, fixed and 
immunofluorescence was performed for Cad6B and clathrin (Fig. 5.2). As observed in 
vitro, Cad6B (NT6B) co-localizes with clathrin in vivo (Fig. 5.2B-B”, arrowheads). Once 
again, though, we note some Cad6B (NT6B)-positive puncta that lack clathrin (Fig. 5.2B”, 
carets). Taken together, these data suggest that Cad6B undergoes clathrin-mediated 
endocytosis in vitro and in vivo as premigratory cranial neural crest cells are undergoing 
EMT. The presence of clathrin-negative, Cad6B (NT6B)-positive puncta, however, is 



















Figure 5.2. Cad6B partially co-localizes with clathrin in vivo. (A-A”) Embryos in which 
neural crest cells are actively undergoing EMT were harvested, fixed and immunostained for 
Cad6B (NT6B; green) and clathrin (red) (n = 5 from 3 embryos). (B-B”) is a higher 
magnification view of the boxed region in (A). Panels represent the 3D composite of 41 Z-stack 
images (0.25 µm/optical slice) acquired at 63x maginification with a confocal microscope. 
Arrowheads in (B”) represent areas of Cad6B (NT6B) and clathrin co-localization, and carets 
indicate Cad6B (NT6B)-positive, clathrin-negative puncta. Scale bars: 10μm. Image reproduced 





5.3. Intracellular Cad6B puncta are at times positive for p120-catenin and β-catenin in 
vitro and in vivo 
Our cell line data revealed that Cad6B (NT6B) puncta co-localize with either p120-catenin 
(Fig. 4.8B’’’’, D’’’’, F’’’’, arrows) or β-catenin (Fig. 4.7B’’’’, D’’’’, and F’’’’, arrows and 
arrowheads). When triple immunostaining was performed for Cad6B (NT6B), p120-
catenin and β-catenin on chick cranial transverse sections, we observe that Cad6B (NT6B)-
positive intracellular puncta occasionally co-localize with both p120-catenin and β-catenin 
in the cytoplasm (Fig. 5.3B’-B’’’’, arrowhead). Nevertheless, we also observe puncta that 
are positive for Cad6B (NT6B) and β-catenin but not p120-catenin (Fig. 5.3D-D’’’’, 
arrowhead). Endocytosis, however, relies upon the removal of the p120-catenin protein, as 
its binding normally serves to inhibit endocytosis, and its loss signals for cadherin 
endocytosis in vitro (Davis et al., 2003; Xiao et al., 2003a; Hoshino et al., 2005). Our in 
vivo co-localization data for Cad6B, β-catenin and p120-catenin suggest that, in some 
instances, whole complexes containing Cad6B and associated catenins are internalized 
rather than individual Cad6B molecules Moreover, considering that Cad6B is 
proteolytically processed by ADAM proteases, it is unlikely that the proteolysed 
extracellular fragment is not released into the explant media, further substantiating the 
likelihood that these NT6B- and p120-catenin-positive immunofluorescence puncta could 
represent full-length Cad6B protein. This process could be occurring through 
macropinocytosis, which involves the internalization of large volumes of plasma 
membrane (Falcone et al., 2006) and has been shown to regulate cadherin levels in vitro 
(Paterson et al., 2003; Bryant et al., 2007; Sharma and Henderson, 2007; Solis et al., 2012). 
Collectively, these results indicate the existence of at least two mechanisms (clathrin-
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mediated endocytosis and macropinocytosis) by which premigratory cranial neural crest 










Figure 5.3. Cad6B-positive cytoplasmic puncta at times co-localize with p120-catenin 
and β-catenin in vivo. Embryos in which neural crest cells are actively undergoing EMT 
were harvested, fixed and immunostained for Cad6B (NT6B; green), β-catenin (red) and 
p120-catenin (purple). (B’-B’’’’) and (D-D’’’’) are higher magnification views of the boxed 
region in (A”’) and (C”’), respectively. The arrow represents membrane-bound Cad6B 
(NT6B), and the arrowhead in (B’-B’’’’) points to a punctum that is also positive for both 
β-catenin and p120-catenin (n = 1). Arrowhead in (D’-D’’’’) points to a Cad6B (NT6B)-
containing intracellular punctum that is positive for Cad6B (NT6B) and β-catenin, but not 
p120-catenin (n = 3 from 3 embryos). Panels represent the 3D composite of 29 (A-B’’’’) 
and 53 (C-D’’’’) Z-stack images (0.25 µm/optical slice) acquired at 63x magnification with 












5.4. Inhibition of dynamin abrogates EMT and leads to the accumulation of Cad6B-
positive intracellular puncta in cranial neural crest cells 
To test these hypothesized mechanisms and elucidate the nature of Cad6B internalization 
in neural crest cells, we pharmacologically inhibited endocytosis and macropinoctyosis in 
neural crest cell explants. We first assessed a role for dynamin, which releases vesicles 
from the plasma membrane during both clathrin-mediated endocytosis and clathrin-
independent mechanisms such as macropinocytosis (Jarrett et al., 2002; Orth et al., 2002; 
Palacios et al., 2002; Cao et al., 2007), by treating explants with Dynasore, a dynamin 
inhibitor (Macia et al., 2006). Our results show that, compared to DMSO-treated control 
explants (Fig. 5.4A-A” and B’-B’’’; arrows indicate membrane staining), inhibition of 
dynamin blocks neural crest cell EMT and migration (observed in 5/5 explants compared 
to 8/8 control explants which underwent EMT and migrated normally; Fig. 5.5B) and leads 
to the accumulation of multiple, large intracellular Cad6B (NT6B)-positive puncta that at 
























Figure 5.4. Addition of Dynasore results in large puncta of Cad6B on the membrane 
and in the cytoplasm. Vehicle (0.5% DMSO, A-A”) (n = 8 explants) and 100μM 
Dynasore (C-C”) (n = 5 explants) were added to the media of explanted cranial dorsal 
neural folds. Explants were then incubated to allow for EMT to occur, fixed and 
immunostained for Cad6B (NT6B; green) and p120-catenin (red). (B’-B’’’) and (D-D’’’) 
are higher magnification views of the boxed region in (A”) and (C”) respectively. Arrows 
and arrowheads represent Cad6B (NT6B) and p120-catenin co-staining at the membrane 
and cytoplasm, respectively. Carets point to Cad6B (NT6B)-positive, p120-catenin-
negative puncta. Panels represent the 3D composite of 39 (A-B’’’) and 66 (C-D’’’) Z-
stack images (0.25 µm/optical slice) acquired at 63x maginification with a confocal 
















Figure 5.5. Inhibition of actin polymerization, dynamin-mediated internalization or 
macropinocytosis abolishes EMT in premigratory cranial neural crest cell explants. 
Vehicle (0.5% DMSO, A; n = 8 explants), 100µM Dynasore (B; n = 5 explants), 30nM 
Latrunculin A (LatA, C; n = 7 explants), or 50µM EIPA (D; n = 7 explants) were added to the 
media of explanted cranial dorsal neural folds. Explants were incubated for 3.5 hours to allow 
for EMT to occur, fixed and imaged under differential interference contrast. Panel (A) represent 
cranial neural crest cells that have undergone EMT and are migrating, as evidence by the 
appearance of cell protrusions (arrows). These cells and protrusions are absent in all types of 




5.5. Cad6B undergoes macropinocytosis in cranial neural crest cells 
To determine whether macropinocytosis mediates internalization of Cad6B and associated 
catenins during neural crest cell EMT, we prevented the formation of macropinosomes 
through two methods. Macropinocytosis is critically dependent on dynamic actin 
polymerization and depolymerization (Mercer and Helenius, 2009) and indeed, we notice 
intense actin polymerization occurring near large Cad6B (NT6B)-positive membrane-
bound punctum (see Fig.5.6B’-B’’’, asterisk), suggestive of a macropinocytic event. We 
inhibited actin polymerization by Latrunculin A (Spector et al., 1983; Mercer and Helenius, 
2009) and investigated its effects on the putative macropinocytosis of Cad6B. Latrunculin 
A treatment negatively affected actin polymerization as evidenced by the marked reduction 
in phalloidin staining (Fig. 5.6C’) compared to DMSO control-treated explants (Fig. 
5.6A’). Importantly, addition of Latrunculin A severely decreased the presence/number of 
Cad6B (NT6B)-containing puncta (Figs. 5.6C-C’’ and D’-D’’’), with the majority of 
Cad6B (NT6B) still localized to the plasma membrane (Fig.5.6 D’-D’’’, arrows), in 
contrast to what was observed with DMSO-treated control explants (Fig. 5.6A”, 
arrowheads). Nonetheless, we did notice some intracellular Cad6B (NT6B) in Latrunculin 
A-treated explants (Fig. 5.6D’’’, arrowheads). Finally, Latrunculin A treatment inhibited 
EMT (in 7/7 explants examined compared to normal EMT and migration observed in 8/8 



















Figure 5.6. Inhibition of actin polymerization results in persistence of Cad6B on the 
plasma membranes of cranial neural crest cells. Vehicle (0.5% DMSO, A-A”; n = 8 
explants) or 30nM Latrunculin A (C-C”; n = 7 explants) were added to the media of 
explanted cranial dorsal neural folds. Explants were then incubated to allow for EMT to 
occur, fixed and immunostained for Cad6B (NT6B; green) and stained with phalloidin (red). 
(B’-B’’’) and (D’-D’’’) are higher magnification views of the boxed region in (A”) and (C”) 
respectively. Arrows represent membrane-localized Cad6B (NT6B), arrowheads point to 
Cad6B (NT6B)-containing puncta, and the asterisk shows a large Cad6B (NT6B)-positive 
punctum with intense actin polymerization occurring near it. Panels represent the 3D 
composite of 37 (A-B’’’) and 124 (C-D’’’) Z-stack images (0.25 µm/optical slice) acquired 
at 63x magnification with a confocal microscope. Scale bars (A-A’’’) and (C-C’’’): 10μm; 








We next tested the sensitivity of Cad6B internalization to the amiloride EIPA, 
which prevents maturation of macropinosomes by lowering sub-membraneous pH and 
inhibiting Rac and Cdc42 activity (Koivusalo et al., 2010) (Figs. 5.7C-C”, D’-D’’’). EIPA 
treatment results in the appearance of multiple, large intracellular Cad6B (NT6B) 
cytoplasmic puncta that co-localize with p120-catenin and also abolishes EMT (Fig. 5.7D’-
D’’’, arrowheads; 7/7 explants show an absence of EMT and migration compared to normal 
EMT and migration in 8/8 DMSO-treated control explants, see Fig. 5.5D). The size of the 
accumulated puncta (1.5-3μm, 18 puncta measured from 5 different explants) in this assay 
is also indicative of macropinocytosis (Swanson, 1989; Hewlett et al., 1994; Schnatwinkel 
et al., 2004). To further corroborate the EIPA data, we specifically inhibited Rac1 through 
the chemical inhibitor NSC23766 and observed that it could partially recapitulate the 














Figure 5.7. Cad6B is internalized as whole adherens junction complexes in 
premigratory cranial neural crest cells. Vehicle (0.5% DMSO, A-A”, duplicated from 
Fig. 5.4, as the experiments were performed on the same day; n = 8 explants) and 50μM 
EIPA (C-C”; n = 7 explants) were added to the media of explanted cranial dorsal neural 
folds. Explants were then incubated to allow for EMT to occur, fixed and immunostained 
for Cad6B (NT6B; green) and p120-catenin (red). (B’-B’’’) and (D-D’’’) are higher 
magnification views of the boxed region in (A”) and (C”) respectively. Arrows and 
arrowheads represent Cad6B (NT6B) and p120-catenin co-staining at the membrane and 
cytoplasm, respectively. Carets point to Cad6B (NT6B)-positive, p120-catenin-negative 
puncta. Panels represent the 3D composite of 39 (A-B’’’) and 48 (C-D’’’) Z-stack images 
(0.25 µm/optical slice) acquired at 63x with a confocal microscope. Scale bars (A-A’’’) and 






A more rigorous examination of p120-catenin localization in explants after 
inhibitor treatment revealed some surprising results. Many of the large Cad6B (NT6B) 
cytoplasmic puncta observed upon Dynasore (Fig. 5.4D’-D’’’, carets) or EIPA (Fig. 5.7D’-
D’’’, carets) were in fact p120-catenin-negative, in contrast to our expectation that these 
putative macropinocytic compartments would possess both Cad6B and p120-catenin as 
internalized whole adherens junctions. To investigate if these observations were perhaps 
due to extraneous effects of these inhibitors, we examined Cad6B (NT6B) and p120-
catenin co-localization in untreated cells, explants and embryos. Indeed, we noticed in 
several instances that Cad6B (NT6B) puncta did not co-localize with p120-catenin in 
untreated cells in vitro (Figs. 4.8 B’’’’, D’’’’, carets), explants (Fig. 5.4 B’’’, carets), and 
embryos in vivo (Fig. 5.3D’’’, arrowheads), implying that they are either endocytic vesicles 
or that p120-catenin dissociates later from the complex post-macropinocytosis. Moreover, 
the large NT6B-positive p120-catenin-negtive puncta are unlikely to be ADAM-mediated 
proteolytic products of Cad6B (the N-terminal extracellular domain) (Schiffmacher et al., 
2014), as the N-terminal fragment generated post proteolysis in an ex vivo system is likely 
released into the explant media. Taken together, our results reveal for the first time that 
Cad6B is internalized during cranial neural crest cell EMT through dynamin-dependent, 
clathrin-mediated endocytosis and macropinocytosis, with the absence of internalization 








Cells dynamically modulate cadherin levels on the plasma membrane through multiple 
mechanisms (Chapter 1, Section 1.6.2.3), and internalization of cadherins is recognized to 
be one important means that is critical for development and disease (reviewed in 
(Kowalczyk and Nanes, 2012)). In premigratory cranial neural crest cells, Cad6B localizes 
to the cytoplasm, pointing to the possibility that it could be internalized (Chapter 3). We 
subsequently identified a functional p120-catenin binding motif in the cytoplasmic domain 
of Cad6B-HA and demonstrated that mutation of critical residues within the core-binding 
region of p120-catenin enhances Cad6B-HA endocytosis and reduces the stability of 
Cad6B-HA (Chapter 4). In this Chapter, we sought to investigate the molecular pathway 
through which Cad6B is internalized, as cadherins are known to removed from the plasma 
membrane through clathrin-dependent and -independent endocytosis and via 
macropinocytosis (Le et al., 1999; Akhtar and Hotchin, 2001; Paterson et al., 2003; Bryant 
et al., 2005; Palacios et al., 2005; Xiao et al., 2005; Bryant et al., 2007; Toyoshima et al., 
2007). We chose a strategy that would not only address this question, but also delineate the 
importance of Cad6B internalization in neural crest EMT. 
Our observation that Cad6B (NT6B) co-localizes with clathrin in vitro and in vivo 
was immediately suggestive of clathrin-mediated endocytosis and is in line with what is 
observed for other cadherins (Le et al., 1999; Xiao et al., 2003b; Ivanov et al., 2004; Izumi 
et al., 2004; Bryant et al., 2005; Gavard and Gutkind, 2006). Retention of Cad6B (NT6B) 
on the plasma membrane and accumulation in large puncta/vesicles upon addition of 
Dynasore, a dynamin inhibitor, also supports this mechanism of internalization. 
Interestingly, however, we noticed several Cad6B (NT6B)-positive, clathrin-negative 
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puncta, indicating that mechanisms other than clathrin-mediated endocytosis could exist to 
remove plasma membrane-bound Cad6B. Furthermore, we noticed that these Cad6B 
(NT6B)-positive puncta were at times immunoreactive for both β-catenin and p120-
catenin. Although internalized cadherins have at times been observed to co-localize with 
β-catenin during endocytosis (Le et al., 1999; Davis et al., 2003; Xiao et al., 2003b; Kam 
and Quaranta, 2009), co-localization with p120-catenin has only been reported by one 
group during macropinocytosis of E-cadherin (Bryant et al., 2007). As discussed in Chapter 
1 (Section 1.6.2.3.2.4), dissociation of p120-catenin and the resulting exposure of the 
cadherin AP2 adaptor protein-binding site (which in many cadherins is the dileucine motif) 
is the classical mechanism by which clathrin mediates endocytosis of cadherins. Indeed, 
our in vitro observations show that p120-catenin masks a critical region of Cad6B-HA, the 
exposure of which causes enhanced internalization of Cad6B-HA, among other effects 
(Chapter 4, Sections 4.3-4.8). Thus, the presence of p120-catenin in large Cad6B (NT6B)-
positive puncta raises the intriguing possibility that Cad6B could be internalized as whole 
adherens junction complexes, independent of the binding state of p120-catenin to Cad6B. 
Such internalization of large volumes of the plasma membrane occurs through a 
mechanism called macropinocytosis (Falcone et al., 2006).  
To corroborate a role for macropinocytosis in reducing surface levels of Cad6B in 
neural crest cells, inhibitors of macropinocytosis were applied to neural crest cell explants 
and effects on Cad6B (NT6B) documented. In explants treated with Latrunculin A, a potent 
inhibitor of actin polymerization that is critical for macropinocytosis (Spector et al., 1983; 
Mercer and Helenius, 2009), we noted a reduction in Cad6B (NT6B) puncta in neural crest 
cells. In addition, treatment of explants with EIPA, another macropinocytosis inhibitor, 
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results in the accumulation of large puncta/vesicles of Cad6B (NT6B) in the cytosol (and 
associated with the membrane) of premigratory and early migratory neural crest cells, 
lending further credence to a role for macropinocytosis in Cad6B (NT6B) internalization. 
Similar large puncta were also noted during Dynasore treatment of explants, implicating 
dynamin in the pinching off of vesicles and/or macropinosomes during Cad6B 
internalization. Moreover, treatment with Dynasore, Latrunculin A, and EIPA all blocked 
neural crest cell EMT and migration in explants, implying that the downregulation of 
Cad6B through endocytosis and macropinocytosis is critical for EMT. Although the 
qualitative effect of inhibitors is drastic i.e. appearance of large Cad6B puncta, a 
quantitative estimate of the difference in the number of Cad6B across treatments is lacking, 
and methods to quantify the number of puncta in composite 3D z-stack images is currently 
being investigated. The use of macropinocytosis to remove cadherins from the plasma 
membrane has only been observed in vitro for E-cadherin molecules not actively engaged 
in cell-cell adhesion (Bryant et al., 2007) and for N-cadherin at the leading edge of 
migratory cells (Sharma and Henderson, 2007). In another study, Solis et al. (2012) 
demonstrated that EGF receptor signaling, modulated by reggies/flottilin proteins, 
promotes E-cadherin macropinocytosis and recycling, thereby regulating cell adhesion 
(Solis et al., 2012). Although noted in vitro, cadherin macropinocytosis has never been 
demonstrated in an in vivo EMT and in any neural crest cell population. As such, our work 
is the first to report the significance of cadherin macropinocytosis and endocytosis during 
neural crest cell EMT. 
 Although treatment with Latrunculin A caused significant retention of Cad6B 
(NT6B) on cellular plasma membranes, we still noticed small puncta of Cad6B (NT6B), 
157 
 
raising questions as to their nature. Dynamic actin polymerization and de-polymerization 
is critical not only for macropinocytosis but also for endocytosis (Mooren et al., 2012), but 
it is less likely that these Cad6B (NT6B)-positive puncta are intracellular endocytic 
structures because we have substantially blocked the actin polymerization required for 
endocytosis. Cadherins in adherens junctions are organized into molecular clusters (Tepass 
and Hartenstein, 1994; Angres et al., 1996; Muller and Wieschaus, 1996; Adams et al., 
1998), and the actin cytoskeleton regulates not only the assembly/disassembly of cadherin 
monomers into clusters but also controls the lateral mobility of these clusters (reviewed in 
(Collinet and Lecuit, 2013)). Interestingly, actin depolymerization does not dissolve 
cadherin clusters but instead affects their lateral mobility along the plasma membrane 
(Cavey et al., 2008). This raises the possibility that the observed puncta in the presence of 
Latrunculin A could actually be membrane clusters of Cad6B (NT6B) that have failed to 
undergo endocytosis or macropinocytosis due to the disruption in the actin cytoskeleton. 
Evidence for this hypothesis is provided by the observation that E-cadherin is organized 
into local clusters before being endocytosed through the clathrin-mediated pathway in 
Drosophila embryos (Levayer et al., 2011). Indeed, closer examination of several such 
puncta in the y-z plane of explants treated with Latrunculin A reveals that they are on the 
cell surface rather than within the cell (data not shown).  
In Chapter 4, we were unable to address the importance of Cad6B endocytosis 
motifs on neural crest cell EMT by expressing Cad6B endocytosis mutants in vivo. To 
demonstrate a correlation between Cad6B internalization and EMT, the effects of inhibitors 
of endocytosis and macropinocytosis on the EMT process were examined using the explant 
assay. Taken together, these experiments provide insights into the requirement for Cad6B 
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endocytosis and macropinocytosis during neural crest cell EMT. The reduction in EMT 
observed upon inhibition of Cad6B (NT6B) internalization through EIPA or Dynasore (and 
NSC23766, data not shown) show that Cad6B macropinocytosis and endocytosis could be 
critical for neural crest cell EMT. However, these chemical inhibitors could have some 
non-specific effects (reviewed in (Ivanov, 2008)). For example, EIPA can induce 
reorganization of F-actin in epithelial cells (Lagana et al., 2000) and alter morphology and 
the intracellular distribution of early and late endosomes in HeLa cells (Fretz et al., 2006). 
On the other hand, Dynasore has been shown to impair cholesterol trafficking and 
transcription of sterol-sensitive genes in HeLa cells and macrophages (Girard et al., 2011), 
and can inhibit caveolar endocytic pathways in some cells (Macia et al., 2006), showing 
that it can have minor effects on internalization pathways besides those that are clathrin-
based.  As such, our results are correlative in nature, and further genetic studies are required 
to establish a role for macropinocytosis and clathrin-mediated endocytosis in the 
internalization of Cad6B. 
Another interesting observation from this study is the localization of p120-catenin 
with respect to Cad6B (NT6B). Although several Cad6B (NT6B)-containing puncta are 
also positive for p120-catenin, many puncta lacked p120-catenin, raising questions as to 
the nature and function of p120-catenin during neural crest cell EMT. As mentioned 
previously, Cad6B (NT6B)-positive, p120-catenin-negative puncta could either be 
endocytic vesicles or those wherein p120-catenin has dissociated later from the complex 
post-macropinocytosis.  This latter ‘late release’ p120-catenin could then perform other 
signaling roles that directly or indirectly impinge upon neural crest cell EMT (see below 
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and (Bellovin et al., 2005; Yanagisawa and Anastasiadis, 2006; Cheung et al., 2010; 
Johnson et al., 2010)). 
The discovery of Cad6B macropinocytosis and endocytosis also begs the question 
as to the factors that stimulate these processes in neural crest cells. Paterson et al. (2003) 
and Sharma and Henderson (2007) have shown a role for the GTPase Arf6 in E-cadherin 
macropinocytosis (Paterson et al., 2003; Sharma and Henderson, 2007). Arf1 is the only 
gene of the Arf family of GTPases that has been analyzed for expression in chick through 
whole mount in situ hybridization, and neural crest cells are devoid of it (GEISHA 
database; http://geisha.arizona.edu/geisha/index.jsp). Future studies are thus required to 
determine if another Arf GTPase member is expressed in premigratory cranial neural crest 
cells that could mediate Cad6B macropinocytosis. Rac1, another classical marker and 
regulator of macropinocytosis, plays a critical role in E-cadherin macropinocytosis in vitro 
(Bryant et al., 2007). Rac1 is expressed in premigratory and migratory cranial neural crest 
cells (Kee et al., 2007), but its function in the head is unknown. Conversely, Rac1 is 
observed only in delaminating and migratory trunk neural crest cells but not premigratory 
trunk neural crest cells (Shoval and Kalcheim, 2012). Proper spatiotemporal expression of 
Rac1 at the leading edge of the cells is critical for trunk neural crest cells to initiate 
migration, as both constitutively active and dominant negative forms of Rac1 inhibit neural 
crest cell emigration (Shoval and Kalcheim, 2012). Indeed, inhibition of Rac1 through 
NSC27366 also results in partial recapitulation of EIPA phenotype (data not shown), 
suggestive of a role of Rac1 in this process. Interestingly, N-cadherin-bound or free p120-
catenin inhibits or promotes Rac1 activity, respectively (Grosheva et al., 2001). Given our 
observation that several Cad6B-postive puncta are negative for p120-catenin, this points to 
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a possible mechanism wherein p120-catenin regulates both Cad6B endocytosis and 
macropinocytosis as well as cell motility through Rac1. Another possible scenario could 
be a reduction in Ca2+ levels in the vicinity of neural crest cells that could directly lead to 
rapid downregulation of Cad6B, as observed with other cadherins (Pokutta et al., 1994). 
Studies performed by McKinney and Kulesa (2012) with a genetically-encoded calcium 
sensor GCaMP3, however, failed to show appreciable change in calcium dynamics in the 
chick midbrain, indicating that such a mechanism is unlikely (McKinney et al., 2012). 
Finally, Solis et al. (2012) demonstrated that the degree of EGF receptor phosphorylation 
stimulated by prion protein and reggies/flottilins in turn regulates E-cadherin 
macropinocytosis (Solis et al., 2012). The expression or function of prion proteins or of the 
reggies/flottilins in neural crest cells is not known at this time. Because neural crest cell 
EMT is regulated by a myriad of hierarchical signaling factors, a detailed analysis is 
therefore required to delineate the precise signals that stimulate Cad6B macropinocytosis 
and endocytosis. 
It is intriguing that cranial neural crest cells employ multiple mechanisms 
(internalization (this work) and proteolysis (Schiffmacher et al., 2014)) to reduce surface 
Cad6B levels en masse during EMT. One possibility is that these mechanisms are used in 
different sub-populations of cranial neural crest cells that exist in the dorsal neural tube 
(Lee et al., 2013; Ridenour et al., 2014). Alternatively, this rapid reduction in Cad6B 
protein may be necessary to release β-catenin and p120-catenin to the cytosol so that they 
can perform signaling functions (i.e., transcription, regulation of Rac1 activity) and/or form 
complexes with other mesenchymal cadherins, such as Cadherin-7 and Cadherin-11 
(Nakagawa and Takeichi, 1995; Chalpe et al., 2010), to mediate neural crest cell migration. 
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Finally, removal of Cad6B from premigratory cranial neural crest cells could be occurring 
simply to eliminate any physical barriers, such as those provided by adherens junctions, 
that initially hold premigratory neural crest cells together prior to their delamination and 
EMT. In summary, we have now demonstrated the existence of a novel macropinocytic 
and endocytic mechanism to removed Cad6B from the plasma membrane of premigratory 
cranial neural crest cells, the disruption of which causes a significant loss of neural crest 
cell EMT and migration. 
 The broader implications of the existence of redundant mechanisms to remove 
proteins from the plasma membrane also beg the question on its evolutionary significance. 
To begin with, it would be interesting to investigate if such a mechanism exists in proto-
vertebrate species with proto-neural crest cells, such as amphioxus, hagfish and lampreys. 
Although they may not possess an equivalent cadherin, investigations could focus on the 
existence of redundant mechanisms of downregulation of proteins in this proto-neural crest 
cell population. Nonetheless, it could be hypothesized that redundant mechanisms to 
regulate multiple proteins apart from cadherins evolved very early during the evolution of 
chordates. As biological systems became complex, redundant mechanisms may have come 
forth through convergent evolution to regulate processes that are critical for organismal 
development. As such, extrapolating from such a possibility points to a situation where loss 
of Cad6B could be critical for neural crest cell EMT. On the other hand, Cad6B could be a 
simple transient factor to segregate premigratory neural crest cells from other cells, and 
once EMT is initiated, the requirement for Cad6B could become unnecessary, prompting 
the cells to remove this protein through multiple mechanisms. Studies examining the 
162 
 
potential functions of the C-terminal and N-terminal ends of Cad6B will provide critical 


















































One of the overarching goals of our lab is to understand the role and mechanism of 
regulation of cellular junction components during cranial neural crest cell EMT. To this 
end, this dissertation aims to understand the molecular mechanisms underlying the 
downregulation of the transmembrane cell adhesion protein Cad6B. Specifically, the 
objective of this dissertation was to investigate if downregulation of Cad6B protein occurs 
through internalization mediated by endocytosis or other processes. The lab previously 
identified ADAM-mediated proteolysis as one means by which Cad6B levels are reduced 
in premigratory cranial neural crest cells, Intrigued by the observation that Cad6B is found 
in intracellular puncta, however, we hypothesized that Cad6B could get internalized in 
addition to being cleaved by proteases. To address this hypothesis, we first generated cell 
lines that stably express Cad6B-HA from a single genomic locus in CHO cells, which lack 
endogenous cadherins. Using these cell lines and embryo sections, we revealed that Cad6B 
(NT6B) is localized to the cytoplasm in vitro and in vivo, suggestive of internalization 
(Chapter 3). Antibody feeding assays were subsequently performed to show that the Cad6B 
(NT6B) puncta are endocytic rather than exocytic in nature. We then negated the possibility 
that addition of Cad6B (NT6B) antibody was stimulating Cad6B internalization by 
modifying the antibody feeding technique to include a low pH wash, which removed any 
Cad6B (NT6B) antibody bound to non-internalized (cell surface) Cad6B protein. Thus in 
Chapter 3 we first established that Cad6B undergoes internalization in premigratory cranial 
neural crest cells and in cultured cells. 
In Chapter 4, we sought to biochemically demonstrate Cad6B internalization in 
vitro and examine its requirement for neural crest cell EMT in vivo through the generation 
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of two Cad6B-HA constructs containing mutations in putative endocytosis motifs. 
Mutation of the LI residues, which form the dileucine motif, had a minimal influence on 
Cad6B-HA internalization, interaction with the actin cytoskeleton and stability, but it did 
affect the localization of β-catenin. In contrast, mutation of the EED residues, which are 
within the putative p120-catenin binding region of Cad6B, enhanced Cad6B-HA 
internalization, decreased its interaction with the actin cytoskeleton and its overall stability, 
and prevented proper localization of both α- and p120-catenin proteins. Although 
suggestive of a reduced interaction with Cad6B-HA, immunoprecipitation experiments 
showed no effects on the ability of the EED666AAA-HA mutant to biochemically interact 
with p120-catenin. We then asked whether the mutants impacted neural crest cell EMT in 
vivo. To this end, we expressed these mutants in premigratory cranial neural crest cells and 
analyzed embryos for effects on neural crest cell EMT. Surprisingly, expression of the 
mutants caused no further effects on neural crest migration as compared with expression 
of wild-type Cad6B-HA. Although it is tempting to conclude that internalization mediated 
by these motifs does not play any role in neural crest cell EMT, we believe that this is not 
the case and that instead the technical limitations associated with our system preclude us 
from evaluating the true effect of these mutants on the EMT process. In summary, our work 
in Chapter 4 allowed us to functionally validate motifs in the cytoplasmic domain of Cad6B 
and demonstrate that the EED motif regulates Cad6B internalization. 
In Chapter 5, we sought to determine the molecular pathway through which Cad6B 
is internalized. We noted partial co-localization of Cad6B (NT6B) with clathrin in vitro 
and in vivo, indicating that Cad6B likely undergoes some degree of clathrin-mediated 
endocytosis. The partial co-localization with clathrin, however, suggested the existence of 
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alternative pathway(s) for internalization of Cad6B. Taking into account our observation 
that Cad6B (NT6B) puncta were also at times positive for p120-catenin, a protein that 
normally dissociates from endocytosed cadherins, we strongly suspected that whole 
membranes containing Cad6B adherens junction complexes were being internalized 
through macropinocytosis, which has been noted in a few instances for E-cadherin in vitro 
(Paterson et al., 2003; Bryant et al., 2007; Solis et al., 2012). We tested this hypothesis by 
chemically inhibiting endocytosis and macropinocytosis in neural crest cell explants and 
analyzing these explants for changes in Cad6B (NT6B) distribution and EMT. Treatment 
with the actin polymerization inhibitor Latrunculin A, a broad spectrum inhibitor of several 
internalization pathways including macropinocytosis, resulted in a near complete loss of 
Cad6B (NT6B) puncta, corresponding with the persistence of plasma membrane-bound 
Cad6B (NT6B), and a loss of EMT. Further investigations with specific inhibitors such as 
Dynasore, a dynamin inhibitor, and EIPA, a macropinocytosis inhibitor, revealed the 
accumulation of large Cad6B (NT6B) puncta characteristic of macropinosomes and the 
absence of EMT. Taken together, we have now demonstrated for the first time that Cad6B 
undergoes internalization through a novel dynamin-dependent macropinocytic and 
clathrin-mediated endocytic pathways, and that this downreguation of Cad6B is critical for 
cranial neural crest cell EMT. 
 
6.2. Significance 
The dissertation has not only advanced our understanding of the molecular regulation of 
neural crest cell EMT but also adds evidence to the existence of uncommon pathways 
regulating cadherin proteins in an in vivo system. Specifically, this study is the first to 
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document the downregulation of a cadherin through macropinocytosis during any in vivo 
EMT and in any neural crest cell population. Earlier studies documented cadherin 
macropinocytosis solely in cell lines and in simulated conditions of cell migration such as 
wound healing assays (Paterson et al., 2003; Bryant et al., 2007; Solis et al., 2012). 
Moreover, by demonstrating a severe loss of neural crest cell EMT upon inhibition of 
macropinocytosis and dynamin-mediated internalization pathways, our work has provided 
a novel link between a cell biological process (Cad6B internalization) and an essential 
physiological outcome in vertebrates (neural crest cell EMT). At the molecular level, this 
dissertation also validates the importance of p120-catenin in regulating cadherin levels on 
cellular plasma membranes. Furthermore, our lab is the first to show the simultaneous 
existence, and importance, of both internalization (this dissertation) and proteolysis 
(Schiffmacher et al., 2014) to reduce levels of a cadherin in vivo. The use of 
macropinocytosis to reduce levels of cell surface cadherins in vivo during EMT now opens 
up interesting questions with respect to the existence and relevance of macropinocytosis in 
pathogenic conditions that rely upon EMT, such as cancer cell metastasis and fibrosis. 
 
6.3. Future Directions 
6.3.1. Coordination of Proteolysis and Internalization of Cad6B 
An important question that remains is the temporal and spatial coordination of ADAM-
mediated proteolysis and endocytic/macropinocytic internalization of Cad6B during neural 
crest cell EMT. Indeed, in the Cad6B antibody feeding assays, we notice puncta that are 
immunoreactive for the C-terminal Cad6B antibody but not for the N-terminal extracellular 
domain Cad6B antibody (Chapter 3, Fig. 3.7B”), suggesting that these could be C-terminal 
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Cad6B fragments generated post-ADAM-proteolysis. To test this requires co-treatment of 
neural crest cell explants with inhibitors of both ADAM proteases (e.g., GM6001, 
Marimastat) and endocytosis/macropinoctyosis (e.g., EIPA, Dynasore) and examination of 
Cad6B distribution. The lack of accumulation of large Cad6B puncta in the presence of 
ADAM inhibitors and EIPA or Dynasore would suggest that proteolytic cleavage is a 
requisite for endocytosis and/or macropinocytosis to occur. Conversely, ADAM-mediated 
proteolytic cleavage could be occurring post-endocytosis or –macropinocytosis. One 
caveat to this approach, however, is that the combinatorial treatment of explants with 
multiple inhibitors could be toxic. A better strategy might instead be to employ a 
combination of both genetic (e.g. CRISPR) and chemical disruption of these 
factors/pathways and evaluation of effects on Cad6B. 
 
6.3.2. The fate of internalized Cad6B 
Although we have demonstrated that Cad6B undergoes internalization through endocytosis 
and macropinocytosis, the fate of internalized Cad6B is still unknown. As described in 
Chapter 1, Section 1.6.2.3.2.1, internalized cadherins can be recycled to the plasma 
membrane or degraded in lysosomes. Since Cad6B is not observed in migratory cranial 
neural crest cells, one hypothesis is that it is likely degraded in lysosomes and/or by the 
proteasome. Inhibitor strategies in neural crest cell explants could be adopted again as 
described above, using agents that disrupt lysosomal or proteasomal activity in the presence 
or absence of endocytosis and macropinocytosis inhibitors, and changes in the distribution 
of Cad6B examined. Retention of Cad6B puncta in the presence of a lysosomal or 
169 
 
proteasomal inhibitor without an endocytosis/macropinocytosis inhibitor would directly 
demonstrate that Cad6B is degraded in lysosomes after internalization. 
 Interestingly, unpublished studies from our lab show that the C-terminal fragment 
of Cad6B that is generated upon Cad6B cleavage plays important roles in modulating 
neural crest cell EMT through transcriptional regulation of genes associated with EMT. 
Once again, it will be interesting to determine the role, if any, of the internalization 
mechanisms described herein during proteolysis and the generation of this soluble C-
terminal Cad6B fragment. In addition, we observed that Cad6B-positive macropinosomes 
were not always positive for p120-catenin, suggesting that these p120-catenin molecules 
could be released and in turn play novel signaling roles to promote EMT. Combinatorial 
chemical inhibition of endocytosis/macropinocytosis and proteolysis/lysosomes will 
provide interesting results and further address these questions.  
 
6.3.3. Molecular mechanisms regulating Cad6B macropinocytosis 
As discussed in Chapter 5, macropinocytosis of cadherins is regulated by multiple factors, 
including Arf6, Rac1 and reggies/flottilins. Each of these molecules could be tested for 
their relevance in Cad6B macropinocytosis through the use of dominant active and 
dominant negative approaches. Indeed, our preliminary data through a chemical inhibitor 
of Rac1 show that it could potentially play a role in this process. A potential issue here, 
though, would be the ability to precisely and consistently target neural crest cells that are 
actively downregulating Cad6B. We hypothesize that expression of dominant active Arf6 
or Rac1 would result in the accumulation of large Cad6B puncta, similar to what is 
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observed in the presence of EIPA. Conversely, expression of dominant negative Arf6 or 
Rac1 would result in inhibition of macropinocytosis and a loss of Cad6B puncta.  
 
6.3.4. Other components of Cad6B-positive macropinosomes 
The observation that whole Cad6B-containing adherens junctions undergo 
macropinocytosis opens up intriguing questions with respect to the composition of these 
Cad6B-positive macropinosomes. Do they contain other components of premigratory 
cranial neural crest cell adherens junctions, such as N- and/or E-cadherin? Our lab has also 
noted that loss of tight junction components is critical for neural crest cell EMT (Wu et al., 
2011; Fishwick et al., 2012), so it would be interesting to determine whether tight junctions 
in premigratory cranial neural crest cells are internalized through similar pathways 
(Bruewer et al., 2005). Immunofluorescence could be performed for the known repertoire 
of cadherins and tight junction proteins expressed in premigratory cranial neural crest cells, 
such as N- and E-cadherin and claudin-1 (Dady et al., 2012; Fishwick et al., 2012), to 
address this question.  
 
6.3.5. Upstream factors stimulating endocytosis and macropinocytosis 
Once the molecular factor(s) controlling Cad6B macropinocytosis have been elucidated, 
the next step would be to determine the upstream signal(s) that stimulates this process. 
Clues to the identify of potential regulators emerge from studies examining the role of 
Annexin A1 in phagosomes during phagocytosis, a process similar to macropinocytosis 
(Patel et al., 2011). Here, the authors showed that Annexin A1 promotes F-actin 
polymerization near phagosomes in the presence of calcium. Furthermore, another 
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Annexin, Annexin A6, promotes clathrin-coated pit assembly by directly binding to the µ 
subunit of the AP2 adaptor protein (Creutz and Snyder, 2005). Interestingly, prior work 
from our lab showed that overexpression and knockdown of Annexin A6 in premigratory 
cranial neural crest cells causes premature loss and persistence of Cad6B, respectively (Wu 
and Taneyhill, 2012). Given our unpublished observations that Wnt regulates Annexin A6, 
and that Snail2 is a Wnt target gene that is upregulated during cranial neural crest cell EMT, 
a mechanism that ultimately results in en masse downregulation of Cad6B can now be 
postulated (i.e., through Snail2 repression of cad6B at the transcriptional level and Cad6B 
protein post-translational proteolysis and internalization, the latter all regulated by Annexin 
A6). This hypothesis could be tested simply by overexpressing Annexin A6 in 
premigratory cranial neural crest cells, explanting premigratory neural crest cells and 
observing whether the number of the Cad6B puncta changes. A potential hurdle to this 
experiment could be the potential rapid downregulation of Cad6B upon overexpression of 
Annexin A6, thereby making it difficult to adequately capture the macropinosomes through 
confocal imaging. Knockdown of Annexin A6 could be employed as an alternative, as in 
this treatment macropinosomes should still form on the membrane but would fail to pinch 
off into the cytoplasm due to lack of F-actin polymerization. As a result, large Cad6B 
puncta may be observed, similar to what was noted after EIPA or Dynasore treatment. 
 
6.3.6. Identification of additional Cad6B endocytosis motifs 
Although we determined that Cad6B possesses a functional p120-catenin binding motif in 
its cytoplasmic domain, we were unable to observe any adverse effects on internalization 
of Cad6B upon mutation of the putative dileucine motif. Moreover, mutating the EED 
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residues also did not cause a complete abrogation of Cad6B-p120-catenin interaction 
biochemically. Considering the fact that loss of p120-catenin binding causes enhanced 
internalization of Cad6B, and that p120-catenin masks the dileucine motif recognized by 
AP2 adaptor proteins of the clathrin-mediated pathway, we can speculate that unknown 
motifs still exist within the region protected by p120-catenin in Cad6B, and that there are 
additional residues important for Cad6B-p120-catenin interaction. Cad6B constructs with 
individual and combinatorial point mutations in the Cad6B cytoplasmic domain must be 
generated and tested for difference in endocytosis to determine the exact motif(s) that is 
responsible for clathrin-mediated endocytosis.  
 
6.3.7. Relevance of Cad6B internalization during neural crest cell EMT at other axial 
levels  
Another question that requires addressing is the validity of these internalization 
mechanisms with respect to the regulation of Cad6B in neural crest cell populations at other 
axial levels, such as in the trunk and hindbrain. As described in Chapter 1, Section 1.6.2.2, 
Cad6B is not downregulated in the trunk but instead persists until early emigration and 
migration of neural crest cells into the mesenchyme (Park and Gumbiner, 2010), and 
migratory hindbrain neural crest cells also express Cad6B (T. Jen and A. Schiffmacher, 
HHMI project, unpublished). Although this suggests that the mechanisms underlying the 
downregulation of Cad6B could be different, our unpublished observations in vivo do 
provide evidence of Cad6B puncta in these other neural crest cell populations. Therefore, 
it is attractive to propose conservation of Cad6B internalization (and perhaps proteolysis) 
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mechanisms in these other neural crest cell populations, albeit with these post-translational 
processes being regulated differently in the hindbrain and trunk than in the crania.  
  
In conclusion, this dissertation reveals that premigratory midbrain neural crest cells of the 
chick embryo downregulate the adherens junction protein Cad6B through a novel and 
uncommon pathway of macropinocytosis, in addition to clathrin-mediated endocytosis, 
and that disruption of these pathways inhibits neural crest cell EMT. This work provides 
important insights into the dynamic regulation of cadherins that is requisite for cell 
migration not only during neural crest cell EMT but also during normal embryonic 
development, tissue repair and pathological conditions. Our approach has direct biological 
relevance because it uses both in vitro and in vivo assays to establish cadherin 
internalization. Importantly, our data also integrate cell biology and physiology by 
revealing how a cellular event, the active down-regulation of a membrane protein, results 
in a physiological event, neural crest cell EMT and migration. Finally, our results urge for 
a critical rethink for how in vivo EMTs occur, including whether such uncommon pathways 












Table A1. Tested antibodies to endosomal markers that do not recognize their cognate 












































Fixation and permeabilization conditions tested: 
1. 4% PFA for 20 minutes at room temperature or overnight at 4˚C. Permeabilization 
with 0.2% TX100 in TBS for 10 minutes at room temperature. 
2. -20˚C 100% MeOH for 10 minutes at -20˚C; no permeabilization. 
3. Ice-cold 5% Acetic Acid/ 95% Ethanol for 10 minutes at 4˚C; no permeabilization. 
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Appendix II: Endosomal marker-fluorescent protein fusions tested in the chick embryo. 
The following constructs (obtained from Dr. Iqbal Hamza) were expressed in the chick 
embryo at trace levels (1μg/μl) along with sub-phenotypic levels of Cad6B-HA in the pCI-
H2B-RFP backbone (0.8 μg/μl), with the following observations noted. Exogenous Cad6B-
HA was introduced because of the challenges faced in detecting endogenous co-
localization events in a small population of neural crest cells that is rapidly downregulating 
Cad6B. 
Table A2. Endosomal marker-fluorescent protein fusions tested in the chick embryo and 
their co-localization with exogenous Cad6B-HA. 
Expression 
construct 
Gene Expression pattern 
Distribution with respect to 
exogenously-expressed Cad6B 
pCLC-YFP Human light chain clathrin Ubiquitous (Fig. A2.1) N/A 
pCaveolin-
GFP 
Dog caveolin-1 Punctate Co-localization (Fig. A2.2) 
pGPI-GFP GPI-GFP 
Ubiquitous on the 
membrane 
Ubiquitious membrane co-
localization with Cad6B 
pEGFP-N2-
Lgp120 
Rat LAMP1 (lysosome) Punctate No co-localization 
pRab4-YFP Dog Rab4 (Early endosome) Ubiquitous N/A 
pRab5-YFP Dog Rab5 (Early endosome) Punctate Co-localization 
pRab7-YFP Dog Rab7 (Late endosome) Ubiquitous N/A 
pRab11-
YFP 
Dog Rab11 (Recycling 
endosome) 
Ubiquitous N/A 




Figure A2.1. Example of expression constructs that exhibit non-specific localization 
in the chick. (A) Sub-phenotypic levels of clathrin-YFP and Cad6B-HA expression 
constructs were introduced into chick premigratory cranial neural crest cells. Embryos 
were incubated to EMT stages, fixed and immunostained for Cad6B, HA, and RFP. (B’-
B’’’’) are higher magnification view of the boxed region in (A), where the exogenous 
constructs are expressed and neural crest cells are delaminating and undergoing EMT. The 
localization of clathrin-YFP is non-specific and thus appears diffuse throughout cells. 
Immunostaining for endogenous clathrin, however, reveals puncta that are at times positive 
for Cad6B in vivo (Figs. 5.1, 5.2). Similar localization patterns were observed for other 
constructs, as listed in Table A1. The images in (B’-B’’’’) represent the 3D composite of 
several Z-stack images acquired with a confocal microscope. Scale bars: 10μm. 
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Exogenous Cad6B-HA co-localized with caveolin1-eGFP in chick delaminating 
cranial neural crest cells (Fig. A2.2), suggesting that Cad6B could be internalized through 
caveolin-mediated endocytosis. Co-localization, however, was not observed in vitro in 
FlpInwtC6B-HA cell lines (Fig. A2.3) or on neural crest cell explants (Fig. A2.4), 
suggesting that the observed co-localization of exogenously-expressed Cad6B-HA and 
caveolin-1 could be due to elevated levels of these proteins (caveolin antibody failed to 



















Figure A2.2. Exogenous Cad6B co-localizes with exogenous caveolin1-eGFP. (A) Sub-
phenotypic levels of caveolin1-GFP and Cad6B-HA expression constructs were introduced 
into chick premigratory cranial neural crest cells. The embryos were incubated to EMT 
stages, fixed and then immunostained for Cad6B, HA and RFP. (B’-B’’’) are higher 
magnification view of the boxed region in (A), where the exogenous constructs are 
expressed and neural crest cells are delaminating and undergoing EMT. Exogenous 
Cad6B-HA partially co-localizes with caveolin1-eGFP (arrows and arrowheads represent 
co-localized and non-co-localized puncta, respectively). The images in (B’-B’’’) represent 







Figure A2.3. Cad6B-HA does not co-localize with endogenous caveolin-1 in 
FlpInwtC6B cells. FlpInwtC6B-HA cells were fixed and immunostained for endogenous 
Cad6B (NT6B; green) and caveolin-1 (red). Carets indicate Cad6B (NT6B) puncta that do 
not co-localize with caveolin-1. Images represent the 3D composite of several Z-stack 
images acquired with a confocal microscope. Inset boxes in (A-A”) show the original 
image at 63x, with the asterisks in (A) indicating the location of the higher magnification 
field of view shown in the main panels. Scale bars: 10μm. Image reproduced from 












Figure A2.4. Cad6B does not co-localize with caveolin-1 in neural crest cell explant 
cultures. (A) Cranial dorsal neural folds possessing premigratory neural crest cells were 
explanted onto chamber slides, allowed to undergo EMT, fixed and immunostained for 
endogenous Cad6B (NT6B; green) and caveolin-1 (red). (B’-B’’’) are higher magnification 
views of the boxed region in (A”). Caveolin-1 in general does not co-localize with Cad6B 
(NT6B) (arrows in A’), but is rarely seen co-localizing (arrowheads in A).  Images 
represent the 3D composite of several Z-stack images acquired with a confocal microscope. 






Appendix III: Mosaic nature of electroporation of the combination of Cad6B 
morpholino and wild-type or endocytosis-mutant Cad6B expression constructs. 
Electroporation of Cad6B morpholinos, along with a wild-type or endocytosis mutant 
Cad6B-HA expression construct, is uneven, and both the number and location of cells 





Figure A3.1. Mosaic nature of electroporation of the combination of Cad6B 
morpholino (MO) and Cad6B-HA expression construct (wild-type or endocytosis 
mutant). 0.5mM Cad6B MO along with 1.5μg/μL pCIH2BRFP-Cad6B-HA or mutant 
Cad6B-HA expression construct was introduced unilaterally into premigratory neural crest 
cells, and embryos were harvested at stages when neural crest cells are undergoing EMT 
and cryosectioned transversely to reveal electroporation efficiency. Shown here are 
representative transverse sections of embryos with varying efficiencies of electroporation, 
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